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Summary.
The ubiquitous human octamer-binding transcription factor, Oct-1, is 
believed to regulate the expression of a number of ubiquitously expressed 
genes. These include genes which are expressed throughout the cell-cycle 
(eg. snRNA genes) and histone H2B genes, whose expression is tightly 
coupled to nuclear DNA synthesis at S-phase of the cell-cycle.
I have isolated and completely sequenced two laevis homologues of 
Oct-1. The high degree of relatedness of the two homologues indicates 
that these are likely to be copies of the same gene, which arose during 
the theoretical genome duplication event in X. laevis evolution.
X. laevis and human Oct-1 display strong evolutionary conservation (85% 
Identity over a stretch of 750 amino acids), which presumably means that 
X. laevis has a similar, if not identical function to human Oct-1. 
Homology between human and laevis does, however, break down shortly 
before the N terminal end, at a point where alternate splicing is known 
to occur in hunan Oct-1 (W. Herr, pers. comn.). The full length X. laevis 
cDNA clone which I have isolated may represent a novel alternately 
spliced form of Oct-1.
Two octamer-binding proteins have been identified (in band shift assays) 
in X. laevis oocyte, embryo and tissue extract. Oct-1, and a second, 
previously unidentified octamer-binding protein which has been termed 
Oct-R, for octamer-related. Oct-1 does not bind to a degenerate octamer 
motif most often seen in X^ laevis H2B promoters. Oct-R binds more 
strongly to this degenerate motif than the consensus motif, but only in 
the context of the H2B promoter, and does not bind either motif in 
another sequence context. This suggests that Oct-R may have a role in 
regulation of H2B transcription, although no direct evidence has been 
obtained.
Since Oct-1 is believed to stimulate the S-phase specific induction of 
histone H2B gene transcription the possibility that Oct-1 binding 
activity is cell-cycle regulated is of interest. X. laevis Oct-1 (and 
Oct-R) binding activity does not appear to be celT^cycle regulated.
Oct-1 and Oct-R are stored in the oocyte (partly in the cytoplasm), in 
an amount equivalent to at least 80 000 somatic cells. Histone protein 
and message are stored in the oocyte as part of the mechanism to provide 
enough histones to keep-up with the high rate of DNA synthesis in early 
Xenopus development. It is possible that histone gene transcription 
factors are stored for the same purpose.
By mutation of the octamer motif in the promoter of a L  laevis histone 
H2B gene promoter I have tentatively concluded that the octamer motif is 
required for the expression of a H2B gene (independently of DNA 
synthesis) in the oocyte. The H2B gene occurs in association with a H2A 
gene, as part of a divergently expressed gene pair. The octamer motif may 
be required for the expression of both H2B and H2A genes. The degenerate 
octamer motif contained in this H2B promoter does not bind efficiently to 
Oct-1 in vitro, but binds well to Oct-R, indirectly suggesting that Oct-R 
is required for the expression of the H2B gene.
A polyclonal antiserum raised against the N terminal domain of X^ laevis 
0ct-l reacts to proteins other than 0ct-l on Western blots of oocyte and 
embryo extract. These proteins, which are antigenically related to the N 
terminal domain of 0ct-l, are entirely located in the cytoplasm of the 
oocyte, and entirely located in the nucleus of somatic cells. These 
proteins are synthesised during oogenesis, and stored in the oocyte in an 
amount equivalent to at least 100 000 somatic cells.
xxiii
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CHAPTER 1: INTRODUCTION.
1.1 The Octamer Paradox.
The octamer motif vas first shown to be a transcriptional 
control element in the immunoglobulin kappa chain promoter 
(Falkner and Zachau (1984)). The octamer motif (ATTTGCAT) 
or its inverse complement was subsequently recognised as a 
conserved promoter/enhancer sequence element involved in 
the regulation of a range of genes with diverse patterns of 
expression. These genes include immunoglobulin heavy and 
light chain genes (the expression of which is restricted to 
B lymphocytes), U SnRNA genes (ubiquitously expressed) and 
histone H2B genes (ubiquitously expressed at S-phase of the 
cell-cycle). The octamer motif associated with these genes 
was shown to bind a common factor (Sive and Roeder (1986)). 
Following this there was an explosion of interest in how a 
the same motif, binding a common factor was a able to 
specify diverse patterns of gene expression. Prior to 
recognising the octamer motif as important the accepted 
model was that the DNA binding domain of a transcription 
factor conferred the specificity of transcriptional 
activation by attaching the activation domain to a 
particular promoter. This model cannot explain how a common 
promoter element is able to regulate diversely expressed 
genes. The 'octamer paradox' has been partially resolved by 
the identification of several factors which bind the 
octamer motifs associated with these genes.
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In the few years since their discovery, octamer-binding 
transcription factors have probably become the 
transcription factors about which most is known. Properties 
which have been investigated for the octamer-binding 
transcription factors, are applicable to other factors. 
These include regulation of diversely expressed genes (also 
seen with, for example, NF-kB which regulates 
immunoglobulin genes and a variety of genes in non-B cells; 
see Lenardo and Baltimore (1989)), flexible binding site 
requirements (also seen with, for example, NF-kB and 
CREB/ATF; see Lenardo and Baltimore (1989), Jones et al
(1988)), and occurrence as a family of proteins binding to 
the same sites (also seen with, for example, fos/jun and 
CREB/ATF; see Ziff (1990)).
Following the cloning octamer-binding transcription 
factors it became apparent that that these proteins contain 
homeoboxes. The homeobox was identified as a conserved 
region between Drosophila homeotic proteins (Gehring
(1987)). Mutations in homeotic genes transform certain 
parts, or an entire body segment into the corresponding 
structures of another body segment. Since homeobox genes 
have been cloned largely by classical genetic analysis or 
by homology to other homeobox genes, the target genes of 
these putative transcription factors are much less well 
defined than the targets of octamer-binding transcription 
factors. A study of octamer-binding transcription factors 
will no doubt provide an insight as to how homeobox genes
2
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in general regulate transcription and thereby specify 
segmental identity. It is becoming apparent that several 
Drosophila homeobox proteins bind to common sites (reviewed 
in Biggin and Tijan (1989)), and features discovered for 
the octamer-binding transcription factors, such as 
interaction with other proteins via specific residues in 
the homeobox, may be applicable to the mechanisms by which 
homeobox proteins in general differentially activate 
transcription through common binding sites.
This section describes the genes associated with the 
octamer motif, and their diverse patterns of gene 
expression for which the octamer motif is necessary. As 
already noted, the 'octamer paradox' has been partially 
resolved by the identification of several factors (using 
band shift assays) which bind to the octamer motifs 
associated with these genes. Here, I describe binding 
studies on the best characterised octamer-binding proteins 
(Oct-1 and Oct-2A/Oct-2B) using crude extracts and part- 
purified octamer binding proteins in relation to the 
expression of these genes. Studies on the differential 
abilities of Oct-1 and Oct-2 (including cloned Oct-1 and 
Oct-2) to activate transcription will be discussed in more 
detail in later sections, as will studies on other octamer 
binding proteins.
1.1.1 The octamer motif and immunoglobulin gene expression.
Transcription of immunoglobulin genes is both tissue
3
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specific (in B lymphocytes) and developmental stage 
specific (lower levels of expression in early B cell 
development). The transcription of immunoglobulin genes is 
controlled by both promoter and enhancer (downstream of the 
promoter, within introns) sequence elements, which contain 
a complex array of functionally active trans-acting factor 
binding sites (for recent review see Calame (1989)).
Octamer motifs occur within the heavy chain gene (IgH) 
promoter, the IgH enhancer, the kappa light chain gene 
(IgK) promoter, and the IgK enhancer (a non-consensus 
octamer) (Calame (1989), Currie and Roeder (1989)). An 
extensive series of transfection studies (carried out by 
numerous groups) using constructs containing Ig 
promoters/enhancers with normal and mutated octamer motifs 
have examined the role of the octamer motif in Ig 
transcription. The octamer motif in Ig promoters is 
absolutely required for gene expression (Eaton and Calame
(1987), Falkner and Zachau (1984)) and deletion of the 
octamer motif within the IgH enhancer reduces gene 
expression (Gerster e_t al^  (1987), Lenardo ej^  a_l (1987)).
The octamer is also a determinant of the B cell specific 
expression of Ig genes. Six copies of the IgH enhancer 
octamer downstream of the /8-globin gene are a B cell 
specific enhancer (Gerster et al (1987)) and synthetic 
octamer motifs inserted into the renin gene promoter (which 
is normally expressed only in highly specialised tissues) 
linked to the y8-globin TATA box create a high activity
- 4 -
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lymphoid specific promoter (Dreyfus £t al^  (1987)), as do 
octamer oligonucleotides upstream of the £-globin TATA box 
(Wirth et al (1987)).
A variety of proteins binding to the octamer motif have 
been identified using band shift assays. The best 
characterised octamer-binding proteins are Oct-1 (Singh 
et al (1986), Landolfi e£ j»l (1986), Gerster e_t ¿1 (1987), 
Fletcher e£ al (1987) - also known as OTF-1, 0BP100, NFA1 
and NFIII) and 0ct-2A (Landolfi et al^  (1986), Gerster et al
(1987) , Staudt et al (1986), Scheidereit et al (1987) - 
also known as OTF-2, NFA2, IgNFA), which bind 
indistinguishably to the octamer motif. Oct-1 has been 
found in all cell types tested, and consequently implicated 
in the regulation of ubiquitously expressed octamer- 
containing genes. 0ct-2A is predominantly expressed in 
lymphoid tissues (expression is also detected in the 
central nervous system, and other tissues), and is 
consequently implicated in the regulation of Ig genes. A 
second lymphoid specific octamer-binding protein has been 
identified (0ct-2B) (Gerster e£ a_l (1987), Schreiber et al
(1988) ) by band shift assays. 0ct-2A/0ct-2B have 
subsequently been shown to be derived from the same gene by 
differential splicing (Hatzopoulos et al (1990)). 0ct-2A 
itself may consist of three protein species (Scheidereit
e^ al^  (1987)). Subsequent labelling of cells transfected 
with cloned Oct-2 with ^ S  and has shown that different
phosphorylated forms of 0ct-2A exist (Tanaka and Herr
- 5 -
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(1990)), this may explain the multiple forms of 0ct-2A 
identified by purification of the protein. The observation 
that bacterial lipopolysaccharide, which activates 
immunoglobulin expression in B cell lines, induces Oct-2 
(but not Oct-1) binding activity (Staudt et al (1986)) adds 
weight to the theory that Oct-2 is involved in Ig gene 
transcription.
The binding patterns of extract from lymphoid and HeLa 
cells to octamer-containing DNA fragments originally 
described did not always consist simply of three bands 
(Oct-1, 0ct-2A, 0ct-2B) probably because the original band 
shift probes were restriction fragments with other binding 
sites (particularly Landolfi e_t aJL (1986), whose probe 
contained an heptamer motif, not then recognised as an 
octamer binding site - see later), and because some groups 
did not detect Oct-2B in their extracts (probably a 
technical problem).
The heptamer motif is a conserved sequence element 
adjacent to the octamer in the IgH promoter (Eaton and 
Calame (1987)), which contributes to the activity of the 
promoter. Both Oct-1 and 0ct-2A bind to the heptamer motif, 
but only when the intact octamer motif is present and 
occupied (Landolfi et al (1988), Poellinger and Roeder
(1989)). Binding studies with cloned 0ct-2A have shown that 
the same region of 0ct-2A is responsible for binding to the 
octamer and the heptamer (a highly degenerate octamer 
motif) (LeBowitz ejt al (1989)). 0ct-2B also binds in a
\
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similar cooperative fashion (Kemler e£ al (1989)). This 
feature may have a role in the activation of IgH genes 
before Igk genes. Pre B cell lines have been shown to 
contain less 0ct-2A (Staudt et_ £l (1988)), and the 
cooperative binding may favour the activation of IgH in the 
presence of low levels of 0ct-2A.
There is no simple relationship between Ig expression and 
Oct-2 expression. Oct-2 expression is detected (at lower 
levels) in cells which do not express Ig genes (see section 
1.3.1). The role of Oct-2 in cells not expressing Ig genes 
is not clear. Also, IgH expression occurs in cell lines 
which do not express Oct-2 (Cockerill and Klinken (1990)). 
This serves to point to the involvement of other factors in 
the control of Ig gene expression.
Another aspect of Ig gene expression is extinction in 
hybrid cell fusions. Genes activated by the IgH enhancer 
are inactivated on the fusion of B cells with a T cell 
lymphoma cell line. Likewise, genes activated by a 
multimerised octamer (which is a B cell specific enhancer) 
are inactivated. This does not correspond to the loss of 
0ct-2 binding activity (Yu e_t al (1989)). Inactivation is 
dominant to activation by the SVAO enhancer, and so 
possibly not due to the loss of an IgH enhancer 
transactivator. This suggests that T cells contain a 
negative regulator, which associates with the octamer 
motif. There is other evidence of negative regulators 
acting via the octamer motif (Lenardo e £  a^. (1989)). An
- 7 -
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octamer-containing fragment from the IgH enhancer is active 
in non-lymphoid cells, but inactive in the F9 (embryonal 
carcinoma) cell line. However, mutation in the octamer 
renders the fragment an active enhancer. An F9 specific 
octamer binding activity (NFA-3) has been detected, and is 
a candidate for the negative regulator. However extinction 
of the Igk enhancer on fusion of a myeloma cell line with a 
fibroblast cell line is associated with decreased Oct-2 
binding activity (and message) (Bergman eJL al. (1990)). 
Similarly, B cells stably transfected with a construct 
containing the Igk promoter upstream of a y^-globin reporter 
gene show extinction of the reporter gene on fusion with a 
fibroblast cell line (Junker et al (1990)). This extinction 
is dependent on the octamer motif (if replaced by NF1 or 
Spl binding sites there is no extinction). The extinction 
is overcome by transfection with cloned 0ct-2A, and 
extinction is associated with the loss of 0ct-2A/B message 
and protein.
1.1.2 The octamer motif and histone H2B gene expression.
The major class of histone genes in eukaryotes is 
replication dependent. Biosynthesis is closely linked to 
nuclear DNA synthesis at S-phase of the cell-cycle. A 
subclass of histone genes show a low level of constitutive 
expression. The regulation of the reiterated replication- 
dependent histone genes occurs at post transcriptional 
(control of mRNA stability, and regulation of 3' end
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formation) and transcriptional levels (for review see 
Schumperli (1988)). The transcriptional regulation of 
histone subtypes in higher eukaryotes seems to depend on 
subtype-specific promoter elements. As I will describe in 
more detail below, H2B genes have an octamer motif in the 
promoter required for the S-phase stimulation of 
transcription. HI genes have a subtype-specific consensus 
element, shown by mutational analysis to be required for 
the S-phase specific stimulation of Hi expression in 
transfected HeLa cells (Dalton and Wells (1988)). The level 
of a factor binding to this element is increased at S-phase 
of the cell-cycle (Dalton and Wells (1988A)). The 
arrangement of cis-acting sites in H4 genes is much more 
complex (see Dailey et al (1988) and references therein), 
but a subtype-specific consensus element has been 
identified and a binding factor purified. It is not clear 
from any mutational analysis that this element is required 
for the S-phase specific stimulation of transcription in 
vivo, but this factor is able to activate transcription 
from promoters containing the consensus element _iii v i t r o .
No clear consensus element has been described for histone 
H3 promoters, but sequences required for the S-phase 
specific stimulation of transcription of a hamster H3 gene 
have been identified, and factors binding to these 
sequences show enhanced levels at S-phase of the cell-cycle 
(Artishevsky et al^  (1987)).
Another aspect of histone gene regulation is the
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The structure of histone H2B gene promoters.
Human, chicken and X_j_ laevis histone H2B gene promoters are 
illustrated schematically (see LaBella et al^  (1988), Sturm 
et aJL (1988), Aldridge (1986)). In chiclcen and X. laevis 
"tHe H2B gene generally occurs as a divergently expressed 
gene pair in association with a H2A gene. The boxes 
indicate the coding region for each gene, and the arrows 
the direction of transcription. CCAAT boxes, TATAA boxes 
and H2B boxes (with core octamer) are illustrated, as are 
two sequence motifs (direct repeats and hexamer) specific 
to the human H2B promoter. Numbers refer to the approximate 
position relative to the H2B transcription start site.
Figure 1.
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coordinate expression at S-phase of the cell-cycle. If 
subtype-specific elements are responsible for the S-phase 
specific stimulation of transcription, there must be a 
common mechanism for the expression/modification of binding 
factors (including Oct-1, if it regulates histone H2B 
genes). Histone genes are multicopy, and occur in clusters. 
In birds and mammals the clusters are 'randomly' organised, 
but in amphibians and lower eukaryotes the histone genes 
are generally organised into quintets of the 5 subtypes, 
and in some cases the quintets are strictly ordered (for 
review see Old and Woodland (1984)). The quintet 
organisation was once thought to have some regulatory 
significance (perhaps in coordinate control), but there is 
no evidence for this. Instead, the quintet organisation may 
have an evolutionary significance associated with the 
pressure to maintain equal numbers of histone gene subtypes 
on multiplication.
The structure of typical human, chicken and Xenopus laevis 
histone H2B gene promoters is illustrated in figure 1. In 
chicken and Xenopus laevis H2B genes generally occur 
associated with H2A genes as part of a divergently 
expressed gene pair. An octamer motif occurs in the H2B 
gene promoter, as the core of a longer consensus sequence 
known as the H2B box.
Transfection studies with reporter constructs containing a 
wild-type, and mutations of a, human histone H2B gene 
promoter have revealed the following facts (LaBella e^ al
- 10 -
A sequence comparison of H2B boxes.
H2B boxes from X. laevis. chicken, mouse and human H2B gene 
promoters are aTTgned. A species consensus sequence is 
determined for laevis and chicken, since the sequence of 
several H2B promoters is available. Beneath the consensus 
sequence the number of times a particular base occurs is 
shown. Making the assumption that the single mouse and 
human sequences available are representative, an overall 
consensus is determined from these sequences and the 
chicken and X^ _ laevis consensus sequences. Sequences are 
from LaBella et al (T988), Sturm et al (1988), Perry et al^  
(1985), Moorman et al (1982), Wells’ TT986), Zhong et aT 
(1983) and AldriHge“ Cl986).
Figure 2.
H2B BOX
SPECIES CLONE
X. laevis X1HW23
X1HW11
X1H1
X1HW8
X1H3
XlHhil
X1HW7
X1HW28
CONSENSUS 
OUT OF 8
Chicken pCH3.3E
PCH22.0B
pCH3.5E
pCHll.OEL
pCHll.OER
CHI-10
CONSENSUS 
OUT OF 6
Human pHh4c
Mouse pMH2B
OVERALL CONSENSUS 
OUT OF 4
OCTAMER
CTGCCTC GTTTGCAT GGGA 
CTGCCTC GTTTGCAT GGGA 
CTGCCTC GTTTGCAT GGGA 
CAGCCTC GTTTGCAT GCGA 
GCCAGTG CTTTACAT GGGA 
CTGCCTT ATTTGCAT GGGA 
CTACCTT ATTTGCAT GGGA 
CTGCCTT ATTTGCAT GGGA
CTGCCTC GTTTGCAT GGGA 
7667784 48887888 8788
GCTTCTC ATTTGCAT AGAG 
TCTCCTA ATTTGCAT ACCG 
GCTGCTG CTTTGCAT AGCG 
GCTGCTG CTTTGCAT AGCG 
GAACCTA ATCTGCAT ACAG 
CCTCTGT ATTTGCAT AACA
GCTCCTN ATTTGCAT AGCG 
445355- 46566666 6345
TCACCTT ATTTGCAT AACG
GCTTGAC GTTTGCAG ACTC
GCTCCTC ¿TTTGCAT AGGC 
2323332 24444443 3222
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(1988)). The direct repeats, hexaraer and CCAAT box can all 
be deleted without affecting the stimulation of 
transcription on entry into S-phase of the cell-cycle 
(which is normally approximately 5 fold). Mutation of the 
octamer, however, completely abolishes this stimulation.
The direct repeats and CCAAT box are required for both 
basal and S-phase levels of expression. Mutation/deletion 
of these elements gives a lower basal activity, which is 
stimulated approximately 5-fold at S-phase, giving a lower 
S-phase level of activity. The octamer is not required for 
basal expression. The conserved hexamer (which makes a 
small contribution to expression in in vitro assays (see 
Sive e£ al (1986)) has no effect on expression in these 
transfection assays.
The octamer motif has been shown to be required for the 
steady state levels of chicken H2B and H2A transcription in 
transfected cells (Sturm et al (1988)). Here the genes 
occur as a divergently expressed pair, and octamer 
mutations decrease the expression of both genes. Separation 
of the two genes reduces expression of both genes more than 
the octamer mutation, and deletion of the CCAAT box most 
proximal to the H2B gene decreases expression of both, 
genes. Consequently the genes may have other promoter 
elements in common.
As already noted, in H2B gene promoters the octamer occurs 
as the core of a longer consensus sequence, known as the 
H2B box (see figure 2, sequences from LaBella e £  al_ (1988),
- 11 -
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Sturm al^  (1988), Perry <^ t al^ (1985), Moorman et al 
(1982), Wells (1986), Zhong et al (1983), Aldridge (1986)). 
The H2B box is always referred to as being conserved 
between species. The octamer (ATTTGCAT)is well conserved 
between H2B promoters within a particular species and 
between species, although degenerate octamer motifs occur. 
The sequence GTTTGCAT is the most common degenerate octamer 
motif, and GTTTGCAT is the most common octamer motif in 
Xenopus laevis histone H2B gene promoters. However, 
conservation of sequences flanking the octamer is most 
striking between genes within a particular species. This is 
particularly true for Xenopus laevis. where strong 
conservation is seen over a stretch of 19 bases. 
Conservation of sequences flanking the octamer between 
species is, however, not extensive. In figure 2, Xz. laevis 
(from 8 sequences) and chicken (from 6 sequences) H2B box 
consensus sequences have been determined. These sequences 
are not well matched outside the octamer, and do not match 
well to the human and mouse H2B boxes outside the octamer. 
Only one human and one mouse H2B box sequence is available, 
and making the assumption that these sequences are 
representative, an overall consensus from these sequences 
and the chicken and X^_ laevis consensus sequences is shown 
in figure 2.
Human (Sive and Roeder (1986)), hamster (Ito et al
(1989)), and chicken (Dalton and Wells (1988A)) Oct-1 have 
been shown to bind to the H2B octamer, and I have shown
- 12 -
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that Xenopus laevis Oct-1 binds to the H2B octamer. A 
simple model for the S-phase specific stimulation of H2B 
transcription is that the ubiquitous octamer binding factor 
(Oct-1) is the transactivator responsible for activation, 
and that levels of binding activity are enhanced at S-phase 
of the cell-cycle. The data concerning the cell-cycle 
regulation of Oct-1 binding activity are contradictory (and 
will be discussed in more detail later). Briefly, there is 
no evidence that in human cell lines Oct-1 binding activity 
is cell-cycle regulated. In avian cells Oct-1 binding 
activity does not vary through the cell-cycle (Dalton £t al 
(1988A)), whereas in the same cells the factor binding to 
the HI subtype-specific consensus element displays elevated 
levels at S-phase of the cell-cycle. Perhaps this is to be 
expected since Oct-1 is also implicated in the control of 
ubiquitously expressed genes which are not cell-cycle 
regulated (eg. snRNA). Cell-cycle regulated modification of 
Oct-1, or interaction with other factors could account for 
S-phase specific stimulation of H2B genes by Oct-1 
(discussed in more detail later). However, in hamster 
cells, the level of Oct-1 binding activity is elevated at 
S-phase of the cell-cycle (Ito e£ al (1989)).
1.1.3 The octamer motif and snRNA gene expression.
The transcriptional control elements of U snRNA genes are 
distinct from other RNA polymerase II transcribed genes 
(for review see Parry e_t ¿1 (1989)). The genes have no TATA
- 13 -
Introduction
box, but a PSE (proximal sequence element) which serves a 
similar purpose, being necessary for transcription and 
specifying the transcriptional initiation site. Upstream of 
the PSE is an enhancer element, the DSE (distal sequence 
element). The DSE contains octamer motif(s) in association 
with auxiliary binding sites. Deletion of the octamer- 
containing DSE eliminates snRNA expression, which can be 
partially restored by replacement of the DSE with an 
octamer motif (Parry et al (1989), Mattaj e£ ¿1 (1985)). 
Related experiments will be discussed in much more detail 
later. Since the octamer motif is important for U snRNA 
expression, and the genes are generally ubiquitously 
expressed, Oct-1 is thought to be the transcriptional 
regulator.
The U2 snRNA octamer is the consensus octamer (ATTTGCAT), 
which has been shown to bind Oct-1 and Oct-2. The human, 
rat and chicken U1 snRNA genes have a degenerate (but 
conserved) octamer motif (AT£TACAT) (Kemp and Latchman 
(1988)). The same is true for the U3 snRNA octamer, 
although the octamer is again distinct (ATTAGCAT). Most 
snRNA genes are believed to be ubiquitously expressed. 
However, developmentally regulated U1 and U4 snRNA genes 
occur in X enopus. and the U1 genes have distinct octamer 
motifs (Krol et al (1985), Lund and Dahlberg (1987)).
U6 snRNA genes are transcribed by RNA polymerase II and 
III. Downstream of the DSE and PSE the U6 promoter contains 
a sequence resembling the pol II TATA box. This sequence
- 14 -
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element is required for pol III transcription (Parry e_t al_
(1989)). Pol III transcripts are functional, but pol II 
transcripts are of uncertain significance. Co-injection of 
the U2 DSE with the U6 gene into Xenopus oocytes diminishes 
U6 transcription (Carbon et al (1987)). This competition 
effect can be relieved by mutations in the U2 DSE octamer 
motif. Consequently, U2 and U6 DSE's seem to bind a common 
oocyte octamer factor required for the pol Ill-dependent 
transcription of U6 snRNA genes.
1.1.A The SV40 enhancer contains an octamer motif.
Mutational analysis of the simian virus AO (SV40) enhancer 
has shown that it is composed of multiple sequence elements 
which act synergistically to generate enhancer activity 
(for review see Jones et al (1988)). The sph motif is one 
such sequence element. Two direct repeat copies of the sph 
motif occur, and at the junction of these copies an octamer 
motif is present. The octamer motif is a 7/8 match to the 
consensus (CTTTGCAT, not ATTTGCAT). The sph motif is 
required for enhancer activity in HeLa cells, however the 
octamer is not. The reverse situation is true for B cells 
(Davidson et a^ l (1986)). Correspondingly, interaction with 
the octamer motif (and not the sph motifs) can be detected 
by DNase footprinting with B cell extract, the reverse 
situation being true with HeLa cell extract. This leads to 
the model that Oct-2 binds to and activates the enhancer in 
B cells, whereas sph binding factors perform this role in
- 15 -
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HeLa cells. Such models will be discussed in more detail 
later. The situation Is complicated by band shift assays. 
Band shift assays detect factors binding to the octamer 
motif in both B cells and Hela cells, but do not detect sph 
binding factors (Rosales et al (1987)). Rosales et al 
(1987) detect A octamer binding proteins interacting with 
the SVAO enhancer octamer, and the IgH enhancer octamer.
The previously reported B cell specific 0ct-2A (here called 
0ct-B2) is identified. 0ct-2B is not. It is suggested that 
the ubiquitous binding activity, Oct-1, is in fact 2 
distinct proteins of similar mobility - one being B cell 
specific, and the other absent from B cells. This is on the 
basis of apparently different ability to protect the IgH 
and SVAO enhancers in footprinting assays, and since 
elution from an ion exchange chromatography column occurred 
at different salt concentrations. These differences have 
not been reported by other workers, and perhaps could 
represent differences in Oct-1 modification. Studies with 
cloned Oct-1 indicate that the message is ubiquitously 
expressed (Sturm e_t al^ (1988A)). Rosales et al (1987) also 
detect a minor ubiquitous binding activity, which has not 
been reported elsewhere and could represent a degradation 
product. This reflects the general complexity and confusion 
when comparing the band shift data from from the many 
groups working in this area, particularly since a second 
adjacent octaraer site has been identified in the SVAO 
enhancer (a situation reminiscent of the IgH heptaraer).
- 16 -
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HeLa cell Oct-1 binds both sites (GTTTGCAT and ATTGAGAT) 
(Sturm ¿t al^  (1987), Baumruker e_t al^ (1988)) giving an 
upper band in band shift assays corresponding to both sites 
being occupied. This phenomenon was not reported by Rosales 
et al (1987).
1.1.5 The octamer motif and the expression of HSV alpha 
(immediate early) genes.
Herpes simplex virus (HSV) alpha genes contain a conserved 
TAATGARAT motif (R is a purine) in the promoter. Functional 
studies have identified this motif to be necessary for the 
induction of alpha genes following infection (Gellman and 
Silverstein (1987), Gaffney et al (1985), Mackem and 
Roizman (1982)) In most cases an octamer motif is found 
overlapping this motif. An example of such an element (from 
the HSV-1 ICPO gene) is shown below.
TAATGARAT 
7/8 octamer 
ATGCTAATGATAT 
TACGATTACTATA
A viral protein VP16 (also known as Vmw65, alpha TIP)
present in the viral particle is necessary for the 
induction of alpha genes via the TAATGARAT motif (Campbell
et al (1984)).
However, binding of VP16 to DNA cannot be demonstrated 
(Marsden et al (1987)). In band shift assays with the 
sequence above as probe and extract from virally infected 
HeLa cells, an additional complex, of lower mobility to the
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Oct-1 complex, is formed (Preston et al (1988), O'Hare and 
Goding (1988), McKnight <it ¿1 (1987), Gerster and Roeder
(1988) ). Oct-1 and VP16 bind together to the alpha gene 
extended octamer motif, VP16 binding only when Oct-1 is 
present. Oct-1 can bind alone. Oct-1 and VP16 together (but 
not Oct-1 alone) seem to activate reporter genes containing 
an alpha gene consensus element in the promoter, in HeLa 
cells (O'Hare et al (1988)). This will be discussed in more 
detail later. Oct-1 is also able to bind (albeit with lower 
affinity) to the TAATGARAT motif without associated 
octamer, which is the arrangement seen in some alpha gene 
promoters (apRhys et al (1989)).
1.1.6 The octamer motif and the expression of other genes.
The 7SK RNA gene has an unusual promoter resembling the 
the U6 snRNA promoter (Murphy e£ al (1987), Murphy e£ al^
(1989) ). There is a TATA box (normally a requirement of RNA 
pol II transcription) just upstream of the transcription 
start site, upstream of this an element resembling the PSE 
of U snRNA genes, and further upstream at least three 
degenerate octamer motifs. The 7SK RNA gene is transcribed 
by RNA polymerase III. Mutational analysis of the promoter 
indicates that the octamer motifs operate cooperatively to 
activate 7SK transcription in vitro. The consensus octamer 
motif is able to substitute for the degenerate upstream 
octamer motifs. Purified Oct-1 and Oct-2 activate 
transcription from this promoter in v i t r o , and are able to
- 18 -
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bind to the very degenerate octamer motifs associated with 
this gene.
An octamer motif occurs in the promoter of the human 
Y-globin gene (Gumucio et al (1988)). Expression of 
^-globin in erythroid cells is normally repressed at birth. 
One mutation associated with elevated /-globin expression 
in the adult is in the octamer motif of the )f-globin 
promoter. Oct-1 and Oct-2 like binding activities from an 
erythroleukaemia cell line bind to the 3(-globin octamer. 
Binding is inhibited by the mutation associated with 
elevated 2f-globin expression. Here, it seems that octamer 
binding proteins may act as repressors of transcription. 
Erythroid-specific factors bind to activator sites found in 
close association with the octamer. Another site 
(significance to expression untested) overlapping the 
octamer binds an erythroid-specific factor. Octamer factor 
binding may inhibit the association of activator proteins 
with the ^-globin promoter.
Octamer motifs occur upstream of other genes, and many 
more octaraer-associated genes will no doubt be identified, 
particularly in view of the fact that multiple octamer 
binding proteins have now been identified (discussed later) 
and because Oct factors are able to bind remarkably 
degenerate octamer motifs (the flexible binding 
requirements of Oct factors will be discussed later), for 
example the IgH heptamer, in the 7SK promoter and the HSV 
alpha gene TAATGARAT motif. This point can be illustrated
- 19 -
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by the finding that a repressor site in the human c-myc 
promoter (expression of c-myc is associated with the growth 
state of cells) forms two complexes in band shift assays 
(Takimoto £t tQ (1990) and references therein). These 
complexes were identified by competition with known binding 
sites. The API (fos/jun complex, a transactivator of viral 
and cellular genes) binding site competed out one complex, 
and the consensus octamer motif the other complex. API and 
Oct-1 protect highly overlapping regions in the repressor 
element, and these represent very degenerate binding sites 
for the two factors, which would not have been readily 
identified by sequence analysis.
1.1.7 The octamer motif and adenovirus replication.
Octamer motifs are conserved in the adenovirus (Ad) origin 
of replication (Pruijin £t al^  (1987), Verrijrer £t til
(1990) and references therein). The Ad2 origin contains the 
octamer ATTATCAT, and the Ad4 origin the consensus octamer, 
ATTTGCAT. Both these octamer motifs bind Oct-1 (the factor 
binding was originally called NFIII, but is identical to 
Oct-1), and purified Oct-1 is able to stimulate DNA 
replication from the Ad origin dji vitro. It is interesting 
to note that a common factor (Oct-1) is implicated in the 
activation of DNA replication and the activation of histone 
H2B gene transcription, which is tightly coupled to DNA 
synthesis.
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1.2 Models of transcriptional activation by 0ct-l/0ct-2 from 
transfection studies in B and non-lymphoid cells.
The evidence that Oct factors were involved in gene 
regulation was originally circumstantial. Octamer elements 
(as already described) were demonstrated to be required for 
the expression of diversely expressed genes, presumably by 
association with trans-acting factors. Oct-1 and Oct-2 were 
discovered, and found to bind indistinguishably to the 
octamer motifs within the promoters/enhancers of these genes. 
Oct-2 was originally believed to be restricted to lymphoid 
tissue (Oct-2 has subsequently been found at lower levels in 
other tissues) was said to be the octamer-binding 
transcription factor regulating Ig genes, and Oct-1 (because 
of its ubiquitous distribution) was the octamer-binding 
transcription factor regulating ubiquitous genes. The fact 
that ubiquitously expressed genes showed different patterns 
of expression (H2B genes are expressed at S-phase of the 
cell-cycle) was explained by hypothetical modification of 
Oct-1, or association with another factor(s).
This section will describe the promoter/enhancer constructs 
that have been used for transfection studies in B cells 
(expressing Oct-1 and Oct-2) and non-lymphoid cells 
(expressing Oct-1) to analyse the mechanism of 
transcriptional activation by Oct-1 and Oct-2. It should be 
borne in mind that the models derived from these experiments 
make the assumption that Oct-1 and 2 are the only octamer- 
binding transcription factors present, and are genuine in
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vivo transactivators. Studies on transcriptional activation 
using cloned Oct-1 and Oct-2 will be discussed in a later 
section.
1.2.1 Oct-1 and Oct-2 are transcriptional activators.
An important demonstration, and key to any model of 
transcriptional activation by Oct-1 and Oct-2, was that 
purified Oct-1 and Oct-2 were able to activate transcription.
As described earlier, the octamer motif is required for the 
S-phase specific stimulation of histone H2B transcription in 
vivo. In vitro transcription assays using the human H2B 
promoter show that octamer mutations have no effect on 
transcription using G2-phase Hela cell extract (Fletcher 
et al (1987)). However, these mutations diminish the 
transcription observed with S-phase extract. So, in line with 
the jLn vivo transfection data, there seems to be an 
enhancement of an octamer-dependent transcription activation 
activity at S-phase of the cell-cycle. However, it is not 
clear whether or not HeLa cell Oct-1 binding activity is 
enhanced at S-phase of the cell-cycle. In other systems the 
data concerning the levels of Oct-1 through the cell-cycle 
are contradictory (see section 1.1.2). In an avian cell-line 
Oct-1 binding activity is enhanced at S-phase, whereas in a 
hamster cell line the level of Oct-1 binding activity is 
constant through the cell-cycle. Ion exchange and DNA 
affinity chromatography have been used to purify Hela cell 
Oct-1. The purified, approximately 90 kd protein is able to
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stimulate in vitro transcription from the intact H2B 
promoter, but not from a promoter with mutations in the 
octamer motif. The single 90 kd protein band cut from an SDS 
gel after electrophoresis of purified Oct-1 is an active 
octamer binding protein. The band shift seen is identical to 
that seen with crude extract.
B cell 0ct-2A has also been purified by ion exchange and DNA 
affinity chromatography (Scheidereit ej: al (1987)). Octamer 
mutations in the kappa promoter diminish activity in B cells 
(but not in HeLa cells). Octamer-factor-depleted extract (by 
oligo affinity, and showing no Oct binding activity in band 
shifts) shows no difference in the level of transcription 
from Oct+ and Oct- kappa promoters. However, adding purified 
0ct-2A stimulates transcription from Oct+ (and not Oct-) 
promoters. SDS-PAGE of affinity purified 0ct-2A shows that it 
consists of three major bands of similar size (62, 61, 58.5 
kd). Each of these proteins isolated from a gel is active in 
octamer binding, as assayed by band shift assays. 
Differentially phosphorylated forms of cloned 0ct-2A have 
subsequently been shown to have different electrophoretic 
mobility on SDS-PAGE (Tanaka and Herr (1990)). This is 
potentially the source of the three 0ct-2A species observed 
here.
A question which arises is ’Why doesn't Oct-1 stimulate Ig 
transcription in non-B cells?' As will be described in the 
following section, Oct-1 may have a weaker activation domain 
than Oct-2, which requires other factors to activate the TATA
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box transcription complex. However, the answer may be, in 
part, quantitative (LeBowitz et al (1988)). Low levels of 
octamer-dependent transcription are observed in transfected 
non-B cells, and similarly octamer-dependent Ig transcription 
occurs at low levels in vitro, with extract from non-B cells. 
Also affinity purified Oct-1 added to HeLa cell extract 
proportionally stimulates octamer-dependent transcription 
from an Ig promoter (it is also possible that an inhibitor is 
titrated out by the Oct-1 added).
1.2.2 Transfection of SVAO enhancer-containing constructs 
into B and non-lymphoid cells.
As already noted the octamer motif linked to a heterologous 
promoter forms a B cell specific promoter/enhancer (see 
section 1.1.1), leading to the suggestion that Oct-2, and not 
Oct-1, is able to activate such promoters, and that Oct-2 is 
a determinant of the B cell specific expression of Ig genes. 
Such experiments were extended further by a series of 
constructs containing the SVAO enhancer Sph motifs linked to 
heterologous promoters (Tanaka et_ al^ (1988)).
The SVAO enhancer (section 1.1.A) contains two direct repeat 
copies of the Sph motif. At the junction of these repeats an 
octamer motif is present. Three mutations were made in the 
Sph region to: (1) inactivate the Sph motif, which is 
required for HeLa cell activity of the enhancer, but does not 
inactivate the octamer motif, which is required for B cell 
activity of the enhancer [sph“oct+ J; (2) inactivate the
- 2A -
Introduction
octamer motif, giving less activity in B cells (and less Oct 
factor binding), but not the Sph motif (activity in HeLa 
cells unaffected) [sph+oct~]; (3) inactivate both motifs, 
giving reduced activity in both cell types [sph“oct“ ]. Six 
copies of the sph motifs were cloned upstream of the yg-globin 
TATA box, 2.2 kb downstream of the/S-globin start site, and 
upstream of the U2 snRNA PSE, with the octamer-containing DSE 
removed (see section 1.1.3). Transcription of these 
constructs was assayed after transfection into HeLa and NS1 B 
cells.
In line with previous results, sph+oct+ and sph"oct+ are 
active in B cells, upstream or downstream of the ^ -globin 
start site (although 12 times less efficiently downstream). 
sph+oct” and sph"oct” are inactive in B cells. sph+oct+ and 
sph+oct“ are active when associated with the /?-globin 
promoter in HeLa cells. sph“oct+ and sph“oct” are inactive. 
Sph and Oct motifs are, therefore, separable and overlapping 
motifs, the sph motif being required for HeLa cell activity, 
and the octamer motif for B cell activity.
In these assays the U2 genes give two transcripts. A 
transcript from the correct start site which terminates at 
the conserved 3' box (which directs correct 3', 
unpolyadenylated end formation). There are also incorrect 
transcripts from cryptic promoters, which terminate at an 
adenovirus polyadenylation site found in the vector 
downstream of«the 3' box. These are more like mRNA 
transcripts, and the effects of the enhancer mutations on the
- 25 -
Figure 3
A model for transcriptional activation by Oct-1 and Oct-2.
SV40 enhancer sph motifs inserted upstream of the beta- 
globin TATA box or U2 snRNA PSE, as described in the text, 
are illustrated schematically (see Tanaka et al (1988)).
Six copies were inserted, but for simplicity only a single 
copy is shown. In all cases the octamer motif at the 
junction of the sph motif is intact, and in all cases 
except (C), where the motifs are mutated, the sph motifs 
are intact. The constructs were transfected into the cell 
types indicated, and in the case of (E) co-transfected with 
a VP16 expressing construct. The boxes over the sph/oct 
motif represent the association of Oct-1, Oct-2 and sph 
binding factors. Oct-2 may have a stronger activation 
domain, illustrated by a larger stipled box. In (E) VP16 
associates with the Oct:DNA complex, providing an acidic 
activation domain (stipled box). TATA box and PSE 
transcription initiation complexes are illustrated by a 
circle or square, respectively. The TATA box binding 
protein, TFIID is illustrated. The ability of the sph/oct 
complex to activate the transcription initiation complex is 
indicated by + or -. An arrow indicates that transcription 
occurs, and a cross that transcription does not.
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level of the incorrect snRNA transcripts is the same as 
observed for the /£-globin transcripts. However, the promoter 
mutations have a different effect on the level of the 
correctly initiated snRNA transcripts in HeLa cells. In HeLa 
cells correct transcripts are activated by sph+oct+ and 
sph”oct+ , whereas sph+oct“ and sph'oct” are inactive.
Upstream of they^-globin promoter, in HeLa cells, sph“oct+ is 
inactive and sph+oct” is active. So, in HeLa cells the 
octamer motif is able to activate the U2 promoter, but not 
the /S-globin promoter.
Making the assumption that Oct-1 is responsible for 
transcriptional activation from octamer elements in HeLa 
cells, and that Oct-1 and Oct-2 are responsible for 
transcriptional activation in B cells the model of 
transcriptional activation illustrated in figure 3a-d is 
derived from this data. Oct-2 binds to the SV40 octamer in B 
cells and activates transcription from the TATA box, whereas 
in HeLa cells sph factors bind to the SV40 enhancer to 
activate transcription from the TATA box. When the sph motif 
is inactivated, Oct-1 binding in HeLa cells is unable to 
activate transcription from the TATA box. However, Oct-1 
binding to the SV40 enhancer is able to activate 
transcription from the PSE in HeLa cells. Sph factor binding 
is unable to activate transcription from the PSE.
In HSV alpha genes a TAATGARAT motif is responsible for 
activation of transcription via the viral transactivator VP16 
(see section 1.1.5). This motif frequently occurs in
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conjunction with an overlapping octamer, and is itself a 
degenerate octamer motif able to bind Oct-1. VP16 itself does 
not bind to DNA, but associates with Oct-1:DNA complex. In 
HeLa cells, in the presence of VP16 the normally inactive 
sph“oct+ enhancer activates^S-globin transcription. However, 
only in the proximal position. This is illustrated in figure 
3e. A simple model, outlined in figure 3, is that Oct-2 
presents a strong activation domain able to activate the TATA 
box transcription initiation complex. Oct-1 has a weaker 
activation domain, and is only able to activate the TATA 
complex in conjunction with the acidic activation domain of 
VP16. However, the Oct-1 activation domain is sufficient to 
activate transcription from the PSE complex. Recently the 
VP16 transactivator protein has been shown to interact 
selectively and strongly with TFIID (a TATA box binding 
protein and component of the TATA box transcription 
initiation complex) via its acidic activation domain 
(Stringer et al (1990)).
O'Hare et al (1988) have shown that an intact HSV alpha gene 
consensus motif with overlapping octaraer linked to a reporter 
gene can be activated in HeLa cells by co-transfection with 
VP16. They report that both Oct-1:VP16:DNA complex formation 
and activation by VP16 requires the GARAT part of the motif 
(which flanks the octamer). However, VP16 can activate 
transcription from the SV40 octamer, the H2B octamer and the 
U3 snRNA octamer (see later) suggesting that the GARAT 
portion of the motif seen in some HSV alpha gene promoters is
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not a strict requirement, and VP16 may have flexible 
recognition requirements.
1.2.3 VP16 and the activation of U snRNA genes.
The U3 snRNA DSE octamer is a non-consensus octamer, similar 
to the HSV alpha gene consensus element which is required for 
transactivation by VP16 (Kemp and Latchman (1988)). The U1 
snRNA DSE octamer is also a non-consensus octamer, but 
dissimilar from the alpha gene consensus. Co-transfection 
with VP16 stimulates U3 but not U1 transcription. U3 
induction by VP16 requires the octamer motif, and the U3 
octamer added to the U1 promoter (with its own octamer- 
containing DSE removed) renders it inducible by VP16. Since 
removal of the DSE reduces U1 expression, and this is 
partially restored by adding back either the U1 or U3 octamer 
it seems that the U1 and U3 elements must bind distinct 
octamer factors, one of which can be activated by VP16. In 
line with this argument is the observation that the U1 
octamer, unlike the perfect octaraer, linked to the^-g l o b i n  
promoter does not create a B cell specific promoter (Wirth 
et al (1987)).
1.2.4 VP16 and the activation of H2B transcription.
Transfection of cells with a VP16 encoding plasmid
stimulates endogenous histone H2B transcription (Latchman 
e£ al (1989)). However, infection with HSV (which introduces 
VP16) represses H2B transcription. This suggests that HSV
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genes and H2B genes compete for VP16 by a common element. H2B 
gene promoters contain an octamer motif, and HSV alpha gene 
promoters a TAATGARAT motif (which itself binds Oct-1) which 
sometimes overlaps an octamer motif. Since VP16 is known to 
interact with the Oct-1:DNA complex, the suggestion is that 
during infection the alpha gene consensus competes for Oct-1 
repressing H2B transcription, whereas when only VP16 is 
present it interacts with the Oct-1 to stimulate H2B 
transcription from the octamer motif. In line with this, the 
HSV alpha gene consensus and the U3 snRNA octamer motif co­
transfected with VP16 overcome H2B stimulation by VP16. In 
contrast, co-transfected U1 octamer motif does not overcome 
induction of H2B transcription by VP16. This is further 
evidence that U1 and U3 octamer motifs bind distinct factors 
(see section 1.2.3).
Transfection of the H2B octamer motif alone (without VP16) 
represses H2B transcription, whereas transfection with the 
HSV alpha gene consensus does not. This suggests that VP16 
promotes interaction of the common H2B promoter - alpha gene 
consensus octamer binding factor (presumably Oct-1) with the 
HSV alpha gene consensus.
VP16 lacking its acidic activation domain is unable to 
stimulate H2B transcription, but in the presence of the 
co-transfected alpha gene consensus is able to repress 
transcription. This implies that different domains of VP16 
are responsible for the activation of transcription and 
interaction with the octamer-binding factor.
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A summary of the relevant points regarding the involvement 
of the octamer motif and Oct-1 in H2B transcription is: (1) 
the human H2B promoter octamer motif (the core of a longer 
consensus sequence known as the H2B box) is required for the 
S-phase stimulation of H2B transcription in vivo, and this 
stimulation is independent of other promoter elements; (2)
H2B genes are ubiquitously expressed, and since Oct-1 is 
ubiquitous it is a good candidate for the octamer-binding 
transcription factor involved; (3) extract from S-phase HeLa 
cell nuclei, and not G2-phase, is able to stimulate octamer- 
dependent transcription of H2B genes in vitro; (A) affinity 
purified HeLa cell Oct-1 is able to stimulate octamer- 
dependent H2B transcription in vitro; (5) there is no 
evidence that Oct-1 binding activity is cell-cycle regulated 
in HeLa cells (human), in other species the evidence is 
contradictory; (6) octamer mutations in the human H2B 
promoter with other control elements inactivated (essentially 
an oct-TATA promoter) decrease expression in transfected HeLa 
cells, whereas mutations in the SVAO octamer upstream of the 
^-globin TATA box do not decrease expression in transfected 
HeLa cells; (7) VP16 is able to activate H2B transcription in 
vivo, in an octamer-dependent manner. VP16 interacts with the 
Oct-1:DNA complex, and activates the SVAO octamer - /i-globin 
construct in HeLa cells.
This is compelling evidence for the involvement of Oct-1 in 
H2B transcription. However, the problem that Oct-1 is also 
involved in the transcription of ubiquitously expressed genes
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which are not cell-cycle regulated remains. One possible 
explanation is that Oct-1 undergoes cell-cycle regulated 
modification. Oct-1 is known to be phosphorylated and 
O-glycosylated (Tanaka and Herr (1990), Murphy et al (1989)). 
Another explanation is that Oct-1 undergoes periodic 
interaction with another factor, which is itself cell-cycle 
regulated. In favour of this explanation is the finding that 
the SV40 enhancer octamer upstream of the y^-globin TATA box 
is inactive, whereas the octamer in the H2B promoter with 
other promoter elements inactivated (essentially an octamer - 
TATA promoter) is active in HeLa cells. This suggests that 
the sequence context of the octamer in the H2B promoter (and 
not in the SV40 enhancer) allows activation by Oct-1. This 
could be the spatial arrangement of the two promoters (which 
is different), but could also be the flanking sequences of 
the octamer in the conserved H2B box. The flanking sequences 
could facilitate interaction of Oct-1 with another cell-cycle 
regulated factor. A cellular analogue of VP16 could be such a 
factor in view of the findings that VP16 activates the SV40 
octamer - TATA promoter and stimulates cellular H2B 
transcription in an octaraer-dependent manner.
1.3 Studies on cloned Oct-1 and Oct-2A/Oct-2B.
The cDNAs encoding Oct-1 and Oct-2A/Oct-2B have been cloned 
and characterised. This section describes the cloning of 
these factors, information which has arisen from examining 
their sequence, and work which has been done to determine the
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regions of the proteins responsible for functions such as DNA 
binding, transcriptional activation and interaction with 
other proteins.
1.3.1 Cloning Oct-1 and Oct-2A/Oct-2B.
Human Oct-1 was cloned by South-Western blotting (screening 
a cDNA expression library with radiolabelled DNA binding 
site) (Sturm et^ al (1988A)), and the cDNA was identified to 
encode Oct-1 by the binding specificity of the product of the 
clone, by the fact that an antibody raised to the clone 
reacts with Oct-1 in band shift assays and by the ubiquitous 
distribution of the message from which the cDNA was derived. 
The distribution of the message was determined by RNase 
protection assays, and the probe used detected an additional 
smaller band with B cell RNA indicating a possible sequence 
homology between Oct-1 and Oct-2.
Human 0ct-2A was cloned by South-Western blotting and by 
screening with oligonucleotides, the sequence of which was 
derived from the protein sequence of purified 0ct-2A (Staudt 
et al (1988), Clerc et al (1988), Ko et al (1988),
Scheidereit j*l (1988), Muller et ¿1 (1988)). The cDNA was 
identified to encode 0ct-2A on the basis of the distribution 
of the message from which it is derived (0ct-2A cDNA used as 
a probe for Northern blots detected transcripts in RNA from B 
cells, but not from non-lymphoid cell lines), binding 
specificity of the product of the cDNA and mobility of the 
product on SDS-PAGE. The transcripts detected on a Northern
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blot were of the sizes 6, 3.9, 3.3 and 2 kb, suggesting the 
potential for related Oct-2 messages, perhaps generated by 
alternate splicing.
Mouse 0ct-2A and 0ct-2B were cloned by homology to the human 
0ct-2A clone (Hatzopoulos e£ al (1990)). Mouse and human 
0ct-2A differ by only a few amino acid substitutions. The 
0ct-2B clone differs from 0ct-2A as follows: a 48bp deletion 
(16 amino acids), and an insertion of 74 bases close to the 
3' end which opens up a new reading frame, so that the last 
12 amino acids of 0ct-2A are replaced by 132 new residues.
The product of the 0ct-2B clone gives bands of the same 
mobility as 0ct-2B in band shifts, and the same mobility as 
purified 0ct-2B on SDS-PAGE. The mouse 0ct-2 genomic clone 
indicates that 0ct-2A and 0ct-2B are alternately spliced 
products of the same gene.
RNase protection assays, using a probe which can distinguish 
between 0ct-2A and 0ct-2B transcripts, have been used to 
examine the distribution of the messages encoding the 2 
factors. 0ct-2A/B is present at much higher levels in 
lymphoid tissue, but also occurs in kidney, testis (an extra, 
smaller protected fragment is also detected indicating an 
additional protected transcript), intestine, brain, F9 
embryonal carcinoma cells and embryos. The relative amounts 
of 0ct-2A and 0ct-2B vary. In situ hybridisation indicates 
that 0ct-2 expression is widespread in the developing nervous 
system, with regions of higher expression. In the adult brain 
expression is restricted to distinct areas.
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Figure A.
The POU domain.
(A) A sequence comparison of the POU domains of Oct-1 and 
Oct-2 (human), Pit-1 (rat) and unc-86 (C. elegans). 
Sequences are aligned to Oct-1. - represents a residue 
conserved with Oct-1, and * a gap made in the sequence 
for maximum alignment. The location of the POU specific 
and homeo box sub-domains is shown, as are the location 
of sub-regions within these sub-domains. The A, B, and 
WFC sub-regions are particularly well conserved. (See 
Herr et al (1988)).
(B) The location of the POU domain within the proteins. The 
numbers refer to the number of amino acids in the 
protein
(C) An alignment of the Oct-1, Oct-2 and antennapedia homeo 
boxes. Vertical lines represent a conserved amino acid. 
The location of possible alpha helices is shown. By 
analogy to bacterial repressor proteins, I, II, A and B 
are possible contact sites with DNA. (See Garcia-Bianco 
et al (1989)).
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1.3.2 Oct-1 and 0ct-2A/B have a conserved POU domain which 
directs DNA binding.
Sequence analysis of human Oct-1 and 2 cDNAs has revealed 
that the proteins encoded have an approximately 150 amino 
acid region of very high homology. This region was termed the 
POU domain, since an homologous region also occurs in the rat 
pituitary specific transcription factor Pit-1 (regulates 
growth hormone and prolactin gene expression) and the 
C. elegans gene unc-86 (involved in neural development; it 
was identified by genetic analysis, and its biochemical 
function is unknown) (POU ■ .Pit, Oct, unc) (Herr e £  ¿1 
(1988)). A POU domain sequence alignment is shown in figure 
AA, and the location of the POU domain within the proteins in 
figure AB.
Oct-1 and 2 show 87X homology within the POU domain. Between 
all four proteins there is 37X identity within this region, 
although this is higher for particular pairs (0ct-2:unc-86 * 
A2X, Oct-1:Pit-l * 52X). There is little homology outside 
this region, except between Oct-1 and 0ct-2 which share 
features such as Q and S/T rich regions, and there is some 
homology between the N termini of Oct-1 and 0ct-2B. These 
similarities will be discussed in a later section.
The POU domain can be divided into 2 subdomains: the POU 
homeo box (a region at the C-terminal end of the homeo box, 
known as the WFC sub region, is particularly well conserved) 
and the POU specific box (which can be divided into A and B 
sub-regions on the basis of a higher degree of sequence
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similarity). Between the approximately 60 amino acid 
subdomains is a region of sequence dissimilarity 
(approximately 20 amino acids, known as the non-conserved 
linker). The POU homeo box shows about 30% homology to the 
antennapedia homeo box (Garcia-Bianco et al (1989)). Homeo 
boxes were first identified as a conserved region between 
Drosophila homeotic proteins which are involved in segmental 
development. Related homeobox proteins have been found in 
mammals, amphibians and elsewhere. An alignment of the Oct-1 
and Oct-2 homeo boxes to the antennapedia homeo box (which is 
considered to be the consensus Drosophila homeo box) is shown 
in figure 4C. The Drosophila homeo box has been shown to be a 
DNA binding motif, and contains a helix turn helix motif 
(helices 2 and 3 in figure 4C) similar to that seen in 
bacterial repressor proteins. Bacterial repressor proteins 
(lambda, 434 and trp) have been analysed by X-ray 
crystallography and the residues involved in DNA binding 
determined from protein:DNA co-crystals. A cluster of basic 
residues (K or R) following helix 3 (II on figure 4C) in 
homeoboxes is well conserved in the 434 repressor, where it 
contacts DNA. Similarly, a cluster of basic residues before 
helix 1 (I on figure 4C) in homeo boxes is conserved in the 
lambda repressor, where it contacts DNA. The residues marked 
A and B (see figure 4C) in helix 1 are well conserved at 
equivalent positions in the bacterial repressors where they 
have been shown to contact DNA. The basic regions I and II 
(RRQKEKR; RRRKKR) are conserved at the underlined positions
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in more than 95% of homeo boxes, including the Oct-1 and 2 
homeo boxes. Consequently, by homology to other homeo boxes, 
and by homology to the bacterial repressors, the homeo box of 
Oct-1 and 2 is predicted to be the DNA binding domain.
The POU domain, containing the homeo box, has been shown to 
be responsible for DNA binding. Oct-1 N terminal deletions up 
to the POU domain have no effect on DNA binding (Sturm and 
Herr (1988)). Oct-1 C terminal deletions have no effect on 
binding up to the POU domain (Sturm e_t aJL (1988A)). However, 
deletions into the POU domain abolish binding. Mutations in 
POU specific box A and B subregions abolish binding, as do 
mutations in homeo box helix 3. However, addition of six A 
residues to the non-conserved linker has no effect on DNA 
binding. The same mutations affect binding to two different 
motifs (SV40 octamer 1, and HSV alpha gene TAATGARAT motif) 
in a similar way. As already noted, Drosophila homeo box 
proteins are known to be DNA binding proteins and contain the 
homeo box in the absence of the POU specific box.
Consequently the function of the POU specific box is not 
clear. It may not contact the DNA directly, but could, for 
example, stabilise interactions between the homeo box and 
DNA. The POU homeo box alone has a low level of DNA binding 
activity (Verrijzer jet al (1990)), which supports the 
suggestion that the the POU-specific box stabilises 
interaction with DNA. The homeo box alone has altered DNA 
binding specificity, and so the POU specific box may also 
have a role in determining the specificity of binding. A
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Figure 5.
Oct-1 binds to degenerate octaraer motifs by association
with flanking sequences.
(A) Part of the sequence of the SV40 enhancer sph motifs is 
shown, and 3 possible octamer binding sites are 
indicated. * represents a base which is different to 
the consensus octamer motif (ATTTGCAT). The occupancy 
of octa-1 and octa-3 sites by Oct-1 is illustrated. The 
mutations indicated were made in the octa-3 site, and 
Oct-1 binding assayed. (See Sturm et al (1987), 
Baumruker et al (1988)).
(B) The SV40 o c t a ^  site is 14 bases long. If the HSV alpha 
gene Oct-1 site is aligned to the SV40 octa-1 site over 
the corresponding 14 bases, they match at only 4 of the 
14 positions.
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similar deletion series, and mutations in the POU domain 
demonstrate that the Oct-2 POU domain is required for DNA 
binding (Ko e£ al (1988), Muller-Immergluck e£ al (1990)).
As already noted, Oct-1/Oct-2 (via the POU domain) bind 
remarkably degenerate octamer motifs including the HSV alpha 
gene TAATGARAT motif, the Ig heptamer motif, two sites in the 
SV40 enhancer, sites in the 7SK RNA gene promoter, and so on. 
The SV40 enhancer octamer sites have been analysed to 
determine the sequence requirements for binding to degenerate 
octamer motifs (Sturm et_ al^ (1987), Baumruker e£ al (1988)). 
As shovn in figure 5A. the SV40 enhancer contains three 
potential octamer binding sites (Octa 1 to 3). DMS and DEPC 
modification protection assays and oligonucleotide 
mutagenesis have been used to show that it is in fact the 
Octa 1 (7/8 match) and Octa 3 (5/8 match) sites which are 
occupied by Oct-1. The 6/8 match Octa 2 site (which overlaps 
the Octa 3 site) is not occupied. Oct-1 contacts over a 
region of 11 bases to associate with the Octa 1 site, and 
over a region of 14 bases to associate with the Octa 3 site. 
This suggests that flanking sequences may be important to 
allow binding to degenerate octamer motifs. If the Octa 3 
site is mutated to contain the consensus octamer (see figure 
5A) then the mutation AT to TA at the 5 ’ end of the binding 
site has no effect on Oct-1 binding, whereas this mutation 
abolishes binding to the wild-type Octa 3 site. The 
stabilisation of binding to degenerate motifs by flanking 
sequences seems to hold true for other sites, where the
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Figure 6,
Homology between Oct-1 and Oct-2 outside the POU domain.
(A) A sequence alignment of the N terminal ends of human 
Oct-1 and mouse 0ct-2B. | = a perfect match, and : a 
conservative match (I:L or S:T). (See Hatzopoulos et al
(1990)).
(B) Apart from the POU domain and the N terminal ends of 
Oct-1 and 0ct-2B, homology between Oct-1 and Oct-2 
consists of regions rich in particular amino acids. 
Amino acid rich regions are illustrated here. Also 
shown is the location of the putative 0ct-2 leucine 
zipper and the 0ct-2 activation domains (represented by 
arrows). The solid part of the arrow represents the 
region which contributes most to transcriptional 
activation. (See Sturm et al (1988), Clerc £t al
(1988), Scheidereit et aTTT988), Muller et al“ Cl988), 
Tanaka and Herr (199UJ and Gerster ejt a_l TT9377) ) .
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dependence on flanking sequences is linked to the degree of 
homology of the core octamer motif to the consensus 
(Baumruker e_t til (1988)). The extent of the degeneracy of 
sites to which Oct-1 is able to bind is illustrated in figure 
5B. Oct-1 binds the HSV alpha gene TAATGARAT motif (4/8 
octamer) and the SV40 enhancer Octa 1 site. The longest 
region over which Oct-1 contacts is 14 bases (SV40 Octa 3 
site). Out of these 14 bases the SV40 octa 1 and TAATGARAT 
motifs have only 4 bases in common.
1.3.3 Other features determined by examination of the 
sequences of cloned Oct-1 and 0ct-2A/B.
As mentioned earlier, alternate splicing causes the last 12 
amino acids of 0ct-2A to be replaced by 132 new residues in 
0ct-2B. The N terminal 127 residues of 0ct-2B show 58% 
homology to the N terminal 121 residues of Oct-1 (see figure 
6A). Within this region a stretch of 81 residues is 79% 
homologous. This extensive homology suggests a similar 
function.
Apart from the POU domain, and the homology described above, 
any homology between Oct-1 and Oct-2 is a consequence of 
regions rich in particular amino acids. The N terminal 
domains are Q rich (residues 22 to 268 in Oct-1 are 26% Q) 
and parts of the C terminal domains are S/T rich (residues 
441 to 560 in Oct-1 are 50% S/T). This arrangement is 
reminiscent of the ubiquitous mammalian transcription factor, 
Spl (reviewed in Mitchell and Tijan (1989)). Oct-2 contains P
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rich regions in the C terminal domain. Proline rich regions 
have been identified as activation domains in the 
transcription factor CTF/NF-1 (reviewed in Mitchell and Tijan
(1989)). As will be described later, these regions have been 
shown to be important for transcriptional activation.
Oct-2 contains a potential leucine zipper. Four leucine 
residues are each separated by exactly seven other residues. 
Such structures are believed to form an amphipathic alpha 
helix, which can align and pair via the hydrophobic leucine 
residues to another leucine zipper, leading to dimerisation 
or interaction with other proteins (reviewed in Busch and 
Sassone-Corsi (1990)). This motif is not seen in Oct-1, and 
as will be described later is not required for 
transcriptional activation by Oct-2 in HeLa cells. However, 
it could still be required in B cells. In immunoglobulin 
promoters/enhancers the octamer motif is part of an array of 
factor binding sites, and perhaps the leucine zipper allows 
Oct-2 to interact with other factors.
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1.3.4 Transcriptional activation by cloned Oct-1 and 0ct-2A.
Three recent papers have analysed the regions of Oct-1 and 
0ct-2A required for transcriptional activation by the cloned 
factors in transfected HeLa cells (Tanaka and Herr (1990), 
Muller-Immergluck et^  al^  (1990), Gerster e± a^ L (1990)).
Tanaka and Herr (1990) used the SV40 enhancer sph motifs 
upstream of the the yi-globin TATA box, upstream of the 
^-globin CCAAT-TATA boxes, and 2.2 kb downstream of the 
^-globin transcription start site as targets for activation 
by co-transfected 0ct-l/0ct-2 in HeLa cells. Six copies of 
the Sph motif were used in each case, with various mutations 
(oct+sph+ , oct+sph” , oct“sph+ , oct“sph~) as described in 
section 1.2.2. 0ct-2 activates from oct+sph“ in either 
upstream position, whereas Oct-1 does not. As a control, 
there is no activation from oct""sph” . These results are 
consistent with those obtained by transfection into HeLa 
cells (expressing Oct-1) and B cells (expressing Oct-1 and 
0ct-2) described in section 1.2.2. However, neither factor 
activates from oct+sph~ when it is located downstream of the 
promoter. 0ct+sph" is active in the downstream position in 
transfected B cells (section 1.2.2), although with 12 fold 
less activity than when located upstream of the TATA box. 
Consequently in B cells there may be another octamer-bipding 
factor, or modification of Oct-2, or interaction of 0ct-2 
with another factor to allow the octamer motif to operate 
from the downstream position in B cells.
The oct+sph+ promoter displays reduced activity if
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co-transfected with Oct-1 or Oct-2 in HeLa cells. This effect 
is not seen with the oct"sph+ promoter. So, Oct-1/Oct-2A 
probably displace sph factors, leading to reduced 
transcription. Mutations in the POU (DNA binding) domain 
abolish the repression effect, and factors with deletions 
outside the POU domain have the same repressive effect. 
Consequently the effect is probably due to DNA binding, 
rather than an inhibitory domain. This repression was used to 
normalise the amount of Oct binding activity present in the 
nucleus in subsequent assays where deleted factors were used 
to locate activation domains.
Oct-1 and 0ct-2A were divided into N terminal (N), POU (P) 
and C terminal (C) domains, and chimeras made. (Oct-1 C, P ♦ 
Oct-2 N) and (Oct-1 C ♦ Oct-2 P, N) did not activate 
transcription, whereas (Oct-2 C, P ♦ Oct-1 N) and (Oct-2 C + 
Oct-1 P, N) did activate transcription from the octamer 
upstream of the^-globin promoter in HeLa cells. Consequently 
the ability of Oct-2 to activate this promoter resides in the 
C terminal domain, and the N terminal and P OU domains are 
interchangeable between the two factors.
Oct-2 N  and C terminal deletions have been used to map the 
activation domains. Deletion of the first 100 or so residues 
of the N terminal domain has no effect on the ability to 
activate transcription from the octamer motif. However, 
deletions which extend into the Q rich regions (see figure 
6B) decrease activation. C terminal deletions also decrease 
activation. Consequently Oct-2 has two interdependent
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activation domains. Mutations in the leucine zipper residues 
(see section 1.3.3) have no effect on activation b y  Oct-2 in 
this assay system. Similar results have been obtained by two 
other groups (Muller-Immergluck et al (1990), Gerster et al
(1990)). However, this sequence motif could be important in 
other cell types.
Phosphorylation of Oct-1, 0ct-2 and chimeric constructs was 
analysed by comparison of in vitro translation products with 
immunoprecipitated products from transfected HeLa cell which 
had been labelled with ^g-methionine or 32Pj an(j w ith these 
products after treatment with phosphatase. Oct-1 an Oct-2 are 
both heavily phosphorylated and Oct-2 and active chimeras 
(but not Oct-1 and inactive chimeras) display an 
electrophoretic mobility shift on phosphorylation. 
Consequently the phosphorylated forms displaying the mobility 
shift are probably involved in the activation of 
transcription. Oct-2 activation domain deletions decrease the 
overall level of phosphorylation, but the electrophoretically 
retarded phospho-proteins still occur indicating that the 
activation domains induce phosphorylation elsewhere in the 
protein.
Essentially equivalent results, indicating that Oct-2 has 
interdependent N and C terminal activation domains were 
obtained by Gerster et al^  (1990). Here the domains were 
mapped more precisely by internal deletions. The N  terminal 
activation domain includes the Q rich region, and an adjacent 
P rich domain contributes to some extent. The first
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approximately 100 amino acids at the N terminus are not 
required for activation. Most of the C terminal domain 
contributes to activation, with the P rich region being most 
important. The 0ct-2 activation domains are illustrated in 
figure 6B.
Conflicting results concerning the 0ct-2 activation domains 
have been reported by Muller-Immergluck e£ al (1990). Their 
0ct-2 deletion analysis in a similar assay system suggested 
that N and C terminal deletions alone have little effect on 
activation potential. Only N and C terminal deletions 
together give reduced activity. This suggests that activation 
domains are not interdependent, but functionally redundant.
An interesting finding described in this paper is that the 
activation potential of deleted Oct-2 varies according to the 
position of the octamer relative to the TATA box. With the 
octamer motif 5 bases from the the TATA box deletion of the C 
terminus has no effect on the activation potential of Oct-2, 
whereas with the octamer motif 20 bases from the the TATA box 
there is a 2 fold decrease in transcription (Gerster et_ a_l
(1990) report a similar decrease in activation with the same 
promoter and a similar Oct-2 deletion, but since the deletion 
causes a 60-100 fold increase in binding activity, the 
deleted Oct-2 is essentially inactive with respect to the 
full length 0ct-2. However, a direct comparison of the 
ability to activate from the 2 promoters is still valid). 
Also, with the octamer 5 bases from the TATA box the POU 
domain alone is able to activate transcription to some
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extent. Consequently, the spatial arrangement of the promoter 
may be important for activation by Oct-2.
As mentioned above, Oct-2 deletions are expressed at 
drastically different levels compared to the full length 
protein (up to 100 times higher). This could account for the 
contrasting results reported by Muller-Immergluck et al^  
(1990). Tanaka and Herr (1990) normalised activation 
potential against the amount of binding activity in the 
nucleus using the Sph repression assay, and Gerster ejt al^  
(1990) against the amount of binding activity seen in band 
shift assays, after demonstrating that the deletions were 
able to enter the nucleus (since co-transfected deletions, 
unable to activate transcription, were able to inhibit 
activation by full length 0ct-2). Perhaps the normalisation 
of activation potential to the amount of nuclear binding 
activity was not as accurate in the assays performed by 
Muller-Immergluck et al (1990).
A by-product of the normalisation used in these assays was 
to show that 0ct-2 deletions reached the nucleus.
Consequently the nuclear localisation signals do not reside 
in the N or C terminal domains of 0ct-2.
1.3.5 The 0ct-l POU domain interacts with VP16.
As already noted VP16 forms a complex with the 0ct-l:DNA 
complex. However, purified VP16 and 0ct-l (assayed by band 
shift assays) do not form this complex with the HSV alpha 
gene TAATGARAT motif (Kristie et al (1989)). A third cellular
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component (found in insect and HeLa cells) is required. This 
3 component complex protects regions flanking the octamer, 
and mutations in these sequences abolish complex formation 
(although the flanking sequence requirements must be 
flexible, since VP16 can transactivate from the TAATGARAT 
motif, the H2B octamer, the U3 snRNA octamer and the SV40 
enhancer octamer - see section 1.2.1). A further complex is 
formed by interaction with another factor found in HeLa cells 
(but not insect cells). The footprint pattern of this complex 
is identical to the previous complex, suggesting that 
formation involves only protein-protein Interactions (and not 
protein-DNA interactions). Formation of these complexes 
requires only the POU domain of Oct-1. Oct-2 forms similar 
complexes, but only at very high levels of VP16.
Stern e_t ¿1 (1989) have shown that the POU homeo box is 
required for interaction with VP16. The Oct-1 and Oct-2 
homeoboxes differ at 7 out of 60 positions. If the residues 
at three of these positions in Oct-1 are mutated to those 
seen in Oct-2 there is no effect on DNA binding, but 
formation of the complex with VP16 is disrupted.
The interaction of Oct-1 with other proteins has obvious 
implications in explaining how Oct-1 regulates diversely 
expressed genes, for example the possibility that a cellular 
analogue of VP16 is involved in the cell-cycle regulation of 
histone H2B genes has already been discussed. The inability 
of the Oct-2 POU domain to interact efficiently with VP16 is
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probably part of the explanation for how two factors binding 
the same element can differentially activate transcription.
1.3.6 The POU domain is sufficient to stimulate DNA 
replication.
As already described the octamer motif is conserved in the 
adenovirus origin of replication, and purified Oct-1 
stimulates adenovirus replication in vitro from the octamer 
motif (section 1.1.7). Over-expression of cloned Oct-1 and 
0ct-2A in vivo stimulates adenovirus replication in an 
octamer-dependent manner (Verrijzer e£ ajL (1990)). Deletion 
of Oct-1 indicates that only the POU domain is required to 
stimulate replication. Verrijzer et^  al (1990) report that the 
POU homeo box alone has a low level of DNA binding activity. 
The Pou homeo box alone inhibits DNA replication (presumably 
by blocking the binding of endogenous Oct-1), suggesting that 
the POU specific box is the region required for the 
stimulation of DNA replication.
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1.4 Other POU domain and octamer-binding proteins.
1.4.1 Homeo box-containing genes form multi-Rene families in 
Drosophila and vertebrates.
Homeotic mutations transform certain parts or an entire body 
segment into the corresponding structures of another body 
segment. In Drosophila genetic analysis lead to the 
identification of homeotic genes specifying segmental 
identity (for review see Gehring (1987)). Structural analysis 
identified a conserved DNA segment (approximately 180bp) 
between homeotic genes, known as the homeo box. Using the 
homeo box as probe a battery of homeotic genes have been 
identified in Drosophila, and in vertebrates. The POU domain 
of 0ct-l/0ct-2 contains a homeo related box with 
approximately 30% identity to the Drosophila antennapedia 
homeobox (considered to be the consensus homeo box, see 
section 1.3.2).
As described in section 1.3.2 the homeo box is related to 
the helix-turn-helix DNA binding motif of bacterial repressor 
proteins. Consequently homeo box proteins were postulated to 
be DNA binding proteins, and probably transcription factors. 
Using similar techniques to those described for Oct factors, 
homeo box proteins have been shown to bind DNA via the homeo 
box, and to activate transcription (reviewed in Levine and 
Hoey (1988), Biggin and Tijan (1989)). In a manner 
reminiscent of Oct-1 and Oct-2 the en, eve, ftz, prd and Ubx 
homeo box proteins of Drosophila recognise some DNA sequences 
with similar affinity, whereas others (eg. bicoid) seem to
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have distinct binding affinities. In transfection assays 
introduction of Drosophila homeo box cDNAs along with target 
promoters/enhancers has shown that Drosophila homeo box 
proteins are transcription factors. Consequently many of the 
questions which have been discussed concerning how Oct-1 and 
Oct-2 are able to differentially activate transcription from 
the same promoter element also arise for homeo box proteins 
in general. As a result studies on octamer binding 
transcription factors have relevance to differential gene 
activation, and hence specification of segmental identity by 
homeo box proteins. For example, the discovery that Oct-1 
interacts with VP16 via its homeo box, and that 3 residue 
changes (to those seen in Oct-2) prevent this interaction may 
indicate a mechanism for differential gene activation 
applicable to homeo box proteins in general (see section 
1.3.5).
Using Drosophila homeo boxes as probe, families of homeo box 
proteins have also been identified in vertebrates (for 
reviews see Dressier and Gruss (1988), Dressier (1989),
Wright £l (1989)). In view of this it might be supposed 
that families of POU domain/octamer-binding proteins occur in 
vertebrates. As will be described below, apart from the 
already isolated Pit-1 (from rat) and unc-86 (from 
C. elegans) identification of 0ct-l/0ct-2 has lead to the 
discovery of an array Oct/POU proteins (mostly in mammals) by 
band shift assays and screening with POU domain probes.
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1.4.2 The unc-86 gene of C. elegans.
In the nematode elegans mutations in the unc-86 gene 
cause specific defects in the nervous system. The unc-86 gene 
was cloned by genetic mapping and chromosome walking (Finney 
et al (1988)). Open reading frames and consensus splice sites 
were used to determine the sequence of the transcript from 
the gene and the protein encoded. As described in section
1.3.2 the protein encoded contains a POU domain (POU - Pit, 
Oct, unc). By analogy to 0ct-l/0ct-2 and Pit-1, the unc-86 
product is presumably a transcription factor, however the 
target genes for this putative transcription are unknown. The 
loss of unc-86 function causes certain blast cells to not 
express their normal fate (but to display the characteristics 
of their mother) and a particular neuron displays its normal 
characteristics early in development, but subsequently fails 
to mature and remains in the quiescent state.
1.4.3 The pituitary-specific transcription factor. Pit-1
Growth hormone (GH) is specifically expressed in
somatotrophs of the anterior pituitary. Prolactin (Prl) is 
expressed in lactotrophs, most of which are derived from GH 
producing precursors (reviewed in Karin et_ al (1990)). A 
protein GHF-1 (said to be somatotroph specific) was 
identified and bound to two adjacent sites in the GH gene 
promoter which are important for in vitro and in vivo 
expression of the gene. The purified GHF-1 protein stimulated 
the GH promoter in conjunction with extract from cells which
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do not express GH or GHF-1 (HeLa cell extract). GHF-1 was 
reported to not bind the Prl promoter. However, another group 
identified a rat factor, Pit-1 (later shown to be identical 
to GHF-1) which bound the same sites in the GH promoter, and 
also bound (possibly with lower affinity) to the prolactin 
promoter. Pit-1 was reported to be expressed in GH and Prl 
producing cells (see Karin e£ al (1990), Nelson e£ al^ (1988) 
and references therein).
GHF-1 (Bodner et al (1988)) and Pit-1 (Ingraham et al_
(1988)) have been cloned, and are identical. GHF-1 was cloned 
by screening with probes derived from the partial amino acid 
sequence of the purified protein, and Pit-1 by screening an 
expression library with the binding site. The 291 amino acid 
protein (henceforth referred to as Pit-1) contains a POU 
domain at the C terminal end of the protein. In a similar 
manner to that described for Oct-1/Oct-2, the Pit-1 POU 
domain has been shown to be required for DNA binding. The 
Pit-1 activation domain resides in the N terminal half of the 
protein. The first 72 amino acids of the protein (which are 
S/T rich) have been shown by deletion analysis to be required 
for transcriptional activation. Pit-1 binds multiple sites in 
the Prl and GH gene promoters, which are required for 
transcriptional activity in vivo and in vitro (Nelson e_t al_ 
(1988)). The consensus binding site is A /TTATNCAT, which is 
clearly related to the octaraer motif (ATTTGCAT). Cross­
competition with GH and Prl promoter binding sites in in 
vitro transcription assays indicates that a common factor
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activates both genes (Nelson e£ ¿1 (1988)) and cloned Pit-1 
activates expression from both GH and Prl promoters on co­
transfection into HeLa cells (Ingraham £t al^ (1988)). Stable 
transfectants expressing cloned Pit-1 at a level 10 fold 
lower than physiological activate both GH and Prl promoters. 
Activation from the GH promoter is much less than from the 
Prl promoter, even though bacterially expressed Pit-1 has at 
least as high affinity for the GH promoter Pit-1 binding 
sites (Mangalam e£ al (1989)). So, the evidence that Pit-1 
(GHF-1) activates two genes with different patterns of 
expression is convincing. This begs the recurring question 
'How can the same factor specify differential gene 
expression?' Modification or interaction with other factors 
are possibilities. Other cis-acting sequences occur in GH and 
Prl promoters, and binding to these sites has been observed. 
As well as being expressed in somatotrophs where it 
stimulates GH (and not Prl) gene expression and lactotrophs 
where it stimulates Prl (and not GH) gene expression, Pit-1 
protein is also present in the thyrotrophs of the anterior 
pituitary where it stimulates neither GH or Prl gene 
expression (Simmons e£ al (1990)). Pit-1 mRNA is also 
detected in the other two cell types of the anterior 
pituitary (gonadotrophs and corticotrophs), however Pit-1 
protein is not present. This suggests that cell-specific 
translation of the Pit-1 mRNA occurs.
A rat prolactin promoter Pit-1 binding site was inserted in 
single copy in front of the Prl gene TATA box, and a series
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of mutations analysed for Pit-1 binding affinity and 
transcriptional activation in Pit-1 expressing cells 
(Elsholtz e£ al (1990)). The in vitro binding affinity does 
not necessarily reflect the ability of a Pit-1 site to 
activate transcription, since some low affinity binding sites 
show significant ability to activate transcription in vivo. 
Oct-2 binds the wild-type Pit-1 binding site, but the 
promoter is not active in B cells. However, conversion of the 
core of the Pit-1 site to a perfect octamer (which is a 
higher affinity Oct-2 binding site) creates a promoter which 
is active in B cells. Pit-1 shows significant, but lower, 
affinity for the consensus octamer promoter, but this 
promoter is not active in Pit-1 expressing cells. The 
explanation here could be that, in vivo, auxiliary factors 
stabilise the interaction of Pit-1 with some low affinity 
sites, and also that auxiliary factors are able to 
destabilise the interaction of Pit-1 with the consensus 
octamer promoter (and destabilise the interaction of Oct-2 
with the Pit-1 site).
The Pit-1 gene has been cloned, and the factors required for 
its expression analysed (McCormick e_t al^  (1990)). The 
promoter contains two CREB (a cAMP responsive transcription 
factor) binding sites, and expression is cAMP responsive. The 
promoter also contains a Pit-1 binding site. Mutation of this 
site reduces expression of the gene, and expression can be 
stimulated by cloned Pit-1. Consequently positive 
autoregulation takes place. Pit-1 binding site mutants are
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still expressed in a cell-type specific manner, and so other 
factors must be involved in the the cell-type specific 
expression of the gene. Similar results have been obtained by 
a second group (Chen et al (1990)), except that a second 
Pit-1 binding site has been identified downstream of the 
transcription start site. Mutation of this site causes a 
Pit-l-dependent increase in expression, so Pit-1 binding to 
this site is inhibitory (perhaps by halting transcription, 
rather than by inhibition of the initiation of 
transcription). It is suggested that Pit-1 stimulates its own 
expression, but that the second inhibitory site limits 
stimulation to a lower level than other target genes.
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l.A.A A family of POU domain genes in the mammalian brain.
Degenerate oligonucleotides for all possible codons of two 
conserved nine amino acid stretches at either end of the POU 
domain were used to clone the POU domain of four new POU 
domain-containing genes by the polymerase chain reaction (He 
et al (1989)). Brn-1 and Brn-2 were isolated from human 
brain, Brn-3 from rat brain, and Tst-1 from rat testes.
Brn-1, Brn-2 and Tst-1 are about 9A% similar to each other 
throughout the POU domain, and 85% similar to Oct-1/Oct-2 in 
the POU specific box, and 6A% similar to 0ct-l/0ct-2 in the 
homeo box. Brn-3 is much more closely related to unc-86 than 
any of the other POU domain genes being 79% similar within 
the POU domain.
In situ hybridisation was used to analyse the expression of 
these POU domain genes (and Pit-1, Oct-1, Oct-2) in the adult 
and developing mammalian brain. Expression of these four new 
POU domain genes is both temporally and spatially restricted 
in the mammalian brain, with each gene displaying a unique 
pattern of expression. As already noted (see section 1.3.1) 
Oct-2 is widely expressed in the developing brain, and 
displays a restricted pattern of expression in the adult 
brain. Pit-1 is expressed early in brain development, with 
transcripts disappearing, and then reappearing exclusively in 
the anterior pituitary. Oct-1 expression is widespread in the 
developing brain, but surprisingly in the adult brain is 
highly restricted to particular regions.
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1.A.5 A  family of octamer-binding proteins in mouse 
embryogenesis.
Band shift assays with an octamer-containing probe (from the 
IgH enhancer) have been used to analyse mouse tissues and 
stages of embryogenesis for the presence of octamer-binding 
proteins (Scholer e£ (1989)). Ten distinct octamer binding 
activities were identified (including Oct-1 and Oct-2) and 
termed Oct-1 to 0ct-10. These factors have distinct 
distributions. 0ct-3 is expressed in the embryo and adult 
brain, and when present is accompanied by 0ct-2 and Oct-7 
(these factors occur without Oct-3). As already noted, Oct-2 
transcripts can be detected in tissues other than lymphoid 
(see section 1.3.1). In line with this, Oct-2 like complexes 
are seen with extract from embryo, brain, spleen and kidney. 
However, these complexes can be distinguished from B cell 
Oct-2 on the basis of stability at increased temperature and 
affinity for different probes. These factors could represent 
modifications of B cell Oct-2, or distinct proteins.
So far, most interest has centred on Oct-A and Oct-5. Oct-A 
is in both male and female primordial germ cells. Oocytes 
(and not sperm) and embryonic stem cells contain both Oct-A 
and Oct-5. Neither factor is present in the post-implantation 
embryo. Oct-A and Oct-5 are, hence, maternally expressed 
octamer binding proteins. F9 and D3 embryonic stem cell lines 
contain Oct-A and 5 (and not Oct-2). The octamer motif placed 
upstream of a reporter gene forms a strong enhancer in these 
stem cells (Scholer et_ al (1989A)). On differentiation of
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stem cells, both 0ct-A/0ct-5 levels and enhancer activity 
decrease, suggesting that Oct-A and/or Oct-5 are 
transcriptional activators. A similar reporter gene is 
expressed in an octamer-dependent manner in the inner cell 
mass of the blastocysts (source of stem cells) in transgenic 
mice. As described in section 1.1.1 contrasting results have 
been obtained by another group (Lenardo e£ ¿1 (1989). Here, a 
more complete IgH enhancer was placed upstream of a different 
reporter gene. Octamer mutations caused the enhancer to 
become active in F9 cells, suggesting the existence of a 
repressive octamer-binding factor. A novel octamer-binding 
factor (NFA-3) was identified, and levels decreased on 
differentiation of F9 cells. This was accompanied by 
activation of the enhancer. The factor NFA-3 is probably 
equivalent to Oct-A, since the Oct-5 binding activity is 
weaker and may not have been detected. A possible explanation 
for the contradictory results is that the context of the 
octaraer determines the effect of factor binding. As described 
in section 1.3.A, transfection of Oct-1 and Oct-2 can 
activate transcription from the SVAO enhancer in HeLa cells 
if the sph motif inactivated, but decreases the activity of 
the SVAO enhancer if the sph motif is intact (presumably by 
blocking sph factor binding). In a particular promoter 
arrangement, Oct factor binding in F9 cells may inhibit the 
formation of a transcription initiation complex.
Three groups have reported the cloning of a novel octamer- 
binding/POU domain factor from embryonic stem cells (Scholer
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et al (1990), Rosner jet al (1990), Okamoto <5t al^ (1990)). 
Rosner £t al^  (1990) report a 352 amino acid open reading 
frame. Scholer e_t_ al (1990) report a 324 amino acid 0RF. The 
cDNAs are identical in sequence except that the Scholer et^  al^  
(1990) sequence is shorter at the 5' end and contains an 
extra A base close to the 5' end. The extra A creates an in 
frame first ATG, causing the predicted protein to be shorter 
by 28 amino acids than that reported by Rosner et al (1990). 
Relative to the sequence reported by Rosner e_t ill (1990), the 
sequence of Okamoto e_t ¿1 (1990) lacks a G residue in the C 
terminal third of the protein, resulting in a different 
reading frame at the 3' end. Since the sequence of Rosner £t 
al (1990) matches one sequence at the 5' end, and the other 
sequence at the 3' end it is probably the correct sequence 
for the factor Oct-4 (called Oct-3 by Rosner e^ al (1990) and 
Okamoto et al (1990)). 0ct-4 is about 75% similar to 
0ct-l/0ct-2 within the P0U specific box, and 58% similar 
within the homeo box.
Scholer et a_l (1990) report that the in vitro translation 
product of their clone gives two bands in a band shift assay, 
of equivalent mobility to Oct-4 and 0ct-5 from F9 cells. It 
is possible that both proteins are translated from the same 
message by use of alternate initiation codons. Rosner et al. 
(1990) report a similar effect, but do not detect 0ct-5 in 
extract from stem cells. Co-transfection of Oct-4 with an 
octamer-containing reporter gene in HeLa cells activates 
transcription from the gene, showing that 0ct-4 is a
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transcription factor. Rosner e£ al (1990) were able to detect 
Oct-4 message in stem cell lines (decreases on 
differentiation), oocytes, pre-implantation embryos, and soon 
after no expression was detected. This matches the band shift 
data (Scholer et^ al (1989)), except that no 0ct-4 protein is 
detected in the post-implantation embryo (expression of the 
message at this stage is restricted, and so the protein is 
probably of too low abundance to be detected in extract from 
whole embryos). However, in contrast to the band shift data, 
0ct-4 message is detected in testis. RNase protection assays 
with ovary RNA give the fully protected species, and a 
smaller protected band, indicating that two related messages 
are present. Only the fully protected band is seen with stem 
cell RNA.
1.4.6 Other examples.
The sea urchin sperm specific histone H2B gene promoter 
contains two adjacent inverted CCAAT boxes flanked at either 
side by an octamer motif (Barberis et al^  (1987), Barberis 
e_t iil (1989)). In spermatocytes (expressing the gene) both 
CCAAT boxes are occupied, whereas in the embryo (non­
expressing) only the CCAAT box most proximal to the TATA box 
is occupied, and by a distinct CCAAT binding factor (CCAAT 
displacement protein) which seems to block any interaction at 
the adjacent site. Sea urchin has an apparently ubiquitous 
octamer-binding protein (presumably Oct-1) of similar 
mobility to mammalian Oct-1 in band shift assays, and of
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similar molecular weight to mammalian Oct-1. This protein 
occupies the octamer site in embryos. In testis a second, 
more abundant and testis specific octamer binding protein is 
present. This protein (Oct-T) is slightly smaller than Oct-1. 
It is suggested that both the CCAAT displacement protein (as 
a repressor in non-expressing cells) and the testis specific 
octamer binding protein (as an activator in expressing cells) 
contribute to the testis specific expression of this H2B 
gene.
In Drosophila the dopa decarboxylase gene (ddc) is expressed 
in selected dopaminergic neurons. A POU domain protein 
binding to a ddc gene promoter sequence element, which is 
necessary for the expression of the gene, has been cloned 
(Johnson and Hirsh (1990)). As yet, there is no direct 
evidence that this protein regulates the expression of the 
ddc gene. As described earlier in this section, several 
mammalian POU domain proteins with unique and restricted 
patterns of expression in the nervous system have been 
identified. However, this is the first POU domain protein 
which has been associated with a specific function in the 
nervous system.
A mammalian octamer-binding protein, apparently specific to 
malignant melanoma cells has been reported (Cox «it al 
(1988)).
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1.5 Project aims.
In view of the intrinsic interest of the 'octamer paradox' 
the project began by trying to clone laevis octamer 
binding proteins using a probe from the histone H2B gene 
promoter to screen expression libraries. When the sequence of 
human Oct-1 and 2 was reported, the X^ laevis homologue of 
Oct-1 was cloned for the following reasons. Firstly, to make 
a comparison of Oct-1 between species. Such comparisons can 
lead to the identification of functionally important regions 
by the extent of homology. Secondly, it was thought that the 
oocyte micro-injection system might provide a transcriptional 
assay system for the activity of the octamer motif and 
octamer binding proteins. Thirdly, the POU domain had been 
shown to contain a homeo box. As noted in the previous 
section, homeo box containing genes in Drosophila and 
vertebrates occur in large families and are developmentally 
important. As Xenopus is an organism amenable to the study of 
development it was decided to see if a family of octaraer- 
binding proteins existed in Xenopus. Some means of 
identifying and eliminating Oct-1 in binding assays was 
considered to be appropriate.
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CHAPTER 2: MATERIALS.
2.1 General reagents.
Enzymes were obtained from the following suppliers: 
restriction endonucleases were from Amersham International 
(U.K.), Northumbria biologicals limited (NBL) and Bethesda 
research laboratories, Maryland U.S.A. (BRL); E. coli DNA 
polymerase I, T4 DNA ligase and T4 polynucleotide kinase 
were obtained from Amersham International; T3 and T7 RNA 
polymerases were from New England Biolabs; DNA polymerase 
Klenow fragment was from NBL; AMV reverse transcriptase was 
from Life sciences Inc. (U.S.A.).
All radioisotopes were supplied by Amersham International 
at the following specific activities: 0<-3^P-dGTP and 
0<-32P-dCTP, 3000 Ci/mnu>l;y-32P-ATP, 5000 Ci/mmol; 
0<-32P-UTP, 3000 Ci/mmol; 0(-35S-dATP, 1000 Ci/mmol; 
35S-methionine, >1000 Cl/mmol.
Nitrocellulose filters (Hybond-C) were obtained from 
Amersham.
Type II agarose (medium EE0) was supplied by Sigma 
chemical company and low melting point agarose was from FMC 
Bioproducts.
Materials for bacteriological media were from Difco 
laboratories (Michigan, U.S.A.) and Oxoid limited 
(England).
E.coli transfer RNA (type XX) and salmon testis DNA were 
supplied by Sigma.
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Foetal calf serum was obtained from Gibco, and tissue 
culture flasks from Falcon.
Acrylamide was supplied by Fisons, and bisacrylamide by 
Kodak.
X-ray film was from Fuji photo company limited (Japan).
Oligonucleotides were synthesised in the department by 
Gill Scott, using an Applied Biosystems automated 
synthesiser.
All other chemicals and reagents were from BDH ('Analar' 
grade) or from Sigma chemical company unless otherwise 
stated.
2.2 Stock Solutions.
Deionised formamide - Formamide was stirred with Amberlite 
monobed resin MB-3 or MB-4 (5g per 100 ml of formamide) 
until the pH was 7, filtered through Whatman No. 1 filter 
paper and then stored at -20°C.
Filtered formaldehyde - A 40X (w/v) solution of 
formaldehyde was filtered through Whatman No. 1 paper.
Stock acrylamide solutions were deionised as described for 
formamide, except for 30 minutes, and then stored in the 
dark at 4°C.
TE - lOmM Tris.HCl (pH7.5), ImM EDTA.
lOx TBE - 0.9M Tris.borate pH8.3, 20mM EDTA.
20x SSC - 3M NaCl, 0.3M Na Citrate, pH7
50x Denhardt's - IX (w/v) each of Ficoll, 
polyvinylpyrolidone, bovine serum albumin.
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lOx MOPS - 0.2M 3-(N-morpholino) propanesulphonic acid, 
50mM sodium acetate, lOmM EDTA, pH7
Phosphate buffered saline (PBS) - 0.8% (w/v) NaCl, 0.02%
(w/v) KC1, 0.115% (w/v) Na2HP0A , 0.02% (w/v) KH2P04 ,
lx barth-X - 88mM NaCl, l.OmM KC1, 2.5mM NaHC03 , 15.0mM 
Tris.HCl p H7.6, 0.3mM CaN03 , 0.41mM CaCl2 , 0.82mM MgSOA .
NAE - 0.3M NaAcetate pH6.5, ImM EDTA.
2.3 Bacteriological Media.
LB broth - 5g yeast extract, lOg bactotryptone, lOg NaCl 
per litre.
H broth - lOg bactotryptone, 8g NaCl per litre.
2x TY - lOg yeast extract, 16g bactotryptone, 8g NaCl per 
litre.
NZY broth - 5g NaCl, 2g MgS0A .7H20, 5g yeast extract, lOg 
NZ amine per litre.
For plates agar was added at 15g per litre.
For top agar, agar was added at 7g per litre and for top 
agarose, agarose was added at 7g per litre.
All media were autoclaved before use.
Antibiotics were used in plates and broth at the following 
final concentrations: ampicillin, 100 or 200 ug/ml; 
tetracycline, 15 ug/ml.
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2.A Bacteria, plasmids and phage.
2.A.1 Genotypes of E_^  coli strains.
JM101 - supE, t hi, A ( l a c -proAB), [F', traD36,pro AB, 
LACiqZDMI5] 17-18 ditto, not tra D36.
MC1061 - F", ara D139, A ( « r « , l e u ) 7696, A l a c  Y 7 A , gal U” , 
gal K” , hsr” , hsm+ , strA.
Y1090 - [ALac U169, proA+ , Ion, araDl39, strA, supF, 
trpC22:TnlO(pMC9)].
BBA - supF58, supEAA, hsdR51A (rk” ,mk” ), galK2, 
galT22,trpR55, metBl, tonA, lambda” , D(arg-lac)U169 [F', 
proAB, lacIqZDMl5, TnlO(tetr )].
71:18 mutL - /^(lac-proAB). supE, thi; F' lacl^ Z M15, 
proA+B+ , TnlO(tetr ), mutL.
TG2 - supE,A(lac-proAB)hsd, A(src-recA) 306::TnlO(tetr ) 
[F'traD36 proAB+ lacl^ lacZ M15 rk” rm ” Rec” ].
B121(DE3) - F” hsdS gal, rB“m B” , lacUV5-T7 gene 1 cloned 
into int (see Studier and Moffat (1986)).
2.A.2 Plasmid vectors.
pBR322 - General purpose cloning vector (Bolivar (1978)). 
pBR325 - pBR322 with chloramphenicol resistance added 
(Prentki e_t ¿1 (1981)).
pATl53 - High copy variant of pBR322 (Tvigg and Sherratt 
((1980)).
pBluescript SK” - The plasmid generated by automatic 
excision from lambda ZAP. Has an extensive polylinker, the
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lacZ colour selection system and promoters for both T3 and 
T7 RNA polymerases (Stratagene, La Jolla, CA, U.S.A).
pET-3 series - Plasmids designed for the high level 
expression of cloned sequences in coli (Rosenberg et al^  
(1987)). 3 vectors with a Bam HI site in each reading frame 
to make in frame fusions to the first 11 amino acids of 
gene 10 of phage T7. The fusion gene is transcribed by T7 
RNA polymerase, and can therefore be expressed in the 
E. coli strain BL21(DE3). This strain contains the T7 RNA 
polymerase gene incorporated into the genome, and under the 
control of the lacUV5 promoter (inducible with IPTG).
2.A.3 Bacteriophage vectors.
M13mpl8 and M13mpl9 - bacteriophage M13 vectors designed 
for sequencing by the dideoxy chain termination method 
(Messing et_ al^  (1981)).
2.A.A Plasmid and Bacteriophage Recombinants. 
pRW23 - Xj. laevis histone gene cluster Xlhw23 in pBR325 
(pers. comm., R. W. Old). Gift of R. W. Old.
pBS - 0ct-l+ - human Oct-1 cDNA in pBSMl3+ (Stratagene) 
(Sturm et al (1988A)). Gift of W. Herr, 
albone A-670 - Xi. laevis albumin (5' end):H3 histone (3' 
end) fusion gene in M13mpl9 (Old et al_ (1988)). Gift of A. 
R. Brooks.
X. laevis mature oocyte cDNA library in lambda ZAP (vector 
described in Short ejt al (1988)). Cloned sequences can be
- 65 -
Materials
automatically excised from the phage vector and converted 
to the plasmid vector pBluescript, for ease of handling. 
Gift of J. Shuttleworth.
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CHAPTER 3: METHODS.
3.1 Tissue Culture.
3.1.1 Growing laevls Xtc cells.
X. laevls Xtc cells (Pudney et^ al^ (1973)) were grown in 
Glasgow modified Eagle medium (GMEM) supplemented with 10% 
(v/v) foetal calf serum, penicillin (lOug/ml) and 
streptomycin (lOug/ml) at 25°C in 5% carbon dioxide.
The cell line grows as a monolayer and was divided 1 in 3 
about every 3 days using the following procedure. The 
medium was removed and the cells washed in 2.5mls of 
versene:trypsin mix. The cells were then incubated in 
2.5mls of fresh versene:trpsin mix for approximately 2 
minutes, whilst agitating the flask to detach the cells 
from the surface. 30mls of medium was added and the cell 
suspension distributed between three 75cm^ tissue culture 
flasks.
3.1.2 Growing mouse L cells
Mouse L929 (Ltk-) (Kit e £  al^  (1963)) cells were grown 
exactly as described for X^_ laevis Xtc cells, except at 
37°C.
3.1.3 Blocking Xj_ laevis Xtc cells at stages of the cell- 
cycle .
Xtc cells were blocked with hydroxyurea by adding the 
inhibitor to a final concentration of 5mM in the culture
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medium of subconfluent cells. The cells were incubated with 
hydroxyurea for 90 minutes, after which time band shift 
extract was prepared from the cells (see section 3.31.3).
Subconfluent Xtc cells were blocked by serum-starvation by 
washing twice in GMEM and then incubating in fresh 
unsupplemented GMEM for 18 hours. Supplemented medium was 
then added back and the cells maintained for a further 6 
hours, after which time band shift extract was prepared 
from the cells (see section 3.31.3).
3.2 Obtaining Oocytes. Eggs And Embryos.
3.2.1 Oocytes
Oocytes were obtained by anaesthetising a female Xenopus 
laevis with MS222 and carrying out a partial ovariectomy. 
The oocytes were manually stripped from the ovary, washed 
in lx barth-X and maintained in lx barth-X at 20°C.
Oocytes were staged according to Dumont (1972).
3.2.2 Eggs and embryos.
Female X^ laevis were induced to ovulate by subcutaneous 
injection with 250 units of serum gonadotrophin (Intervet 
U.K. Ltd) 48 hours before laying followed by 250 units of 
chorionic gonadotrophin B (Intervet U.K. Ltd) 16 hours 
before laying. For 'natural' matings male X. laevis were 
injected with 250 units of chorionic gonadotrophin 8 hours 
before laying. For in vitro fertilisation a male X^ . laevis 
was killed by injection with 0.5ml of 250mg/ml
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phenobarbitone (euthatal, May and Baker), and the testis 
removed into lx barth-X on ice. 50 to 100 eggs layed in lx 
barth-X were transferred to a petri dish and dredged with 
pieces of teased testis for 30 seconds. After leaving for 1 
minute a small amount of distilled water was added. Two 
minutes later the dish was flooded with distilled water.
Fertilised eggs were de-jellied in 2% (w/v) cysteine 
(adjusted to pH8 with NaOH) and then washed at least A 
times in l/10x barth-X.
Prior to gastrulation embryos were transferred to l/10x 
barth-X to avoid exogastrulation.
Embryos were staged according to Nieuwkoop and Faber 
(1956).
3.3 Microinjection Of Xenopus Oocytes.
Large oocytes that had been obtained as described in 
section 3.2 were microinjected using a fine, drawn out 
glass capillary mounted on a micro manipulator. The needle 
was linked via a thin gauge pipe to a syringe driven by a 
vernier, and the system partially filled with oil. Oocytes 
were transferred to a piece of moist filter paper on a 
microscope slide and injected with about lOnl of DNA (in 
sterile water) or RNA (in DEPC treated water) under a 
binocular microscope. For nuclear injections the needle was 
inserted a small distance into the animal pole where the 
germinal vesicle usually lies. Cytoplasmic injections were 
into the vegetal half of the oocyte. Microinjected oocytes
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were maintained at 20°C in lx barth-X.
Oocytes injected with synthetic RNA into the cytoplasm 
were maintained in lx barth-X at 20°C in petri dishes for a 
few hours, and then healthy oocytes were transferred into 
microtitre dishes (so that they could be maintained in a 
small volume) in 5ul lx barth-X (containing 5uCi 
^S-methionine) per oocyte. Oocytes were maintained 
overnight in this medium to allow incorporation of 
•^S-methionine into translation products, and then protein 
extract (using the method described for band shift assay 
extract, see section 3.31.1) was prepared from healthy 
oocytes.
3.A Preparation of RNA.
3.A.1 From X^ laevis oocytes.
Oocytes were homogenised in a glass homogeniser in 
approximately 6 volumes of a 1:1 mixture of NAE (0.3M 
sodium acetate pH6.5, O.lmM EDTA) containing 2% SDS and 
neutral phenol. The homogenate was microfuged at 12000 rpm 
for 5 minutes. The aqueous phase was taken, phenol 
extracted 2 to 3 more times until it became clear and then 
chloroform extracted. RNA precipitated with 2 volumes of 
ethanol at -20°C. RNA was pelleted by microfugation at 
12000 rpm for 10 minutes and resuspended in DEPC treated 
water. RNA concentration was determined by measuring 
absorbance at 260nm. The RNA was then split into aliquots, 
re-precipitated with ethanol and stored at -20°C.
- 70 -
Methods
3.A.2 From adult laevls liver.
RNA was isolated from adult Xenopus liver using the method 
of Chirgwin £t jal (1979). The liver was removed from an 
animal that had been killed with euthatal and cut into 
pieces in phosphate buffered saline (PBS). The pieces were 
washed several times in PBS and then homogenised in five 
tissue volumes of lysis buffer (6 M guanidiniun 
thiocyanate, lOmM Tris.HCl pH7.5, ImM B-mercaptoethanol, AX 
N-lauroylsarcosine). Caesium chloride was added to a final 
concentration of 15X (w/v) and the homogenate centrifuged 
at 2000 rpm in a bench centrifuge to pellet the debris. The 
supernatant was carefully layered onto 2ml of 5.7M caesium 
chloride, lOOmM EDTA (pH8) in an ultracentrifuge tube. The 
tube was centrifuged for 12 to 18 hours in a swing out 
rotor at 36,000 rpm at 20°C. The supernatant was removed 
with a pasteur pipette until about 1ml remained, this was 
poured off and the tube inverted to drain. The RNA pellet 
was resuspended in DEPC treated water and then extracted 
with an equal volume of neutral phenol. The aqueous phase 
was precipitated with 2 volumes of ethanol in the presence 
of 0.3M sodium acetate (pH6.5) at -20°C. The RNA was 
recovered by centrifugation at 10,000 rpm for 15 minutes 
and resuspended in DEPC treated water. The RNA 
concentration was determined by measuring the absorbance at 
260 nanometers assuming a reading of 1 for a AOug/ml 
solution. Finally, the RNA was ethanol precipitated and 
stored at -20°C.
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3.4.3 From microinjected oocytes.
Groups of 10 to 20 healthy oocytes were transferred to 
eppendorf tubes and excess medium removed. 0.5ml of NaE 
(0.3M sodium acetate pH6.5, ImM EDTA pH8) was added and the 
oocytes homogenised by squirting them up and down in a 
Gilson tip. SDS was then added to a final concentration of 
2X (w/v) and the homogenate immediately extracted with an 
equal volume of neutral phenol. The aqueous phase was taken 
and extracted with an equal volume of chloroform and then 
nucleic acids precipitated by adding 2 volumes of ethanol.
3.4.4 Selection Of Polyadenylated RNA By Oligo dT Cellulose 
Chromatography
This was carried out essentially as described by Maniatis 
et al (1982). A 2ml oligo (dT) cellulose column was poured 
in a disposable plastic column and equilibrated with 
loading buffer (20mM Tris.HCl pH7.6, 0.5M NaCl, ln»M EDTA, 
0.1X SDS in DEPC treated water). A column was used several 
times and stored at 4°C. RNA was dissolved in DEPC treated 
water and an equal volume of 2x loading buffer (40mM 
Tris.HCl pH7.6, 1M NaCl, 2mM EDTA, 0.2X SDS) added. This 
solution was applied to the column, warming the column with 
a heating lamp as necessary. The column was washed with 5 
to 10 column volumes of loading buffer and then with 5 
column volumes of wash buffer (20mM Tris.HCl pH7.6, 0.1M 
NaCl, ImM EDTA, 0.1X SDS). The flow through was collected 
in 1 ml aliquots throughout. The A 2^o these fractions
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was measured as they were collected so that the amount of 
RNA coming off the column could be assessed. The column was 
washed with loading buffer and then with wash buffer until 
the A26q  was less than 0.1. Polyadenylated RNA annealed to 
the column was eluted with 2 to 3 column volumes of elution 
buffer (lOmM Tris.HCl pH7.6, ImM EDTA (pH8), 0.05% SDS). 
These eluted fractions were pooled and the RNA 
concentration determined by measuring the ^260' Finally the 
RNA was split into aliquots, precipitated with ethanol and 
stored at -20°C.
3.5 Gels for Resolving Nucleic Acids.
3.5.1 Non-denaturing Agarose Gels.
DNA samples, to which 0.2 volumes of loading buffer (50% 
glycerol, 5x TBE, 0.1% bromophenol blue) had been added, 
were separated in 0.6 to 1.5% (w/v) agarose gels containing 
0.2ug/ml ethidium bromide made in lx TBE buffer. Gels were 
run in lx TBE buffer containing 0.5ug/ml ethidium bromide 
and examined and photographed on an ultraviolet light box.
3.5.2 Low Melting Point Agarose Gels.
These gels were used for the isolation of DNA fragments 
generated by restriction enzyme digests.
DNA samples to which 0.2 volumes of agarose gel loading 
buffer had been added were loaded onto a 0.8% (w/v) low 
melting point agarose gel made in lx TBE buffer and 
containing 0.5ug/ml ethidium bromide. Gels were run in lx
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TBE buffer containing 0.5ug/ml ethidium bromide at a 
maximum of 40 mA. The gel was examined under U.V. light and 
the required bands excised as a small gel slice. Exposure 
of the gel to U.V. light was kept to a minimum to avoid 
U.V. induced DNA damage. Gel slices were transferred to 
1.5ml eppendorf tubes and weighed to calculate the volume 
of the slice (assuming lg ■ 1ml). 4 volumes of NaE (0.3M 
sodium acetate pH6.5, ImM EDTA) was added and the slice 
melted by heating at 65°C for 10 to 15 minutes. After 
cooling to 37°C an equal volume of neutral phenol was 
added, the solution mixed vigorously and left on ice for 10 
minutes. The tubes were then centrifuged at 12000 rpm for 5 
minutes and the aqueous phase transferred to a fresh tube. 
The aqueous phase was ether extracted, and the volume 
reduced to about 300ul by several extractions with 
butan-l-ol. The DNA precipitated with 2 volumes of ethanol 
at -20°C.
3.5.3 Formaldehyde Agarose RNA Gels.
RNA samples (up to 20ug) were resuspended in lOul of DEPC 
treated water and 20ul of denaturing mix (66% deionised 
formamide pH7, 1.3x MOPS, 20% formaldehyde) and 3ul of 
loading mix (50% glycerol, 0.2% bromophenol blue) added.
The samples were loaded onto a 1.5% (w/v) agarose, 15% 
formaldehyde gel made in lx MOPS buffer (20mM MOPS, 5mM 
sodium acetate, ImM EDTA). The samples were electrophoresed 
at 40mA (100 volts) for 5 to 6 hours in lx MOPS buffer. The
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gel was stained by soaking in 250ml of 10X glycine for 10 
minutes, adding lOOul of lOmg/ml ethidium bromide and 
soaking for a further 10 minutes. The gel was destained by 
washing twice, for 15 minutes each, in distilled water and 
then photographed on an ultraviolet light box.
3.5.A Denaturing polyacrylamide gels.
6% or 8% polyacrylamide (19:1 bis) gels containing 42X 
(w/v) urea in lx TBE were poured between 20x AOcm gel 
plates with 4mm spacers. Nucleic acid samples in denaturing 
gel loading buffer (90X deionised formamide, lOmM EDTA pH8, 
0.01X bromophenol blue, 0.01X xylene cyanol) were heated at 
100°C for 5 minutes, loaded onto the gel and 
electrophoresed at 38 watts in lx TBE.
Gels with 35S samples (eg. sequencing reactions) were 
fixed in 10X ethanol (v/v), 10X acetic acid (v/v) for 15 
minutes, transferred to a sheet of blotting paper, dried at 
80°C on a vacuum drier and then exposed to X-ray film at 
room temperature.
Gels with 32P samples (eg. primer extension analysis,
RNase protection assays) were generally not fixed and dried 
before autoradiography. The top gel plate was removed, the 
gel covered in cling film and exposed to X-ray film with an 
intensifying screen at -70°C.
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3.6 Isolation Of Genomic DNA From Adult Xenopus Blood.
An adult female was anaesthetised by immersion in 0.2% 
(w/v) MS222 for 20 to 30 minutes. The thorax was then 
opened on the ventral side to expose the heart. A 10 ml 
syringe was filled with 3ml of lmg/ml heparin in NMT 
(lOOmM NaCl, lOmM Tris.HCl pH7.4, 3mM MgCl2 ) and the needle 
inserted into the still beating heart. Blood was gently 
collected into the syringe and transferred to cold 
universals which were centrifuged at 2000 rpm for 5 
minutes. The cell pellet was resuspended in 10ml of cold 
NMT and re-centrifuged. This w as repeated until the 
supernatant was no longer pink. The cells were lysed by 
resuspending in 10ml of distilled water and leaving at room 
temperature for 5 minutes. 100ml of neutral phenol was 
transferred to a glass bottle and the lysed cell suspension 
added to this. After mixing vigorously the DNA was sheared 
by twice taking the emulsion into a syringe through a 
coarse grade needle. The emulsion was transferred to 
oakridge tubes and centrifuged at 8000 rpm for 20 minutes 
at room temperature. The aqueous phase was carefully 
transferred to a fresh tube and re-extracted with an equal 
volume of neutral phenol. The aqueous phase was transferred 
to a glass beaker and approximately two volumes of ethanol 
was added to precipitate the DNA. High molecular weight DNA 
was spooled onto the end of a pasteur pipette and 
transferred to a plastic universal. The DNA was dissolved 
in 10ml of TE (lOmM Tris.HCl pH7.5, ImM EDTA) by shaking
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gently at room temperature for several hours. Ribonuclease 
A was added to a final concentration of 5ug/ml and the 
solution Incubated at 37°C for 30 minutes. An equal volume 
of 2x PK buffer (0.2 M Trls.HCl pH7.5, 25mM EDTA, 0.3M 
NaCl, 2% (v/v) SDS) and 0.1 volumes of 2mg/ml proteinase K 
were added and the solution incubated at 37°C for 1 hour. 
The solution was extracted with an equal volume of neutral 
phenol and the phases separated by centrifugation at 8000 
rpm for 20 minutes. The aqueous phase w as transferred to 
corex tubes and the DNA precipitated w i t h  ethanol and 
recovered by centrifuging at 10 000 rpm for 20 minutes. The 
pelleted DNA was resuspended in 5ml of T E  and the 
concentration determined by measuring the absorbance at 260 
nanometers, assuming that a 50ug/ml solution has an &260 
1. The DNA solution stored at A°C.
3.7 Southern Blotting.
DNA samples separated in non-denaturing agarose gels as 
described in section 3.5.1 were transferred to 
nitrocellulose using the method of Southern (1975). To 
increase the efficiency of transfer of high molecular 
weight DNA (especially with genomic Southern blots) the gel 
was first treated with 0.25M HC1 for 15 minutes at room 
temperature. This partially hydrolyses the DNA, generating 
smaller fragments which transfer more efficiently. After 
rinsing with distilled water the gel w as incubated in a 
large volume of denaturing solution (1.5M NaCl, 0.5M NaOH)
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with gentle shaking for 20 minutes. This was repeated with 
fresh denaturing solution. The gel was rinsed with 
distilled water and then neutralised by incubating with 
gentle shaking in two changes (for 30 minutes each) of a 
large volume of neutralising solution (3M NaCl, 0.5M 
Tris.HCl, ImM EDTA, pH7). A piece of filter paper (Whatman 
3MM) moistened with 20x SSC was placed on top o f  a platform 
in a tray of 20x SSC so that the ends of the filter paper 
were submerged in the 20x SSC. The gel was placed on top of 
the filter paper and the exposed filter paper covered with 
cling film. A piece of nitrocellulose was cut to the same 
size as the gel, moistened with 2x SSC and lowered onto the 
surface of the gel, making sure that no air bubbles formed. 
Two pieces of filter paper cut to the same size as the gel 
were soaked in 2x SSC and lowered onto the surface of the 
nitrocellulose. Tissue paper was stacked on top of this and 
weighed down with a brick. The gel was left to blot 
overnight after which the nitrocellulose filter was rinsed 
briefly in 2x SSC. DNA was fixed to nitrocellulose filters 
by baking at 80°C under vacuum for 2 hours.
Prehybridisation and hybridisation was carried out in heat 
sealed plastic bags weighed down in a water bath set to the 
appropriate temperature. Filters were prehybridised in 20 
to 50ml (depending on the size of filter) of 5x Denhardt's, 
6x SSC, 0.1% SDS, lOOug/ml coli tRNA, 50% deionised 
formamide at A2°C for 3 hours to overnight. The 
prehybridisation solution was discarded and replaced with
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10 to 20ml of the same buffer containing radiolabelled 
nucleic acid probe. The bag was re-sealed and hybridised at 
42°C overnight.
Filters were first washed twice in 2x SSC, 0.1% SDS at 
room temperature for 5 minutes each and then twice for 30 
minutes each in the final washing conditions (which 
depended upon the hybridisation stringency required). 
Finally, the filters were blotted on filter paper and while 
still damp, wrapped in cling film and exposed to X-ray film 
with an intensifying screen at -70°C.
3.8 Northern Blotting.
After staining with ethidium bromide formaldehyde agarose 
RNA gels were soaked in 250ml of 20x SSC for 20 minutes and 
the RNA transferred to nitrocellulose (Hybond-C, Amersham) 
as described by Thomas (1980). The gel was capillary 
blotted overnight using 20x SSC as the transfer buffer 
exactly as described for Southern blotting (see section 
3.7) after which the nitrocellulose filter was briefly 
dried at room temperature and then baked at 80°C under 
vacuum for 2 hours.
Prehybridisation, hybridisation, washing and 
autoradiography were exactly as described for Southern 
blotting (see section 3.7).
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3.9 Large Scale Preparation Of Plasmid DNA And Purification 
By Caesium Chloride/Ethidium Bromide Centrifugation.
The method used was the alkaline lysis method as described 
by Maniatis e£ al (1982). A single colony was inoculated 
into 10ml of sterile LB containing the appropriate 
antibiotic, and grown overnight at 37°C. The next day 0.3ml 
of this overnight culture was used to inoculate 50ml of LB, 
and this culture grown on a shaker at 37°C for 2 to 3hours. 
This 50ml culture was used to inoculate 500ml of LB in a 2 
litre flask and this culture was shaken (200 rpm) overnight 
at 37°C. The next day, the cells were pelleted by 
centrifugation at 5000 rpm for 10 minutes. The following 
quantities are those used for cells from a single 500ml 
bacterial culture. The pellets were resuspended in a total 
of 10ml of ice cold solution I (50mM glucose, 25mM Tris.HCl 
(pH8), 10mM EDTA (pH8), 5mg/ml lysozyme) and equal volumes 
transferred to two oakridge centrifuge tubes. After 
incubating at room temperature for five minutes 10ml of 
freshly prepared solution II (0.2M NaOH, 1% SDS) was added 
to each tube and the contents mixed by inverting several 
times. The tubes were left on ice for 10 minutes after 
which 7.5ml of ice cold 5M potassium acetate (pH6) was 
added to each tube. The tubes were mixed by inverting 
several times and left on ice for 10 minutes. The pH of the 
solution was then tested with pH paper to ensure that the 
sodium hydroxide had been completely neutralized, and more 
potassium acetate added if necessary. Bacterial debris and
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chromosomal DNA were pelleted by centrifugation at 13 000 
rpm for 30 minutes. 18ml of supernatant from each tube was 
transferred to a 30ml corex tube and nucleic acids 
precipitated by adding 12ml of isopropanol. After 15 
minutes at room temperature the tubes were centrifuged at 
10 000 rpm for 30 minutes at 20°C, and the pellets 
resuspended in a total of 20ml of TE. Exactly 20g of 
caesium chloride was dissolved in this and 0.6ml of 
ethidium bromide (lOmg/ml) added. Using a syringe, this 
solution was transferred to a Beckman heat-sealable 
centrifuge tube. The tubes were topped-up with liquid 
paraffin, balanced to within lOmg and heat sealed. They 
were then centrifuged at 45 000 rpm in a vertical rotor for 
18 hours at 20°C.
The tubes were viewed under U.V. light and the lower band 
(which is supercoiled plasmid DNA) was removed from the 
gradient using a syringe. The solution was extracted at 
least three times with water saturated butan-l-ol to remove 
the ethidium bromide, and then dialysed against 2 litres of 
TE at 4°C overnight. The DNA was precipitated in corex 
tubes at -20°C by the addition of sodium acetate to a final 
concentration of 0.3M and 2 volumes of ethanol. The DNA was 
recovered by centrifugation at 10,000 rpm for 30 minutes at 
4°C and resuspended in 0.5ml of TE. The solution was then 
extracted with neutral phenol and re-precipitated with 
ethanol. The DNA was pelleted by microfugation for 10
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minutes and dissolved in 0.5ml of TE. The DNA concentration 
was determined by measuring the A 2 5 0 •
3.10 Primer Extension Analysis of RNA.
The single stranded oligonucleotide to be used as the 
primer was end labelled with ^ -^^P-ATP (see section 3.29.2) 
and resuspended in 3x PEB (lx PEB is 0.4M NaCl, lOmM PIPES 
(pH6.4), 0.5mM EDTA (pH8)). Hybridisation reactions were 
set up by mixing the RNA sample (in 20ul DEPC treated 
water) and lOul of the labelled primer (in 3x PEB) in a 
0.5ml eppendorf tube. The tubes were tightly sealed and 
incubated overnight at the hybridisation temperature. For 
17mer and 18mer primers 45°C was found to be optimal.
After hybridisation 60ul of ethanol was added and the 
tubes were left at -20°C for 30 minutes. Nucleic acids were 
recovered by microfugation for 10 minutes and dissolved in 
20ul of reverse transcriptase reaction buffer (50mM 
Tris.HCl pH8.3, 6mM MgCl2 , 10mM DTT, ImM each of dATP, 
dCTP, dTTP, dGTP). 9 units of AMV reverse transcriptase was 
added and the reactions incubated at 37°C for 30 minutes. 
Ribonuclease A was added to a final concentration of 2ug/ul 
and the tubes incubated for a further 10 minutes at 37°C. 
DNA was precipitated at -20°C by adding sodium acetate 
(pH6.5) to a final concentration of 0.3M and 2 volumes of 
ethanol. After microfugation the pellet was resuspended in 
4ul of denaturing gel loading dye (90% deionised formamide, 
lOmM EDTA (pH8), 0.01% xylene cyanol, 0.01% bromophenol
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blue), heated at 100°C for 5 minutes and then loaded on to 
a 8% denaturing polyacrylamide (see section 3.5.A). The gel 
was run at 38 watts until the bromophenol blue was about 2 
inches from the bottom of the plate. The plates were prised 
apart, the gel covered with cling film and exposed to x-ray 
film with an intensifying screen at -70°C.
3.11 RNase Protection Assays.
RNase protection assays were carried out essentially as 
described by Zinn et al (1983). 2.5x 10^ cpm of internally 
labelled RNA probe (see section 3.29.A) was hybridised to 
RNA in 30ul of SI hybridisation buffer (AOmM PIPES pH6.A, 
ImM EDTA pH8, O.AM N a C l , 80% deionised formamide) at A5°C 
overnight.
Next day 350ul of digestion buffer (lOmM Tris-HCl pH7.5, 
5mM EDTA, 300mM NaCl) containing RNases was added and the 
reaction incubated at 37°C for 1 hour. A range of RNase 
concentrations were tried. 20ug/ml RNaseA (Sigma) and A00 
units/ml RNaseTl (Boehringer) seemed to give the best 
results. 50ug of proteinase K (Boehringer) and 20ul of 20% 
SDS were added and incubation continued for a further 15 
minutes. The reactions were extracted with neutral phenol 
and precipitated with 2 volumes of ethanol and carrier tRNA 
(lOug). After microfugation samples were suspended in 
denaturing gel loading buffer, boiled for 5 minutes and 
electrophoresed on a denaturing polyacrylamide gel (see
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section 3.5.A) at 38 watts until the bromophenol blue was 
about 1cm from the bottom of the gel.
3.12 Subcloning Techniques.
3.12.1 Restriction enzyme digests.
These were carried out according to the manufacturer's 
instructions. Plasmid DNAs were generally digested for 1 
hour, whilst genomic DNA for southern blotting was digested 
for 5 hours, adding a second aliquot of enzyme after part 
way through the incubation.
3.12.2 Preparation of plasmid vectors for sub-cloning. 
Vectors that had been digested with two enzymes generating
incompatible ends were run on a low melting point agarose 
gel and the linear vector fragment recovered. Vectors cut 
with a single restriction enzyme were treated with calf 
intestinal alkaline phosphatase (CIAP) by adding 1 or 2 
units of enzyme into the digestion reaction at the end of 
the digestion period and incubating for a further 30 
minutes at 37°C. 200ul of NAE was added, followed by 
extraction with neutral phenol, extraction with ether and 
precipitation with 2 volumes of ethanol.
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3.12.3 Preparation of target DNA for subcloning.
Target DNA was generally a restriction fragment isolated 
from a low melting agarose gel (see section 3.5.2).
For some purposes it was necessary to ligate target and 
vector with incompatible sticky ends. In this case 5' 
overhangs (on both target and vector) were 'blunted' by the 
addition of all 4 dNTPs (final concentration ImM) and 10 
units of Klenow fragment of DNA polymerase into the 
digestion reaction (at the end of the digestion period) and 
incubating for a further 30 minutes at room temperature.
3.12.4 Ligations.
lOul reactions were carried out in lx C buffer (66mM 
Tris.HCl pH7.6, 6 .6mM MgCl2 » 10mM DTT), containing ImM ATP, 
vector DNA, target DNA and T4 DNA ligase. Usually, 20ng of 
vector and a concentration range of target DNA was used. A 
control ligation that contained vector alone was always 
included. 0.1 units of T4 DNA ligase was used for sticky 
end ligations and 1 unit for blunt end ligations. The 
reactions were incubated at 14°C overnight.
3.13 Transformation of E.coli with Plasmids.
3.13.1 CaCl2 Mediated Transformation.
This method was used for the coli strains MC1061, TG2, 
71:18 mutL and BL21 (DE3). An appropriate volume of 2x TY 
or LB was inoculated with 0.01 volume of an overnight 
culture of the host bacteria and incubated at 37°C with
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vigorous shaking until the A 5 5Q reached 0.5. The culture 
was then cooled on ice for 1 0 minutes and the cells 
pelleted by centrifugation at 2000 rpm for 5 minutes. The 
pellet was resuspended in 0.5 volume of ice cold 50mM CaCl2 
and left on ice for 20 minutes. The cells were re-pelleted 
and resuspended in 0.1 volume of ice cold 50mM CaCl2 . After 
incubating the cell suspension on ice for a further 10 
minutes (or longer) 0 .2ml aliquots were transferred to 
eppendorf tubes on ice. Half of the appropriate ligation 
reaction (5ul) or approximately lng of uncut plasmid DNA 
was added to an aliquot, followed by mixing and incubation 
on ice for 40 minutes. The cells were then heat shocked at 
42°C for 2 minutes, transferred to ice for 5 minutes, and 
spread onto dried L-agar plates (containing the appropriate 
antibiotic) with an ethanol sterilized glass spreader. The 
plates were incubated inverted at 37°C overnight.
3.13.2 Hanahan High Efficiency Transformation.
This method was used for the transformation of JM101 with 
plasmid and M13 vectors and is essentially as described by 
Hanahan (1983). An appropriately sized culture of host 
cells was grown as described in section 3.13.1, and when 
the A 55 0 reached between 0.3 and 0.4 the culture was cooled 
on ice for 15 minutes. The cells were then pelleted by 
centrifugation at 2000 rpm for 5 minutes and resuspended in 
0.3 original culture volume of transformation buffer (TFB; 
lOmM KMES pH6.3, lOOmM K C1, 45mM MnC1.4H20, lOmM CaCl2 , 3mM
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HAC0CI 3 ). The suspension was left on ice for 15 minutes 
after which the cells were pelleted and resuspended in 0.08 
original culture volume of TFB. At this point the cell 
suspension was transferred to a polypropylene tube and 
left on ice for 10 minutes. Dimethylformamide (DMF) was 
added to a final concentration of 4.75% (v/v), the 
suspension mixed well and left on ice for 10 minutes. A 
solution of 2.25M DTT in lOmM potassium acetate was added 
to 4.1% (v/v), the suspension mixed well and left on ice 
for a further 10 minutes. A second aliquot of DMF was then 
added so that the final concentration of DMF was 9.5%
(v/v). The suspension was incubated on ice for 20 minutes 
and then 0 .2ml aliquots transferred to eppendorf tubes on 
ice. Half of the appropriate ligation reaction (5ul) or 
approximately lng of uncut plasmid DNA was added to an 
aliquot, followed by mixing and incubation on ice for 40 
minutes. The cells were then heat shocked at 42°C for 2 
minutes, transferred to ice for 5 minutes. The transformed 
cells were then spread onto dried L-agar plates (containing 
the appropriate antibiotic) with an ethanol sterilized 
glass spreader, or in the case of M13 transformations 
plated in top agarose (see section 3.14). The plates were 
incubated inverted at 37°C overnight.
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3.14 Plating E.coli Transformed Or Infected With 
Bacteriophage M13.
For each transformation or infection, 3ml of molten H-top 
agar was pipetted into a sterile glass tube in a heating 
block at A5°C. After allowing the top agar to equilibrate 
to A5°C 30ul of X-gal (20mg/ml in DMF), 30ul of IPTG 
(24mg/ml in water) and 2 0 0ul of exponential host cells were 
added, in that order. The transformed or infected host 
cells were then added, the contents of each tube mixed by 
inversion and poured onto a dried H-agar plate. The plate 
was rocked gently to ensure an even covering of top agar 
and then allowed to set at room temperature for 1 0  minutes. 
Plates were incubated inverted at 37°C overnight.
3.15 Small Scale Isolation Of Plasmid DNA And M13 RF DNA.
Single bacterial colonies were inoculated into 2ml of 2x
T Y  containing the appropriate antibiotic using a sterile 
toothpick, and grown in a shaking incubator at 37°C for 8 
to 14 hours. For preparing Ml3 RF DNA 2ml of 2x TY was 
inoculated with 20ul of an overnight culture of the host 
cells and lOul of phage stock or a sterile toothpick which 
had been stabbed into a single plaque. M13 cultures were 
grown at 37°C with vigorous shaking (300 rpra) for 6 to 8 
hours. The cultures were then transferred to 1.5ml 
eppendorf tubes and then microfuged for 5 minutes. In the 
case of M13 infected cells an aliquot of the supernatant
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(which contains bacteriophage particles) was removed and 
stored at -20°C. This supernatant was also used for the 
preparation of single stranded M13 DNA (see section 3.16). 
The pellets were resuspended in 0.2ml of STET (8% sucrose 
(w/v), 0.5% triton x-100 (v/v), 50mM EDTA (pH8 ), lOmM 
Tris.HCl (pH8 )) and lOul of fresh lOmg/ml lysozyme added. 
The tubes were incubated on ice for 10 minutes, and then 
heated at 100°C for 40 seconds. Bacterial debris and 
chromosomal DNA were pelleted by microfugation for 10 
minutes. This viscous pellet was removed using a toothpick 
and nucleic acids in the supernatant precipitated by adding 
0.1 volumes of 3M NaAc (pH6.5) and 1 volume of isopropanol. 
The tubes were left at -20°C for at least 30 minutes and 
then microfuged for 1 0 minutes to recover the nucleic 
acids. The pellet was resuspended in 0.2ml of NaE (0.3M 
sodium acetate pH6.5, ImM EDTA) and the solution extracted 
with an equal volume of neutral phenol. The aqueous phase 
was extracted with ether and nucleic acids precipitated by 
adding 2 volumes of ethanol. After at least 30 minutes at 
-20°C nucleic acids were recovered by microfugation for 10 
minutes and the pellet resuspended in in 40ul of TE. If 
necessary, RNA was removed by treatment with RNase A at a 
final concentration 20ug/ml for 15 minutes at 37°C.
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3.16 Preparation Of Single Stranded M13 Template DNA.
2ml of 2x TY was Inoculated with 20ul of an overnight 
culture of the host strain, usually JM101. Phage particles 
from a single plaque were transferred to the media using a 
sterile toothpick, or alternatively lOul of a frozen phage 
stock was added. Cultures were then incubated at 37°C with 
vigorous shaking (300 rpm) for 6 to 8 hours. The bacteria 
were pelleted by microfugation for 5 minutes and 1ml of the 
supernatant transferred to an eppendorf tube. Bacteriophage 
particles were then precipitated by adding 200ul of 2 0% 
(w/v) polyethylene glycol in 2.5 M NaCl and leaving the 
tubes at room temperature for 20 minutes. The phage were 
pelleted by microfugation for 1 0  minutes and the 
supernatant removed using a Gilson pipette. The tubes were 
re-microfuged for 1 0  seconds to bring down the remaining 
liquid, which was carefully removed using a drawn out glass 
capillary. The pellet was resuspended■in 0.2ml of NaE (0.3M 
sodium acetate pH6.5, ImM EDTA) and the suspension 
extracted with an equal volume of neutral phenol. The 
aqueous phase was extracted with an equal volume of 
chloroform and the DNA precipitated by adding 2 volumes of 
ethanol. After at least 30 minutes at -20°C the DNA was 
recovered by microfugation for 1 0  minutes and dissolved in 
lOul of TE. Template DNA was checked (for concentration and 
contamination with RNA) on a 1% non-denaturing agarose gel 
prior to sequencing.
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3.17 Complementation Tests On Single Stranded M13 DNA
For M13 subclones (Intended for sequencing) in which the
cloned fragment could have been Inserted in either 
orientation, and it was necessary to sequence from each end 
of the cloned fragment, complementation tests on single 
stranded phage DNA were used to select clones of both 
orientations.
lOul of phage supernatant (in 2x TY) from each of two 
clones was mixed with 2ul of 1% SDS and hybridised at 65°C 
for 1 hour. After adding 4ul of loading buffer the samples 
were analysed on a IX non-denaturing agarose gel. The 
presence of a slower migrating band (not present in either 
phage supernatant alone) indicated that the two clones had 
annealed, and therefore contained the insert in opposite 
orientation.
3.18 Plating Bacteriophage Lambda.
An appropriate volume of 2x TY was inoculated with host 
cells (BB4 or Y1090) from an overnight culture and grown on 
a shaker at 37°C until the A 550 reached 0.5. The cells were 
pelleted by centrifugation at 2000 rpm for 5 minutes and 
resuspended in 0.05 original culture volume of lOmM MgS0A . 
Bacteriophage particles (from phage stock in SM buffer(50mM 
Tris.HCl p H 7 .5, 0.58X (w/v) NaCl, 0.2X (w/v) MgSOA .7H20, 
0 .0 1 Z (w/v) gelatin)) were mixed with these host cells and 
allowed to adsorb for 15 minutes at 37°C. Up to 100 000 
phage were absorbed with 0 .6ml of host cells. 6ml of molten
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top agarose was aliquoted in to sterile tubes in a heating 
block at A5°C a nd allowed to equilibrate to A5°C. 0.6ml of 
infected cells was added to the top agarose and this was 
then poured onto dried 10cm x 10cm NZY plates and allowed 
to set on a level surface. The plates were then incubated 
inverted at 37°C until plaques of a suitable size formed.
3.19 Bacteriophage lambda Plaque Lifts.
This procedure was used to transfer bacteriophage DNA from 
plates to nitrocellulose filters and is essentially as 
described by Benton and Davis (1975). The host strains BBA 
or Y1090 were used. Bacteriophage lambda were plated (see 
section 3.18) using top agarose (not agar), and then 
incubated at 37°C for 5 to 6 hours until suitably sized 
plaques formed. Plaques became visible about A hours after 
plating and were allowed to grow for a further 1 to 2 
hours. The plates were then transferred to A°C for at least 
2 hours. Pieces of nitrocellulose, cut slightly smaller 
than the plates, were carefully lowered onto the surface of 
the top agarose ensuring that no air bubbles formed. These 
were left in place for 1 minute during which time the 
position of the filter was marked by making three 
asymmetrical holes through the filter and into the agar 
with a syringe needle. The position of the holes was also 
marked on the base of the plates using a marker pen. The 
filters were carefully removed with a pair of forceps and 
placed, DNA side up, onto a tray containing several sheets
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of filter paper (Whatman 3MM) moistened with denaturing 
solution (0.5M NaOH, 1.5M NaCl). The filters were left in 
place for 1 minute during which time a second 
nitrocellulose filter was applied to each plate. This 
replica filter w as left in place for 2 minutes and 
orientated by m a king holes in the identical positions used 
for the first filter. The replica filter was denatured in 
the same way as the first filter. After denaturation the 
filters were transferred to a tray containing several 
sheets of 3MM moistened with neutralising solution (3M 
NaCl , 0.5M Tris.HCl pH7, ImM EDTA), left in place for 4 
minutes and then transferred to a second tray of 
neutralising solution for a further 5 minutes. Finally 
filters were transferred onto a tray of 3MM soaked in 2x 
SSC for 5 to 10 minutes. The filters were then allowed to 
air dry.
The filters were then baked at 80°C under vacuum for 2 
hours. Prehybridisation, hybridisation and autoradiography 
of filters was as described for Southern blotting (see 
section 3.7)
The region containing a positive plaque was identified by 
the orientation marks made in the filter and plate. Agar 
plugs were cut from the plate, transferred to 1ml of SM 
buffer containing 3ul of chloroform and stored at 4°C. This 
phage stock was replated (at a lower density) and plaque 
lifts performed. Positive plaques were identified and the
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process repeated until the agar plug taken contained a 
single positive plaque.
3.20 Automatic Excision Of Phagemids From lambda ZAP 
Clones.
This was carried o ut exactly as described by the 
manufacturer. A culture of BB4 was grown until the A 5 5 q  was 
between 0.8 and 1. 0.2ml of culture was mixed with lOOul of 
lambda ZAP phage stock (from a single positive plaque, see 
section 3.19) and lOul of R408 helper phage (7x 10*® 
pfu/ml, supplied b y  Stratagene). The cultures were 
incubated in a 37°C shaker at 200 rpm for 4 to 6 hours, 
heated at 70°C for 20 minutes and then centrifuged at 2,000 
rpm for 5 minutes. The supernatant, which contains the 
phagemid particles, was transferred to a fresh tube and 
stored at 4°C. The phagemid was converted to colony form by 
mixing 0.2ml of a fresh BB4 culture (A5 5Q about 0.5) with 
0.1 to lOOul of the phagemid stock, incubating at 37°C for 
15 minutes to allow adsorption of the phage, and then 
spreading 10 and lOOul aliquots onto dried L agar plates 
containing ampicillin (100ug/ml). The plates were incubated 
inverted overnight at 37°C.
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3.21 DNA Sequencing b y  the Dideoxy Chain Termination 
Method.
3.21.1 Sequencing single stranded M13 templates.
This method was first described by Sanger ejt si (1977).
A set of deoxynucleotide and dideoxynucleotide mixes were 
assembled as shown below:
(A) A° C° Go To
0.5mM dCTP 2 0 ul lul 20ul 20ul
0.5mM dGTP 2 0 ul 20ul lul 20ul
0.5mM dTTP 2 0 ul 20ul 20ul lul
TE buffer 2 0 ul 20ul 20ul 20ul
(B) Dideoxy NTP w o rking solutions: 0.03mM ddATP, O.lmM 
ddCTP, 0.075mM ddGTP, 0.5mM ddTTP. These concentrations 
were altered as necessary to suit a particular template, or 
reduced (generally b y  half) to allow reading of sequence at 
a greater distance f r o m  the primer.
(C) Chase mix: 0.5mM of all 4 dNTPs.
For each clone to be sequenced an annealing reaction was 
set up by mixing lul of single stranded template DNA, 6.5ul 
of sterile water, 1 .5ul of freshly prepared klenow reaction 
buffer (9ul of lOx c o r e  buffer (lOOmM Tris.HCl (pH8 ), 50mM 
MgCl2 ) and lul of 7 0 0 m M  B-mercaptoethanol), and lul of M13 
17mer sequencing primer (2ng/ul). To anneal the primer to 
template the tube w a s  placed in a large shallow tray
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containing water at 80 to 85°C and left to cool at room 
temperature for about 30 minutes. For each template, four 
0.5ml eppendorf tubes were labelled A, C, G, and T. lul of 
the A° nucleotide mix and lul of the ddATP nucleotide 
solution was placed into the "A" tube. This was repeated 
for the "C", "G", and "T" tubes using the appropriate 
nucleotide mixes. The annealed template/primer mix was 
centrifuged briefly to bring down any condensation,and then 
lul of 0(-3 5S-dATP and lul of DNA polymerase Klenow fragment 
(5 units/ul) added. 2.5ul of this mix was added to each of 
the tubes containing the nucleotide mixes. The reaction was 
allowed to proceed at 30°C for 20 minutes after which lul 
of chase mix was added a n d  the tubes incubated for a 
further 10 minutes at 30°C. The reaction was terminated by 
adding 5ul of denaturing gel loading buffer.
One third of each reaction was analysed on a 6% denaturing 
polyacrylamide gel (see section 3.5.A) made with a sharks 
tooth comb. The gel was generally run until the bromophenol 
blue in the loading buffer was at the bottom, and then a 
second 1/3 of the reaction loaded. Electrophoresis was 
continued until the bromophenol blue from this loading was 
at the bottom of the gel, and if necessary the process 
repeated with the final 1/3 of the reaction.
3.21.2 Sequencing plasmid DNA.
Plasmid DNA from a small scale isolation treated with 
RNaseA (see section 3.15) was used as template.
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Approximately 2ug of DNA in 200ul of NAE was extracted with 
neutral phenol and precipitated with 2 volumes of ethanol 
at -20°C. DNA was recovered b y  microfugation for 10 minutes 
and suspended in 20ul of 0.2M sodium hydroxide; 0.2mM EDTA. 
The solution was left at room temperature for 5 minutes, 
and then DNA precipitated by a d ding 2ul of 2M ammonium 
acetate (pH4.5) and lOOul of ethanol and leaving at -70°C 
for 30 minutes. DNA was recovered by microfugation for 15 
minutes, and then the pellet w as washed in 80X (v/v) 
ethanol and briefly dried under vacuum. DNA was suspended 
in lOul of a solution made by mixing 1.5ul of reaction 
buffer (see section 3.21.1), 6.5 ul of water and 2ul of M13 
17mer sequencing primer (2ng/ul). Primer was annealed to 
template by incubation at 37°C for 15 minutes, and then 
sequencing reactions carried out as described for single 
stranded M13 templates (see section 3.21.1).
3.22 Oligonucleotide directed mutagenesis.
This procedure (first described by Kunkel (1985)) was used 
to introduce point mutations into M13 subclones.
3.22.1 Phosphorylating synthetic oligonucleotides.
Synthetic oligonucleotides were supplied dephosphorylated 
at the 5' end, and to allow ligation at the end of the 
extension reaction had to be kinased. 12 0ng of 
oligonucleotide was kinased in 20ul of lx C buffer (6 6mM 
Tris.HCl pH7.6, 6 .6mM MgCl2 , 1 0 m M  DTT) containing 2mM ATP
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and 20 units of T4 polynucleotide kinase. The reaction was 
allowed to proceed at 37°C for 1 hour.
3.22.2 Annealing oligonucleotide to template.
6ul of single stranded M13 template (see section 3.16), 
l.Sul of lOx TM buffer (lOOmM Tris.HCl pH7.5, 50mM MgCl2 ), 
6.5ul of water and 3ul of the oligonucleotide kinasing 
reaction were mixed, heated to 65°C for 10 minutes and then 
cooled slowly (over 30 minutes) to room temperature. An 
equivalent reaction with no oligonucleotide was also set 
up.
3.22.3 Extension reactions.
3ul of extension mixture (3ul lOx TM, 3ul 5mM all 4 dN T P s , 
2ul lOmM ATP, 3ul lOOmM DTT, 7ul water) and 5ul of 
annealing reaction were mixed together. 5 units of Klenow 
fragment of DNA polymerase and lunit of T4 DNA ligase were 
added, and the reaction incubated at 14°C for 5 hours to 
overnight. A control reaction with no T4 DNA ligase was 
also set up.
These reactions, and some template DNA, were 
electrophoresed on a low melting point agarose gel (see 
section 3.5.2) and viewed under U V  light. The control 
reaction from an 'annealing' with no oligonucleotide should 
give a single band of the same mobility as template DNA.
The control reaction with no ligase added generally gave a 
high molecular weight band (assumed to consist of multimers
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generated by strand displacement) and a second, faster 
migrating band above the position of the template band 
(assumed to consist of nicked, circular M13 duplexes). The 
reaction with ligase added generally had an additional band 
(above the nicked, circular M13 duplexes and below the 
multimers) which was assumed to consist of closed, circular 
M13 duplex. This band was excised and the DNA purified.
3.22.A Screening for mutants.
Purified closed, circular duplex M l 3 was transformed into 
E. coli 71:18 mutL as described in section 3.13.1. Single 
plaques were picked, grown-up and phage stocks taken (see 
section 3.15).
These phage stocks (which contain single stranded DNA in 
phage particles) were screened for mutants, lul of these 
phage stocks (and phage stock of the original M13 subclone) 
were spotted onto duplicate nitrocellulose filters. These 
filters were then processed as described for bacteriophage 
lambda plaque lifts (see section 3.19), treating them with 
denaturing solution and neutralising solution and then 
baking at 80°C under vacuum for 2 hours.
Filters were then prehybridised and hybridised to end- 
labelled oligonucleotide (see section 3.29.2 for method of 
end-labelling oligonucleotides) as described for Southern 
blotting (section 3.7), except that no formamide was added 
to hybridisation/pre-hybridisation solutions and 
hybridisation was carried out at room temperature.
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The duplicate filters were washed at different 
temperatures in 6x SSC containing 0.1% (w/v) SDS. The 
melting temperature of the oligormutant-template duplex in 
°C was assumed to be 4(G, C content of oligo) + 2(A, T 
content of oligo). One filter was washed at Tm-2, and one 
filter at Tm-15 for 30 minutes to 1 hour. A  hybridisation 
signal should be seen with mutant phage after washing at 
both Tm-2 and Tm-15. A hybridisation signal should be seen 
with non-mutant phage (and the original subclone) only at 
Tm-15, this signal being washed off at Tm-2 (since the 
oligo is mis-matched). The yield of mutants ranged between 
30% and 100% of phage stocks tested.
Some phage stocks were found to consist of a mixture of 
wild-type and mutant phage. Consequently phage were 
purified by infecting coli JM101 with the phage stock, 
plating-out (see section 3.14), taking single plaques from 
these plates and re-screening.
Finally the mutants were checked by sequencing single 
stranded M13 template (prepared as described in section 
3.16), or if the mutation generated a restriction 
endonuclease site by preparing phage RF DNA (see section 
3.15) and checking for the presence of that site.
-100-
Methods
3.23 SDS-Protein Polyacrylamide Gel Electrophoresis.
3.23.1 Running protein gels.
A 20cm x 20cm denaturing gel was poured in two stages. 
Firstly the 16cm separating gel, which consisted of 10 to 
15X acrylamide (37.5:1 bis), 0.3M Tris.HCl pH8 .8 , 0.08X 
(w/v) SDS. After this had set it was overlaid with the 4cm 
stacking gel (into which the slot former was inserted), 
which consisted of 3X acrylamide (20:1 bis), 0.125M 
Tris.HCl pH 6 .8 , 0.1X (w/v) SDS. Protein samples were mixed 
with an equal volume of 2x loading buffer (0.125M Tris.HCl 
pH6 .8 , 20X glycerol, 4X (w/v) SDS, 10X (v/v) 
2-mercaptoethanol, 0.002X bromophenol blue), heated at 90°C 
for 5 minutes and loaded onto the gel. The gel was run at 
10 to 40mA in lx running buffer (50mM Tris, 400mM glycine, 
0.1X (w/v) SDS).
Gels were then transferred to nitrocellulose (see section 
3.24), or stained for protein with Coomassie blue, or 
fluorographed and then autoradiographed.
3.23.2 Staining protein gels with Coomassie blue.
Gels were incubated in stain (10X (v/v) acetic acid, 45X 
(v/v) methanol, 0.1X (w/v) Coomassie blue) for at least 1 
hour on a slow shaker. The gel was then incubated in 
several changes of destain (10X (v/v) acetic acid, 45X 
(v/v) methanol) on a slow shaker, until background staining 
was adequately reduced. Gels were photographed wet, and 
then dried on a vacuum drier at 60°C.
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3.23.3 Fluorography of protein gels.
Gels used to resolve proteins labelled with ^S-methionine 
were fluorographed to enhance the signal seen on X-ray 
film.
Gels were incubated in fixer (10% (v/v) acetic acid, 45% 
(v/v) methanol) for at least 1 hour and then transferred to 
E n h a n c e  (Dupont) for 30 to 45 minutes. The gel was then 
incubated in water (to precipitate the scintillant) for 30 
to 45 minutes, dried on a vacuum drier at 60°C, and exposed 
to X-ray film at -70°C.
3.24 Western Blots.
Proteins resolved on SDS polyacrylamide gels (see section 
3.23.1) were electrophoretically transferred to 
nitrocellulose. The gel was soaked in blotting buffer (20mM 
Tris, 150mM glycine, 20% (v/v) methanol) for 30 minutes. A 
sandwich of 3 sheets of filter paper (Whatman 3MM) followed 
by a sheet of nitrocellulose, the gel and 3 sheets of 3MM 
was assembled. All components were pre-wetted in blotting 
buffer. The sandwich was submerged in blotting buffer, in 
an electro-blotting tank, with the nitrocellulose between 
the gel and the positive electrode. The gel was blotted at 
30 volts overnight (or 60 volts for 3 hours). Blots were 
stored wrapped in cling film at -20°C.
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3.25 Immuno-detection of Proteins on Western Blots.
A Western blot (see section 3.24) was blocked by 
incubating In 100ml of TBS (20mM Trls.HCl pH7.6, 137mM 
sodium chloride), containing 0.1X tween-20 and 5X dried 
non-fat milk, on a slow shaker for 1 hour. The filter was 
washed 3 times in 100ml of fresh TBS, containing 0.1X 
tween-20, for 5 minutes each on a slow shaker. The filter 
was then incubated in a plastic bag with 10ml of TBS 
containing antiserum or affinity purified antiserum 
(usually lOOul) and incubated on a slow shaker for 1 to 2 
hours. The filter was then washed, as before, in TBS 
containing 0.1X tween-20.
Bound antibodies were detected using an Amersham Blotting 
Detection Kit (for rabbit antibodies) exactly according to 
the manufacturer's instructions. The filter was incubated 
in a plastic bag with 10ml of TBS containing biotinylated 
anti rabbit immunoglobulin on a slow shaker for 30 minutes. 
The filter was then washed as before. The filter was 
incubated in a plastic bag with 10ml of TBS containing 
streptavidin-alkaline phosphatase conjugate on a slow 
shaker for 20 minutes. The filter was then washed as 
before. Finally, the filter was incubated in a plastic bag 
with 10ml of diethanolamine buffer (lOOmM
diethanolamine.HCl pH9.5, 5mM MgCl2 ) containing nitro-blue 
tetrazolium (NBT) and 4-chloro-3-indoyl phosphate (BCIP), 
developed as long as necessary, and then the reaction 
stopped by washing in water.
-103-
Methods
3.26 Generation and Purification of a Polyclonal Antiserum.
3.26.1 Purification of a fusion protein produced in coll 
for use as an antigen.
A fusion protein produced from a cloned fragment of X. 
laevis Oct-1 in the pET-3B vector (Rosenberg ejt ¿1 (1987)) 
was purified for use as an antigen by preparative 
polyacrylamide gel electrophoresis.
E. coli BL21 (DE3) carrying the fusion protein construct 
was grown at 37°C in 2x TY (containing 200ug/ml ampicillin) 
to AgQQ-0.8, at which point IPTG was added to ImM to induce 
T7 RNA polymerase (which transcribes message for the fusion 
protein) and growth continued for a further 3 hours. The 
cells were pelleted, resuspended in 0 .0 1 volume of lx 
loading buffer, sonicated, heated at 90°C for 5 minutes and 
the proteins (from approximately 50ml original culture 
volume) resolved on a double thickness SDS polyacrylamide 
gel (see section 3.23.1). The T7 gene 10 - Oct-1 fusion 
protein was visualised by briefly staining the gel with 
0.05X Coomassie blue in water. The gel slice containing the 
fusion protein was excised.
3.26.2 Immunisation of rabbit.
Gel slices were mixed with an approximately equal volume 
of PBS and ground with a pestle and mortar. For the first 
injection this mixture was emulsified with Freund's 
complete adjuvant (see Harlow and Lane (1988)). For 
subsequent injections, slices were emulsified with Freund's
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incomplete adjuvant. Approximately 10ml of blood (for pre- 
imraune serum) was taken from the ear New Zealand White 
rabbit before the first injection. The rabbit was given 3 
injections of 50-100ug of protein at 2 week intervals. 
Bleeding the rabbit took place 2 weeks after the third 
injection. Blood was allowed to clot at room temperature 
for about 6 hours, the clot separated from the side of the 
tube with a needle and then tubes centrifuged at 2 0 0 0rpm 
for 5minutes. The supernatant (serum) was taken and stored 
in aliquots at -20°C.
3.26.3 Affinity purification of antiserum.
This procedure was adapted from Harlow and Lane (1988). 
Extract from 12^ coli expressing the T7 gene 10 - Oct-1 
fusion protein was prepared as described in section 3.26.1. 
Extract containing approximately lOOug of fusion protein 
was loaded across the entire width of, and run on a SDS 
polyacrylamide protein gel (see section 3.23.1). The gel 
was electroblotted onto a nitrocellulose filter (see 
section 3.24).
A narrow strip was cut from the edge of the filter and the 
fusion protein detected with the polyclonal antiserum (see 
section 3.26.2). The section of filter containing the 
fusion protein was then cut out, and incubated with 3ml of 
antiserum mixed with 3ral of TBS (20mM Tris.HCl pH7.6, 137mM 
sodium chloride) on a slow shaker for 4 hours. The filter 
was washed in 3 changes of TBS over 15 minutes, and then
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bound antibody removed by incubating the filter in 3ml of 
lOOmM glycine (pH2.5) for 5 minutes. The glycine solution 
(containing affinity purified antibodies) was mixed with 
300ul of 1M Tris.HCl (pH8 ), and aliquots stored at -20°C.
3.27 Sucrose Density Gradient Centrifugation.
Sucrose density gradient centrifugation was used to 
fractionate oocyte protein extract. Oocyte protein extract 
was prepared as described for band shift assay protein 
extract (see section 3.31.1) except that the glycerol in 
extract buffer was replaced by 8% (w/v) sucrose.
An 11ml 30% (w/v) to 10% sucrose gradient was prepared in 
an ultracentrifuge tube. The sucrose solutions were made in 
band shift assay extract buffer, except with no glycerol 
(50mM Tris.HCl pH8 , 50mM KC1, O.lmM EDTA, 5mM MgCl2 , 2mM 
DTT). The gradient was cooled to A°C and 500ul (equivalent 
to 10 0 oocytes) of oocyte extract layered on top of the 
gradient. The gradient was centrifuged in a swing-out rotor 
at 37000rpm for 45 hours at 4°C.
The gradient was fractionated from the bottom of the tube 
by inserting a hollow needle attached to a peristaltic 
pump, and pumping out approximately 20 equal fractions. The 
fractions were divided before storage, some being stored at 
-20°C (for use in Western blots and immuno-detection of 
proteins) and some stored in liquid nitrogen (for use in 
band shift assays).
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3.28 Preparation of Nuclear Extract from Xtc Cells.
This method (adapted from a method used to prepare nuclei 
from Xenopus erythrocytes, pers. comm., M. T. Vlad) was 
used to prepare extract from nuclei of X^ laevis Xtc 
cells, for use In Western blotting and Immunodetection of 
proteins.
Subconfluent Xtc cells (see section 3.1.1) were scraped 
from the surface of a 75cm^ tissue culture flask in 10ml of 
PBS. The cell suspension was centrifuged at 3000rpm for 5 
minutes and suspended in 200ul of suspension buffer (0.25M 
sucrose, 0.1M KC1, 0.1M Tris.HCl pH7.4, 0.5mM CaCl2 ), and 
then cooled on ice. The cells in this suspension were 
counted using a haemocytometer slide. Half of this 
suspension (whole cell extract) was stored at -20°C. The 
remainder of this suspension was mixed with 10ml of lysis 
buffer (0.25M sucrose, 0.1M KC1, 0.1M Tris.HCl pH7.4, 0.5mM 
CaCl2 , 0.05% saponin (Sigma)). The suspension was 
transferred to room temperature for 3 minutes and then 
centrifuged at 3000rpm for 5 minutes. The pellet (nuclear 
extract) was suspended in lOOul of suspension buffer. The 
nuclear extract was checked microscopically for complete 
cell lysis and the nuclei counted using a haemocytometer 
slide. The yield of nuclei was at least 90%.
The nuclear extract was checked as follows. lOul of 
extract (whole and nuclear) was mixed with 500ul of NAE 
(0.3M sodium acetate pH6.5, ImM EDTA) and the suspension 
extracted with an equal volume of neutral phenol. Nucleic
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acids were precipitated from the aqueous phase by the 
addition of 2 volumes of ethanol. After at least 30 minutes 
at -20°C the nucleic acids were recovered by microfugation 
for 10 minutes, and resuspended in lOul of TE. Nucleic 
acids were resolved on a 1 % non-denaturing agarose gel (see 
section 3.5.1). Whole extract contained both chromosomal 
DNA (nuclear) and ribosomal RNA (cytoplasmic). Nuclear 
extract contained only chromosomal DNA.
Before running on an SDS-proteln gel (see section 3.23.1) 
extract was mixed with an equal volume of 2x loading 
buffer, and sonicated to shear chromosomal DNA.
3.29 Methods For Radiolabelling DNA And RNA.
3.29.1 Nick Translation.
DNA fragments isolated from low melting point agarose gels 
were labelled by nick translation for use as probes in 
Southern and Northern blotting. A 20ul reaction was 
assembled in lx NTB (50mM Tris.HCl (pH7.2), lOmM MgS04 , 
O.lmM DTT, 50ug/ml BSA) containing 100 ng of DNA, ImM 
'cold' dNTPs (dATP, dCTP, dTTP), 40uCi of0<-3 2P-dGTP, lng 
of deoxyribonuclease I (Sigma) and 10 units of coli DNA 
polymerase I (Amersham). The reaction was allowed to 
proceed at 14°C for 3 to 4 hours after which 0.2ml of NaE 
was added. The mixture was run through a 10 ml sephadex 
G-50 gel filtration column in TE buffer. The higher 
molecular weight labelled DNA passes through this column 
faster than unincorporated nucleotides, allowing separation
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of the labelled DNA from unincorporated nucleotides. 
Labelled DNA (first peak of radioactivity) was collected 
from the column, heated at 100°C for 5 minutes, cooled on 
ice, and then added to Southern/Northern blot hybridisation 
buffer.
3.29.2 End-labelling DN* with Jf-3 2P-ATP and T4 
polynucleotide kinase.
Single stranded oligonucleotides (for use in screening 
oligonucleotide directed mutants and in primer extension 
assays) and duplex oligonucleotides (for use in band shift 
assays) were labelled using this method. Synthetic 
oligonucleotides are supplied dephosphorylated at the 5' 
end, and can therefore be labelled by kinasing with 
it-32p -a t p .
A 15ul reaction was assembled in lx C buffer (66mM 
Tris.HCl (pH7.6 ), 6 .6mM MgCl2 , 10mM DTT) containing 4 to 10 
ng of oligonucleotide, 60 to 100 uCi of J - ^ P - A T P  and 20 
units of T4 polynucleotide kinase. The reaction was 
incubated at 37°C for 1 hour after which 0.2ml of NaE was 
added. The mixture was run through a sephadex G-50 gel 
filtration column in TE buffer, in order to separate 
labelled oligo from unincorporated nucleotide. Fractions 
containing labelled DNA were collected and DNA precipitated 
by the addition of sodium acetate (pH6.5) to a final 
concentration of 0.3M and 2 volumes of ethanol. DNA was 
recovered by microfugation for 10 minutes, and resuspended
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in TE buffer.
Essentially the same method was used to end label 
restriction fragments of DNA from which the 5' phosphate 
had been removed with calf intestinal alkaline phosphatase 
(essentially as described in section 3.11.2).
3.29.3 Labelling DNA Fragments by End-Filling.
Up to lug of restricted DNA (ends of DNA with 5' 
overhangs) was labelled by filling in the overhang with a 
nucleotide mix containing one radio-labelled nucleotide. A 
reaction was assembled in lx TM buffer (lOmM Tris.HCl 
pH7.5, 5mM MgCl2) containing DNA, nucleotide mix and 10 
units of Klenow fragment of DNA polymerase. The nucleotide 
mix contained AOuCi of an appropriate 0^-3 2P“dNTP, and the 
other 3 dNTPs (unlabelled) to give a final concentration of 
ImM. The reaction was incubated at room temperature for 30 
minutes. Labelled DNA was separated from unincorporated 
nucleotides by sephadex G50 gel filtration, and recovered 
by ethanol precipitation.
This method was routinely used to prepare radiolabelled 
DNA markers from lambda DNA (CI857) digested with Eco RI 
and Hind III, and from pBR322 digested with Hpa II.
3.29.4 32P Labelled Synthetic RNA Probes.
High specific activity RNA probes were prepared (by 
transcribing subclones in the presence of an 0(- 3 2 P~NTP) for 
use in RNase protection assays.
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Subclones in the vector pBluescript SK- (Stratagene) were 
linearised at an appropriate polylinker restriction site 
and transcribed in a 20ul reaction containing lx 
transcription buffer (40mM Tris.HCl pH8 , 6mM MgCl2 , 20mM 
DTT), 60uC10(-32P-UTP, lmM 'cold' KTPs (ATP, GTP, CTP), 
62.5ug/ml BSA, 10 units human placental RNase inhibitor 
(Pharmacia), 100 to 200ng template (linearised DNA), and 10 
units of T7 or T3 RNA polymerase (New England Biolabs). The 
reaction was incubated at 37°C for 30 minutes, and then 5 
units of RNase-free DNase I (Boehringer) added, and the 
reaction incubated at 37°C for a further 10 minutes. The 
reaction was stopped by the addition of lOOul NAE (0.3M 
sodium acetate pH6.5, lmM EDTA), extracted with an equal 
volume of neutral phenol, and then RNA precipitated from 
the aqueous phase by the addition of 2 volumes of ethanol. 
After at least 30 minutes at -20°C RNA was recovered by 
microfugation for 10 minutes and resuspended in SI 
hybridisation buffer (see section 3.11).
Incorporation of label into probe was measured by the 
following procedure. 0.5% of the probe (in SI hybridisation 
buffer) mixed with 5ml of ice cold 10% (w/v) 
trichloroacetic acid (TCA) and lOOug of salmon sperm DNA. 
The mixture was incubated on ice for 15 minutes, and then 
filtered through a glass fibre filter, using a milipore 
vacuum filtration apparatus. The filter was washed twice in 
10ml of 10% (w/v) TCA and twice in 10ml ethanol, dried at 
room temperature, and then precipitated radioactivity
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measured in a scintillation counter. TCA precipitates the 
RNA (but not unincorporated nucleotide) which is then 
retained on the glass fibre filter. 2x lO^cpm of RNA was 
used in each RNase protection assay. Typically, 50 times 
this amount was obtained from each transcription reaction.
3.30 Preparation of Synthetic RNA for Microin.lection into 
Oocytes.
Subclones in the vector pBluescript SK- (Stratagene) were 
linearised at an appropriate polylinker restriction site 
and transcribed in a reaction containing lx transcription 
buffer (40mM Tris.HCl pH8 , 6mM MgCl2 . 20mM DTT), 0.5mM ATP, 
0.5mM UTP, 0 . 5mM CTP, 0.05mM GTP, 62.5ug/ml BSA, 10 units 
human placental RNase inhibitor (Pharmacia), 200 to 500ug 
template (linearised DNA), 0.5mM RNA Cap structure analogue 
(m7G(5')ppp(5')G, from New England Biolabs) and 10 units of 
T7 or T3 RNA polymerase (New England Biolabs). The reaction 
were incubated at 37°C for 1 hour, then GTP (to a final 
concentration of 0.5mM) and 10 units of T7 or T3 RNA 
polymerase added. The reaction was incubated for a further 
30 minutes at 37°C. The reaction was stopped by the 
addition of 200ul of NAE (0.3M sodium acetate pH6.5, ImM 
EDTA), extracted with an equal volume of neutral phenol, 
the aqueous phase extracted with chloroform, and nucleic 
acids precipitated from the aqueous phase by the addition 
of 2 volumes of ethanol. After at least 30 minutes at -20°C 
nucleic acids were recovered by microfugation for 10
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minutes and resuspended in 5 to lOul of TE buffer. RNA 
concentration was estimated by electrophoresing a fraction 
of the product of the transcription reaction on a non­
denaturing agarose gel (see section 3.5.1) and viewing the 
gel under UV light. RNA prepared in this way was 
microinjected into the cytoplasm of oocytes, and 
translation products labelled with ^S-methlonine (see
section 3.3).
3.31 Preparation of Protein Extract for Band Shift Assays.
The following procedure was used to prepare protein 
extracts for use in band shift assays (see section 3.32), 
and extracts prepared in the same way were also used for 
SDS-protein acrylamide gel electrophoresis. All extracts 
were made in extract buffer: 50mM Tris-HCl pH8 , 50mM KC1, 
O.lmM EDTA, 5mM MgCl2 , lOug/ml aprotinin (Boehringer), 
lOug/ml leupeptin (Boehringer), 25X glycerol.
3.31.1 From Xenopus laevis oocytes, eggs and embryos.
Oocytes and embryos were homogenised on ice in 5ul of 
extract buffer per oocyte/embryo, microfuged at A°C for 10 
minutes and the supernatant snap frozen in liquid nitrogen. 
Enucleated oocyte extract was prepared in the same way from 
oocytes from which the nuclei had been removed by manual 
dissection (the animal pole of the oocyte was pierced with 
the tip of a fine needle, and the oocyte gently squeezed 
with a pair of watchmakers forceps to expel the nucleus
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with little loss of cytoplasm). Isolated nuclei were picked 
up with a Gilson pipette in 5ul of lx barth-X (the medium 
in which oocytes were incubated), glycerol added to 25X 
(v/v), and the extract snap frozen in liquid nitrogen. This 
extract was tested in band shift assays, but was not active 
(either because of leakage of nuclear contents before being 
picked up, or because the barth-X does not maintain binding 
proteins in an active form). However, nuclear extract was 
used for SDS-protein gel electrophoresis.
3.31.2 From adult X. laevis tissues.
Minced tissues were homogenised on ice in 2-3 volumes of 
extract buffer, microfuged at A°C for 10 minutes and the 
supernatant snap frozen in liquid nitrogen.
3.31.3 From cultured cells.
Subconfluent cells were washed in phosphate buffered 
saline (PBS) and scraped from the surface of the 75cm2 
flask in lOmls of ice cold PBS, pelleted and resuspended in 
30ul of extract buffer per flask. The suspended cells were 
homogenised on ice, microfuged at A°C for 10 minutes and 
the supernatant snap frozen in liquid nitrogen. When levels 
of binding proteins were to be compared the protein 
concentration of the extract was measured (Biorad protein 
detection kit) and equalised at 5mg/ml.
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3.31.A From E. coll expressing fusion proteins.
E. coll BL21 (DE3) and E. coll TG2 carrying fusion protein 
constructs were grown In 2x TY (containing 200ug/ml 
ampicillin) to A^ q q  - 1.5, pelleted and resuspended in 0.01 
volumes of extract buffer. The suspended cells were 
sonicated on ice, microfuged at 4°C for 10 minutes and the 
supernatant snap frozen in liquid nitrogen.
3.32 Band shift assays.
3.32.1 Preparation of probes.
Complementary synthetic oligonucleotides (25mers) were 
mixed at a final concentration of lmg/ml in lx medium salt 
restriction digest buffer (lOmM Tris.HCl pH7.4, lOmM MgSO^, 
50mM NaCl, ImM DTT), heated at 85°C for 10 minutes, and 
then left to cool to room temperature in an eppendorf tube 
floating in a 1 litre beaker of water at 85°C. Annealed 
oligonucleotides were then diluted to a concentration of 
2ug/ml in TE buffer. lOng of duplex oligonucleotide was end 
labelled with lOOuCi of )f-^P-ATP and T4 polynucleotide 
kinase (oligonucleotides are supplied dephosphorylated) as 
described in section 3.29.2.
3.32.2 Assays.
25ul binding reactions were carried out on ice for 20 
minutes in binding buffer (45mM KC1, 15mM HEPES pH7.9, 5mM 
spermidine, ImM MgCl2 » lmM dithiothreitol, 0.5mM PMSF,
O.lmM EDTA, 7% glycerol) containing 2ug of pAT153, lug of
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salmon sperm DNA, 20ng of non-specific duplex 
oligonucleotide (ACAGACCGAAGCTTAGCT), 0.3ng of duplex 
oligonucleotide probe, up to 5ul of protein extract (see 
section 3.21) and (when added) lul of antiserum. For 
competition analysis the non-specific duplex 
oligonucleotide probe was replaced by 20ng of specific 
duplex oligonucleotide.
The reactions were electrophoresed on a 5% polyacrylamide 
gel (29:1 bis) in Tris-borate buffer (22.5mM Tris-borate 
pH8 , 0.5mM EDTA) at 200 volts and 4°C for 2 hours. The gel 
was fixed, dried and exposed to X-ray film with an 
intensifying screen for 2-12 hours at -70°C.
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RESULTS AND DISCUSSION.
Chapter A.
Homologues of human Oct-1 occur In the X. laevls genome, and 
In X. laevls oocyte RNA,
Introduction.
The clone pBS-Oct-l+ (see Sturm et al (1988A), gift of 
Winship Herr) contains the entire human Oct-1 cDNA in the 
vector pBSMl3+ (Stratagene). An Eco RI digest releases the 
Oct-1 cDNA from this clone as two fragments of approximately 
equal size (about 1.2 and 1.3 kb). These two fragments were 
isolated together from an agarose gel, and the mixture 
labelled for use as a probe for a X^ _ laevis genomic DNA 
Southern blot, and for a X^ laevis A+ selected RNA Northern 
blot. These were carried out as a preliminary to screening 
for 2L. laevis cDNA homologues of human Oct-1 to ensure that 
homologues existed.
A .1 X. laevis genomic Southern blot.
X. laevis genomic DNA was digested with Eco R I , Bam HI and 
Hind III, electrophoresed on an agarose gel, Southern blotted 
to a nitrocellulose filter and then hybridised to labelled 
human Oct-1 cDNA. The resulting autoradiograph is shown in 
figure 7. Homologues of human Oct-1 are clearly seen at 
relatively high stringency (final washing condition were 0 .2x 
SSC at A2°C). The many hybridising bands may represent 
several genes. There are several mammalian POU domain-
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Figure 7.
Southern blot of X. laevis genomic DNA probed with human 
Oct-1 cDNA.
lOug of X. laevis genomic DNA prepared from the blood of a 
single individual was digested with the restriction 
endonucleases indicated, electrophoresed on a 0.8% agarose 
gel, and the gel Southern blotted to a nitrocellulose 
filter. The filter was hybridised to 50ng of human Oct-1 
cDNA labelled by nick translation. Hybridisation was in 
6xSSC and 50% formamide at 42°C, and final washing 
conditions were 0.2x SSC at 42°C. An autoradiograph after i 
eight hour exposure to the filter is shown. Lambda DNA 
digested with Eco RI and Hind III was run as a marker, and 
the position and size of marker bands (determined by 
ethidium bromide staining of the gel before transfer) is 
shown.
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containing genes, and consequently the Oct-1 POU domain 
present in the probe may hybridise to the POU domains of a 
family of Xenopus laevis genes. Alternatively the many 
hybridising bands could Indicate that the Oct-1 gene is large 
with several introns. Also, laevis is tetraploid with 
respect to a theoretical ancestor, and consequently there are 
probably two copies of a X^ laevis Oct-1 gene. The signal 
strength varies (particularly in the Hind III track), with 
some bands being weaker than those above or below. This may 
indicate that sequences with varying degrees of homology to 
human Oct-1 are present.
4.2 X. laevis A+ selected RNA Northern blot.
I wanted to isolate a X^ laevis cDNA homologue of human 
Oct-1. Two X. laevis cDNA libraries were available in the 
laboratory: adult liver (made by A. R. Brooks) and mature 
folliculated oocyte (gift of J. Shuttleworth). Human Oct-1 is 
ubiquitous, and consequently both libraries should be 
suitable for the isolation of laevis Oct-1. However, a 
Northern blot of X^ laevis A+ selected RNA from these two 
tissues was probed with human Oct-1 cDNA to check that 
homologous transcripts were expressed in these tissues in 
order to determine which of the two libraries to screen.
X. laevis A+ selected RNA from oocytes and liver was 
electrophoresed on a 1.5% formaldehyde-agarose gel, Northern 
blotted to a nitrocellulose filter, and the filter hybridised 
to labelled human Oct-1 cDNA. The resulting autoradiograph is
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Northern blot of 2Ll laevis RNA probed with human Oct-1 cDNA.
lOug of X. laevis A+ selected RNA (from the tissue 
indicatetTT w as electrophoresed on a 1.5% formaldehyde- 
agarose gel, the gel Northern blotted to a nitrocellulose 
filter, and the filter hybridised to 50ng of human Oct-1 
cDNA labelled by nick translation. Hybridisation and washing 
conditions were the same as those described for the Southern 
blot in figure 7. An autoradiograph after a five day 
exposure to the filter is shown. The position of ribosomal 
RNA bands is indicated, and was determined by ethidium 
bromide staining of the gel before transfer.
Figure 8.
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shown in figure 8. Hybridisation to low molecular weight RNA 
is seen in the oocyte RNA track (probably non-specific) and 
also hybridisation to a RNA species of an estimated size 
(from the position of ribosomal RNA bands) of around lOkb. 
This indicates that a large transcript from an Oct-1 
homologous gene is expressed in X. laevis oocytes. The 
transcript is of low abundance (a five day exposure of the 
filter is shown). The size of the human Oct-1 cDNA is around 
2.5kb, and so the homologous X. laevis transcript is 
unexpectedly large. However, large human Oct-2 transcripts 
have been reported (approximately 6kb, see Muller et_ al 
(1988)) and human Oct-1 message is a similar size to the 
transcript detected in X^ laevis oocyte RNA (W. Herr, pers. 
comm.). Much of the excess size over the published cDNA 
sequence is accounted for by the fact that the published cDNA 
sequence does not have the genuine 3' end, and the genuine 
human transcript has a very long 3' untranslated region. No 
hybridisation of human Oct-1 to X^ laevis liver RNA is 
detected. This result does not necessarily mean that the X. 
laevis homologue of Oct-1 is not expressed in liver (which 
would be unlike human Oct-1), but may reflect a difference in 
abundance between oocytes and liver. As will be shown later, 
Oct-1 protein is stored in large amount in laevis oocytes, 
and the message for Oct-1 could have a higher abundance in 
oocytes. As a consequence of this result the 2L l laevis mature 
folliculated oocyte cDNA library was selected to screen for 
homologues of human Oct-1.
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Isolation of Xenopus laevis Oct-1 c D N A  clones from an oocyte 
library.
5.1 Library screening.
A cDNA library (gift of Dr. J. Shuttleworth) prepared with 
A+ selected RNA from laevis oocytes, which had been 
matured in vitro with progesterone, w as screened using human 
Oct-1 as a probe. Eco RI linkers had been added to the cDNA, 
and the linkered cDNAs ligated into the Eco RI site of the 
vector lambda Zap (Stratagene). The library contained 4x10^ 
independent clones, with inserts in the size range 1 to 2.5 
kb, and I received an aliquot of amplified phage stock with a 
titre of 1x10*® pfu/ml. The layer of follicle cells which 
surrounds the oocytes had not been removed, and consequently 
cDNAs from these cells are represented in the library.
A total of l.lxlO6 phage from the oocyte cDNA library were 
screened using the human Oct-1 cDNA probe described in 
chapter 4 (for use in Southern and Northern blots). Screening 
was as described in the Methods section, taking replica 
filters from each plate. Twelve replica positive plugs were 
taken from the first screen, and rescreened until single 
positive plaques were obtained. Three screens were required 
to obtain single positive plaques. A n  example of a third 
round screen is shown in figure 9. Eleven of the twelve 
positives were shown to be genuine positives on rescreening. 
These eleven plaques were then purified by plating-out, and 
picking single plaques without rescreening.
Chapter 5.
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Figure 9
A third round screen of a positive cDNA clone from the 
X. laevis oocyte cDNA library.
Phage from a plug containing a plaque which hybridised with 
human Oct-1 cDNA were plated out at low density onto E. coli 
BB4, and replica plaque lifts taken from the plate. iKe 
replica filters were hybridised to human Oct-1 cDNA labelled 
by nick translation. Hybridisation was at 42°C in 6x SSC and 
50% formamide, and final washing conditions were 42°C in 
lx SSC. An autoradiograph of the replica filters (in the 
same orientation with respect to the plate from which the 
lifts were taken) is shown. Plugs containing a single 
replica positive were taken following this third round 
screen.
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5.2 Automatic excision of the prospective Oct-1 cDNA clones 
from the phage vector and preliminary restriction 
analysis.
The eleven prospective Oct-1 cDNA clones were converted to 
the plasmid form (in pBluescript sk-) by automatic excision 
from the phage vector, according to the manufacturer's 
instructions. Two single colonies were picked and used to 
prepare miniprep DNA, which was then digested with Eco RI to 
release the insert. Two colonies were analysed for each clone 
because there is some evidence that gross rearrangement can 
occur during excision (J. Shuttleworth, pers. comm.).
However, the duplicate colonies gave identical products on 
Eco RI digestion, indicating that no rearrangement had 
occurred. Eco RI digestion released single fragments. Seven 
clones contained an approximately 2.5kb insert, two clones an 
approximately 2.3kb insert, and two clones an approximately 
1.9kb insert. This indicated that three individual clones had 
been isolated, and this was confirmed since representatives 
of the same clone gave the same Pst I digestion pattern 
(there are multiple Pst I sites, the map is described later). 
Consequently representatives of the three individual clones 
(clones 3, 6 and 16) were selected for further analysis.
5.3 Detailed restriction analysis of clones 3, 6 and 16.
A more detailed restriction analysis of the three individual 
positive clones was carried out in order to be able to 
determine a sequencing strategy, and to indicate if the three
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clones were related.
Standard single and double restriction enzyme digests were 
used to determine the preliminary restriction enzyme maps 
shown in figure 10. It was determined that none of the three 
clones had sites for Hind III, Sal I, Kpn I, Xba I, Bgl II, 
and Sac I. Each clone had a single site for Bam HI and Sma I, 
and the position of these sites was determined by double 
digests with a non-cutter located at one end of the clone, in 
the polylinker. Pst I digestion of clones 6 and 16 released 
two fragments, indicating the presence of two sites, whose 
position was mapped by double digests (with Bam HI, Sma I and 
non-cutters in the polylinker at either end of the cDNA).
Pst I digestion of clone 3 released six fragments, indicating 
six sites for Pst I. One fragment was approximately 0.9kb, 
and the other 5 fragments small, in the size range 100 to 250 
bases. Consequently, the sites could not be mapped completely 
by double digestion. However, Bam HI cuts the 0.9kb Pst I 
fragment, and consequently the fragment was determined to be 
centred around the Bam HI site, and flanked by two internal 
Pst I sites. The position of the two Pst I sites was 
determined by a Sma I - Pst I double digest. This lead to the 
Bam HI, Sma I and partial Pst I maps shown in figure 10. The 
three clones are shown aligned by apparently common 
restriction enzyme sites. It should be noted that the 5' most 
Pst I site shown in each clone was shown by sequencing to be 
two very close Pst I sites, and that clone 3, in fact, 
contains nine Pst I sites. This discrepancy (restriction
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Figure 10.
Partial restriction maps of clones 3, 6 and 16 aligned to 
indicate conservation of some sites.
NB. Restriction digest indicated four additional Pst I sites 
in clone 3 which were not mapped. Later sequence analysis 
revealed that clone 3 in fact contains nine Pst I sites, and 
clone 16 three Pst I sites. The complete maps are shown 
later.
5' and 3' ends of the clones were tentatively assigned on 
the basis of the lack of hybridisation of clone 6 to the 5' 
end of human Oct-1 (see figure 11).
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analysis indicated six sites) arose because of the afore­
mentioned 'doublet' of Pst I sites, and because there is a 
'triplet' of very close Pst I sites. The conservation of all 
Bam HI, Pst I and Sma I sites between clones 6 and 16 
indicated that these clones were derived from the same 
message, clone 6 simply being shorter at one end, probably 
the 5' end as a result of premature termination of cDNA 
synthesis (cDNA synthesis was primed from the 3' polyA+ tail 
with oligo dT). The conservation of Bam HI and Sma I sites 
and one Pst I site between clone 3 and the other two clones 
indicates that this clone is related to, but distinct from 
the other two clones.
The suggestion that clones 6 and 16 were equivalent, except 
that clone 16 was longer at the 5' end was tested further. A 
Bam HI - Pst I double digest of pBS-Oct-l+ (human Oct-1 cDNA 
in pBSMl3+, see chapter A) generates five Oct-1 fragments: a 
central approximately 1.3kb fragment; a 5' approximately 
450bp fragment; and three 3' fragments (one of approximately 
300bp, and two of approximately 150bp). A map is shown in 
figure 11A. Such digests were Southern blotted and hybridised 
to labelled clones 3, 6 and 16. The result is shown in figure 
11B. Clones 3 and 16 detect all fragments. Clone 6 does not 
detect the 5' end fragment. Consequently it was concluded 
that clones 6 and 16 were equivalent, clone 6 simply 
representing premature termination of cDNA synthesis from the 
same transcript. On the basis of the lack of hybridisation of 
clone 6 to the 5' end of human Oct-1, and alignment of the
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Figure 11.
Clone 6 does not hybridise to a fragment from the 5' end of
human Oct-1.
(A) A Bam HI - Pst I map of the human Oct-1 cDNA from 
pBS-Oct-l+ (Sturm e_t a_l (1988A).
(B) Three Bam HI - Pst I digests of pBS-Oct-l+ were 
electrophoresed on a IX agarose gel and the gel Southern 
blotted to a nitrocellulose filter. The filter was cut 
into strips, and one strip hybridised to the Eco RI 
insert from clone 3, 6 or 16, labelled by niclc 
translation. The hybridisation and washing conditions 
were as described for the Southern blot in chapter A.
The positions of fragments from human Oct-1 cDNA and the 
position of the vector fragment is indicated.
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three clones by apparently conserved sites, the 5' ends of 
the three clones were tentatively assigned.
Clones 3 and 16 were, therefore, selected for sequence 
analysis. It was intended to sequence from M13 subclones, and 
to facilitate this restriction maps were extended to include 
Stu I and Pvu II sites. These sites were mapped in the same 
way as Bam HI, Sma I and Pst I sites, using single and double 
digests. The position of these sites is shown in later maps 
describing the sequencing strategy.
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Chapter 6.
Sequence analysis of Oct-1 homologues.
6.1 Sequencing clones 3 and 16.
Clones 3 and 16 were completely sequenced. The sequencing 
strategy is shown in figures 12 and 13. Sequencing (by the 
dideoxy chain termination method) was largely from single 
stranded template, derived from M13 subclones, with the M13 
17mer sequencing primer. The position of Sma I, Bam HI,
Pvu II, and Stu I sites used for subclones was determined by 
restriction mapping. The position of Pst I sites used for 
subclones was determined partly by restriction mapping, and 
partly from the sequence of other subclones. Three 17mer 
oligonucleotides were made using the sequence of subclones 
and used as sequencing primers. In one case the primer was 
used to sequence from a double stranded plasmid template 
(since the sequence obtained from single stranded M13 
templates indicated that the primer also hybridised to a site 
in the Ml3 sequence). During sequencing all restriction sites 
were overlapped to ensure that sites determined by 
restriction mapping were not in fact 'doublets' of two sites 
close together. This turned out to be the case for some Pst I 
sites, where sites were too close for the small intervening 
fragment released on digestion to be seen on a agarose gel. 
Any ambiguities in the sequence were resolved by sequencing 
both strands.
The complete nucleotide sequence of clone 3 is shown in 
figure 14. Translation of the longest open reading frame,
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Sequencing strategy for clone 3
Figure 12.
E * Eco RI 
P - T sT I 
V - Pvu II 
T - Ttu I 
B - Bam HI 
S - 5ma I
Sequencing was largely from the subclones indicated by the 
boxes, made in M13mpl8 or M13mpl9. The arrows indicate the 
direction and extent of sequencing. Sequencing from these 
subclones was from the M13 17raer sequencing primer on single 
stranded template. Two oligonucleotides were made to the 
sequence of clone 3 (17mers, position indicated) and 
sequencing from these primers was carried out as follows: 
from oligo 2, using the complete Eco RI fragment in M13; 
from oligo 1, using the complete Eco RI fragment in 
pBluescript SK- (ie. sequencing on a double stranded plasmid 
template).
I 0LIG0 1 I OLIQO 2
Sequencing strategy for clone 16
Figure 13.
E
P
V
T
B
S
Eco RI 
Tat I
Pvu II 
~5Tïï I 
"Earn HI 
Sma I
Sequencing was largely from the subclones indicated by the 
boxes, made in M13mpl8 or M13mpl9. The arrows indicate the 
direction and extent of sequencing. Sequencing from these 
subclones was from the M13 17mer sequencing primer on single 
stranded template. One oligonucleotide was made to the 
sequence of clone 16 (17mer, position indicated) and 
sequencing from this primer was carried out on the 
Pst I - Eco RI fragment in M13.
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from the first in frame methionine is shown. A stop codon 
occurs three codons before this methionine, indicating that 
this is the authentic translation start point. The clone has 
no poly A+ tail, which could be a result of premature second 
strand cDNA synthesis. The clone probably represents a full- 
length coding sequence.
The complete nucleotide sequence of clone 16 is shown in 
figure 15. Translation of the longest open reading frame is 
shown. There are no in frame stop codons upstream of the 
first methionine, and as will be confirmed in a later 
comparison with human Oct-1, this clone probably represents 
an incomplete reading frame. This clone has a polyA+ tail, 
and two potential polyA+ addition signals are shown. 
Consequently this may represent the authentic 3' end of the 
message.
An alignment of the nucleotide sequences is shown in figure 
16. The two cDNAs show 93% identity, within the region of 
overlap. As predicted from the restriction analysis (by 
conservation of some sites, and hybridisation to a human 
Oct-1 digest) clone 3 is longer at the 5' end, and clone 16 
longer at the 3' end. As will be described in the following 
section, clones 3 and 16 represent genuine homologues of 
human Oct-1, and henceforth will be described as follows: 
clone 3 * Xl-Oct-IA (for Xenopus laevis Oct-1, A) and clone 
16 - Xl-Oct-IB.
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Complete nucleotide sequence of clone 3 (Xl-Oct-IA).
Translation from the first in frame methionine is shown. The 
position of an in frame stop codon two amino acids before 
the first in frame methionine is shown.
Figure 14.
0001 GCÀGCGGCGGCÀGCAGGGÀCGCÀGÀTGTAÀÀÀÀGGAGCAGGTTTGGTGTCACCÀÀÀTCÀTTTTCTÀÀGTCTATCCÀGCGTTAÀTTTTTTA0091 OCGGAAGAGCCTGAAA?AAGTAGAACACTCTGGGAAGAGCAGTCGTCYJ¿¿TACAOCATGAAATTGCAncnCTTCCAAGATTCAAAAC
STOP 0 K  L I S S S K I Q I  0181 CÀTGCCTGGCTGTCÀGATGCÀÀGÀÀTGAÀCAÀTCCGTCGGÀÀÀCGÀGTÀÀÀTCÀCCÀGÀGAGCGGGGÀTGGGAÀCÀCAGGCACTCÀAÀCG 
B A W L S D A I ■ ■ ■ P S I T S U S P I S G D G ■ T C T Q TI G L D P Q K Q A V P I G A I T S A Q A Q A L L 6 I L I Q V  0361 CAGCTCGCTGGCACAAGTRACAGGCTGCTGCOCATTOCCTAAATGTACAGACTAAATTTAAAGAAGAGOCTGGGGAGCCGATGCAAGTG Q L A G T S L Q A A A I S L I V Q T K F K B B P G E P 1 Q V  0451 GTCCAGCCTTCCCAGCAOCCCTCACTGCÀGGCAGCEATCCCCCAGACTCAGCTCÀTGCTAQCTGGCXXACÀAAtCGCTGGOCTCACACTGV Q P S Q Q P S L Q A A I P Q T Q L 1 V A G  G Q I  A G L T T P A Q Q M  L L H  A Q A Q L L A A A V Q I S A I Q Q I  A A G A T I S A S A A T P 1 T Q I P L S Q P I Q I A Q D LQ L Q Q L Q Q Q I L I L Q Q T V L T I P T T I L Q S A Q P I  O lii ATCTCTCÀGACGCCGCÀGGGGCÀGCÀAGGCCTOCTGCAGGCGCÀGAATCTCTTÀACTCAACTÀCCTCAGCÀÀÀGCCAAGCCÀÀCCTCCTG I S Q T P Q C Q Q C L L Q A Q I L L T Q L P Q Q S Q A I L L  0901 CAGTCTCAGCCAAGCATCACOCTCACCTCACAGOCAGCAACCOOCACGCGCACAATAGCTGCCACCOCTGTACAGCAACTTCCACAAAGC Q S Q P S I T L T S Q P A T P T I T I A A T P V Q Q L P Q S  0991 CAGACAACACCAAAGCGAATCGACAGCOCAAGOCTGGAAGAGCCCAGTGAOCTTGAGGAGCnGAGCAATTTGCCAAGACATRAAACAG Q T T P K I I D T P S L B B P S D L B B L B Q F A K T F R QI I I K L G F T Q G D V G L A I G K L Y G I D F S Q T T I1171 CGTWCGÀAGCCTTGAATOTAGCTTTÀAAAATITGTGCAÀATTAÀÀGCCTCTTCTGGÌAÀACTGGCTTÌITGÀCGCAGTTTTAGÀÌlAAC K F I i L I L S F K I I C K L K P L L I K I L I D A T I . i l  1261 AÏAACGTCTGACTCTACCCTGÀCCAÀCCAÀÀGTGTTGTGÀÀCTCGCCÀGGÀCACGGÀATGGAAGGGCTGAATCGCAGGAGGAAGAAACX3C I  T S D S T L T ■  Q S ?  L ■  S P G I  G I  I  G L I  I  I  I  K K IT S I B T I I 1 V A L B K S F L B I Q K P T S B B I T I I AD Q L I 1 B K B V I K V R F C I I I Q K B K 1 I 1 P P S S  1531 GGATCCAGCAGTTCTCCCÀTTÀÀÀTCÀCTGTTCTCCAGTCCAAÀTCCGCTGGTGGCCÀGTÀCCCCÀÀGCCTTCTGÀCCAGTÀGTCCA G S S S S P I K S L F S S P I P L V A S T P S L V T S S P  1621 ACTACÀCTGACTGTAAACCCAGTGCTCCCGCTTACAAGTGCTGCTGCTÀTÀACCAGCTTTCATATTCCAGGCACAACAGGAACTTCC T T L T V I P V L P L T S A A A I T S F I I P G T T G T S  1711 GCTAÀCACAGCAACTGTGATCTCAACAGCACCOCCTGTATOCTCTGTOCTGACGTCTCCTTCTCTAAGTTCTTCOOCCTCGGCTÀCT A I T A T V I S T A P P V S S V L T S P S L S S S P S A T  1801 GCATCATCAGAAGCAICTACAGGCGGCGAGACGAGCACGACGCAAAGCACATCCACTCCAATGAOCTCTTCATTAAACACTGGTCAA A S S E A S T A G E T S T T Q T T S T P R T S S L I T G Q  1891 ATGGTGACTGCATCCGGAATCCACACGGCAGCGGCTACGGCACTACAGGGCGCAGCACAGTTGOCTAOCAATGCAAGTCTTGCTGOC M V T A S G I H T A A A T A L Q G A A Q L P T I  A S L A AA A A A G L I P G L 1 A P S Q P A A G G A L P S L I P G A L  2071 GGGAGCGOCCTTAGCOCTGCTCTCATGAGTAATAGTACACTGGCAACAAnCAAGCTCCTGCATCAAGTGGATCTCnCCAATAACATCC G S À L S P A L R S H S T L A T I Q A L À S S G S L P I T S  2161 CTGGATOCTOCTOGCAACTTGCTCTTTCCCAAOOCTCGACGGACCOCTAACAHCTAACTOOCCOCnATTCCTCAATCCTCAGAACCTC L D A A G I L V F A I A G G T P I I V T A P L F L I P Q I L  2251 TCTCTGTTTÀ(XÀGCAACCCTGTTAGCTTGATCTCTGCAGCTTCCGCTGGGGCTACTGGCCCCÀTCÀCÀAGCCTTCATGCCACCACCTCC S L P T S I P V S L I S À A S À G A T G P I T S L B A T T S  2341 TCÀÀTTGATTCCÀTCCÀGÀÀCGCÀCTATTTÀCCATGGCCTCTGCTÀGCGGAGCTGCTTCCACCÀCCACÀTCTGCCTCCÀAGGCGCÀÀ  ^S I D S I Q I A L F T R A S A S G A A S T T T S A S K A Q  STOP
Complete nucleotide sequence of clone 16 (Xl-Oct-IB).
Translation of the longest open reading frame is shown. The 
first in frame methionine is boxed. There are no in frame 
stop codons 5' of the first in frame methionine. The 
location of two potential polyA addition signals (AATAAA) is 
indicated.
Figure 15.
0091
0181
0271
0361
0451
0541
0631
0721
0811
0901
0991
1081
0001 HAAATGTACAGACTAAATTTAAAGAAGAGCCTGGGGAGCCGATGCAAGTGGGCCAGCCTTCCCAGCATCCCTCACTTCAGGCAGCC L I V Q T K F K E B P G E  P [ ¥]  Q V G Q P S Q H P S L Q A AP Q T Q L 1 V A G G P I T G L T L T P A Q Q Q L L L Q Q AA Q L L A A A V Q I S A S Q Q H S A A G A T I S A S A A T  ATGACACAGATTCCCCTTTCTCAGCCAATACAGATTGCACAGGATCTACAGCAGTTGCAGCAGTTTCAACAACAAAATCTTAACTTGCAG ■  T Q I  P L S Q P  I  Q I  A Q D L 0 0 L 0 0 F Q Q Q 1 L 1 LQ P V L V I P T T I L P P A  Q F I  I  S Q T P Q C Q Q C L lA Q I L L 9 Q L P Q Q S Q A I L L Q S Q P S I T L T S Q PT P T I T I A A T  P V Q Q L P Q S Q T T P R I I D T P S LE P S D L E E L E Q F A R T F R  Q 1 1  I  R _L G
S Q T T I S I F E A L I LR L R P L L E R H L I D A E I I T D S T L T I Q
V J  • • V
LAAAAIATG
G I G I E G L I I 1 I R R K T S I E T I I I V A
GAGAAOCAAAAGCCTAACTCGGAGGAGATCACCATGATTTCAGAOCAGCTGAACATGGAGAAAGAAC 
E I Q R P I S E E I T 1 I S D Q L I 1 E R E V I
1 I Q R E R I I I P P S S G G S S S S P I R S L
1171 GCCACTACCXXAAGCCTTGTGACCAGTAGTACAGCAGCCACACTCACTGTAAACCCAGTGCTCCCGCTTACAAGTGCTGCTGCTATAACC
A T T P S L F T S S T A A T L T V I  P ? L P L T S A A A I
G F S V P G T T G T P S A  I T A T V I S T A P P I S S F L
S P S L S P S P S A T A A T S E A S T A S E T I T T Q T T  1441 ACTCCAATCACCTCTCCAnAAGCACTGGCCAAGTCATGGTGACTGCATCTGGAATCCACGCGGCTACGGCACTACAGGGTGCAGCAi T P R T  S P L S T G Q V I  V T A S G I B A A T A L Q G A A
1531 TTGCCGACCAATGCAAGTCTTGCTGCCATGGCTGCTGCAl
L P T I A S L A A 1 A A A A G L I P G L 1 A P S Q F T A G  
1621 GCCTTATTTAG0CTClAICCAGGGGCACTGGGGAGCGCCCTTAGCCCTGCTCTaTGAGTAAaG7ACACTGGCGAaATTCAAGCTCTT 
A L F S L I P G A L G S A L S P A L 1 S I S T L A T I Q A  
1711 GCATCTAGTGGATCTCTTCCAATAACATCCCTGGAT'GCTAGTGGGAACTTTGTCTTTGCCAACGCTGGAGGGACCCCTIACATTGTGACT 
A S S G S L P I T S L D A S G I F V F A I A G G T P I I V  
1801 GOCOOCTTATTOCTCAATCCTCAGAATCICTCTCTGCTCAOCAGCAAIOCTGTTACTTTGCTCTOGGCIGGAGCTACTGGOOOCATCACA 
A P L P L M P Q M L S  L L T S M P V S L V S A G A T G P I  
1891 AGCCTTCATGCX^ CCACCTTATCGATCGATTCCAT'CCAAAACACACTATTTACCATGGCCTCTGCTAGCGGAGCTGCTTCCACCACCACA 
S L I A T T L S I D S  I Q I T L F T 1 A S A S G A A S T T  
1981 TCGGCCTCCAAGGCGCAAIS^ GTTTTGGTGGGGGGCAGAGACATGGCXXTGCAAACCAGACCATGGTAGCATTGTCGCTTACTGAIAGCC 
S A S R A Q STOP2071 AACAACTAC^ J^ AAAAACAATCGGATTTGCXXXXXTATCTTAGCGTTTCAAGTGAAGTAGAGTGGCGGGAAGGAAACAAAACACATG
poiy * ____ _____2161 AACAAATAACGCATGCACACTTTGCCTAATTTTATAATAAACCTTTCTCTTTTCAGGATCGCAACTGArrGCAGAGCTTTCTAACCAAAA
poly A2251 ATCTAAAAAAAAAAAAAAAA
Nucleotide sequence alignment of clone 3 (Xl-Oct-IA) and 
clone 16 (Xl-Oct-IB).
Clone 3 is shown above clone 16. Vertical lines represent a 
conserved nucleotide, and gaps in the sequence are made for 
maximum alignment. Clone 3 is longer at the 5' end, and 
clone 16 longer at the 3' end. Within the region of overlap 
there is 93% homology.
Figure 16.
) COJUklCACWQOCCAAACTACTilCTCCCCTtTCGAAGCCTTCWTCTTAGCTTIAAA 
I) CGÀÀÀTGACTTCACCCAAACTACTAIATCCCCCTTCCAACCCTTCAACCTTAGCinAAA
(B ) WiT»TCTGOJiAIT***GCCTCTTCTGGÀJJiACTGGCTCÀATCACCC CGAAAAC 
<A) *T«(XTCTaCTCT*CCCTa(XAA<miCTCTTCT<^CTCCCa«^aCCaAT<;
mi miiiiiimmiiiiiiimiimmiiiimiiiiiimiiii
(B ) A T U  CTCACTCTACCCTGACCAACCAAACTCTTCTCAACTCCCCAGCACACCGAATC
i) mCACAACACTTTCCTCGAGAACCAAAACCCTACCTCGGACCACATCACCAICATICCA
llllllllllllllllllllllllllllllllll llllllllllllllllllllll III) TTAGAGAACACTTTCCTGGAGAACCAAAAGCCTAACTCGGACCAGATCACCATGATTTCA
AATCCCATHOCCCCCCTATCTTACCCTTTCAACTGAACTACACTCCCCCCAACCAAACA
AAACACATCAACAAATAACCCATCGACACTTTCCCTAATTHATAATAAACCTTTCTCTT
TTCAGGAÎGGCAACTCATTCGAGAGCTTTCTAACCAAAAATCÎAAAAAÀÀAAAAAAAAA
7844133114
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6.2 Comparison of X. laevis Oct-1 protein sequences with 
human and chicken Oct-1.
Figure 17 shows a predicted protein sequence alignment for 
human Oct-1, chicken Oct-1, Xl-Oct-IA and Xl-Oct-IB.
The C terminal ends of Xl-Oct-IA and Xl-Oct-IB match the C 
terminal ends of chicken and human Oct-1. The N terminal end 
of Xl-Oct-IA extends further than chicken Oct-1, and as 
mentioned earlier contains a stop codon before the first in 
frame methionine. Consequently Xl-Oct-IA probably contains a 
complete open reading frame. Xl-Oct-IB is 83 amino acids 
shorter than Xl-Oct-IA at the N terminal end, and the reading 
frame contains no stop codon before the first in frame 
methionine. Consequently this clone probably does not 
represent a complete open reading frame. Within the region of 
overlap, Xl-Oct-IA and Xl-Oct-IB are 93%Ao**cfegou& in predicted 
amino acid sequence (and 93%koi»olojotiS in nucleotide sequence). 
Xenopus laevis is tetraploid with respect to a theoretical 
ancestor. This high level of homology probably means that the 
two clones are copies of the same gene, arising from the 
theoretical genome duplication event.
Conservation between species is strikingly high. Human and 
chicken Oct-1 are 96%Ao*M>leyo*u in amino acid sequence 
throughout the entire length, and identical within the POU 
specific and homeo boxes. Over a stretch extending from the 
first in frame methionine of human Oct-1 to the C terminal 
end, human Oct-1 and Xl-Oct-IA are Q5X kat^ deyous.in amino acid 
sequence. In the region of overlap human Oct-1 and Xl-Oct-IB
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Predicted amino acid sequence alignment of human Oct-1, 
chicken Oct-1, Xl-Oct-IA and Xl-Oct-IB.
The sequences are aligned to human Oct-1.
- « residue conserved with human Oct-1.
Differences to the human sequence are shown.
* = gap in sequence made for maximum alignment.
Human and chicken Oct-1 show 96% homology.
Human Oct-1 and Xl-Oct-IA/B show 85% homology.
Human Oct-1 sequence is from Sturm et^ al (1988A). 
Chicken Oct-1 sequence is from Petrynialc et al (1990).
Figure 17.
HUM 001 SQDESS***AAAAÀÀADSRMNHPSETSKPSMESGI>GIITGTQTMGLDFQKQPVPVGGAISTAQAQAFLGHL
CHK 001 *******************-------------------------------------- p-------------
X1A 001 MKLH— SLIQNH-WLS-A----------*-P-------------------- A— *1--TS----- L----
XIB 000 **********************************************************************
HUM 068 HQVQLAGTSLQAAAQSLNVQSKSNEBSGDSQQPSQPSQQPSVQAAIPQTQLMLAGGQITGLTLTPAQQQL
CHI 052 -------------------------------------------------------------------------
X1A 069 -------------- H-----T-PX— P—BPM—W -------L-----------V-----A----------M
XIB 001 ****************--- T-PX— P—BPM—VG----H— L----------V P--------------
HUM 138 LLQQAQAQAQLLAAAVQQHSASQQHSAAGATiSASAATPMTQIPLSQPIQIAQDLQQLQQLQQQNLNLQQ
CHI 1 3 2 ---**------------ *-------------------------------------***H-------------
XIA 1 3 9 ---**----------- *----N M----------------------------------------------
HUM 208 
CHK 186 
X1A 206 
X1B 122
FVLVHPTTMLQPAQPIISQTPQGQQGLLQAQHLQTQLPQQSQANLLQSQPSITLTSQPÀTPTRTIAATPI
---------------------------------- L--------------------- A---------------
POU—SPBCIPIC BOX
HUM 278 QTLPQSQSTPKBIDTPSLKÈPSbLtBLWAXtPXliltlKLfirWDWLAMGKLtCWb^SOTTlSBPtA
CHK 256 -P-----------------------------------------------------------------------
HUM 414 
CHK 394 
X1A 416 
X1B 328
POU HOMEO BOX
-S----- SL-S--HP---S----
S----- SL-S— **--------
HUM 484 VTSSAATTLTVSPVLPLTS*AA VTHLSVTGTSDTTSHHTATVI STAPPASSI VTSPSLSPSPSASASTSE
CHK 464 ----------- M------- *P---S------ TB----------------------------------- 1--
X1A 486 ----P------ N-------A— I-SPHIP— TG-S-A------------V— VL------S--- T-AS—
X1B 396 ----T-A----M-------A— I-GF— P— TG-P-A----------- 1— VL-----------T-A---
HUM 553 ASSASBTSTTQTTSTPLSSPLGTSQVMVTASGLQTAAAAALQGAAQLPANASLAAMAAAAGLHPSLMAPS
CHK 533 ------------------------------------------------------------------- G-- S-
X1A 556 — T-G-----------MT-S-H-G--------IH---- T--------- T---------------G-----
X1B 466 —  T---M---------MT---S-G--------IH**— T----------T--------------- G----
HUM 623 QFAAGGALLSLNPGTLSGALSPALMSNSTLATIQALASGGSLPITSLDATGNLVFANAGGAPNIVTAPLF
CHK 603 -----------------G--------------------- S---------- S----------T---------
X1A 626 --------F-----A-GS-------------------- S---------- A----------T---------
XIB 534 — T---- F----- A-GS-------------------- S---------- S— F------ T---------
HUM 693 LNPQKLSLLTSNPVSLVSAAAASAGHSÀPVASLHATSTSAESIQMSLPTVASASGAASTTTTASKAQ 759
CHK 673 --------------------------A-C-------------------- L--------T----------739
X1A 696 --------F------- 1-**-----ATG-IT-----TS-ID---- A---M-----------S-----760
X1B 604 ------------------ *****— ATG-IT-----TL-ID—--- T M-----------S-----665
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are 85 X similar In amino acid sequence. This level of 
homology must Imply that the proteins have closely related 
functions. Within the POU specific box human Oct-1 and 
Xl-Oct-IA are 97% Aomolcgous (a two amino acid Insertion in 
Xl-Oct-IA, just before the non-conserved linker) and human 
Oct-1 and Xl-Oct-IB are identical. Within the POU homeo box 
Xl-Oct-IA and human Oct-1 are identical, and Xl-Oct-IB and 
human Oct-1 are 97%Ao/*ofcge>u£ (two amino acid substitutions). 
Consequently conservation in the POU homeo and specific boxes 
is higher than elsewhere in the protein. The differences in 
the POU homeo and specific boxes (two amino acid differences 
in each) between Xl-Oct-IA and Xl-Oct-IB are probably not 
functionally significant, although three amino acid 
substitutions in the human Oct-1 homeo box do prevent 
interaction with the viral transactivator, VP16 (see section 
1.3.5). Within the non-conserved linker (between POU homeo 
and specific boxes) human and X^ laevis Oct-1 are about 50% 
similar. This is in line with evidence that the linker has no 
specific functional purpose (see section 1.3.2).
There is no stop codon in front of the published first in 
frame methionine of of human Oct-1, and this reflects the 
fact that this is not the authentic translation start site 
(W. Herr and G. Das, pers. comm.). The Oct-1 reading frame 
extends further at the N terminal end than published. The 
current unpublished state of the human Oct-1 N terminal end 
(which probably extends further than the longest cDNA so far 
cloned) is illustrated in figure 18. Alternate splicing
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Alternate splicing occurs at the N terminal end of human 
Oct-1.
The sequence of the N terminal end of human Oct-1, which 
extends further than the published sequence is shown (W.
Herr and G. Das, pers. comm.). An additional exon is 
inserted in some human Oct-1 cDNA clones by alternate 
splicing. This splice brings a stop codon into frame, which 
may be overlooked by ribosomal frameshifting. The sequence 
of the N terminal end of Xl-Oct-IA is aligned to human Oct-1 
to show that there is a complete breakdown in homology after 
the splice site.
Figure 18.
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occurs at the N terminal end, resulting in an Insertion of 
approximately 100 bases in some human Oct-1 cDNAs. The N 
terminal end of Xl-Oct-IA displays no homology to either 
spliced form of human Oct-1 upstream of this splice site. 
Consequently, Xl-Oct-IA may represent a third alternately 
spliced form. It should be noted that the presence of the 
additional exon in human Oct-1 causes the reading frame to 
include a stop codon two amino acids after the splice site.
W. Herr and G. Das (pers. comm.) have evidence to suggest 
that this stop codon is overlooked by ribosomal frameshifting 
(for recent example see Belcourt and Farabaugh (1990)).
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Southern blot of X. laevis genomic DNA probed with POU 
domain, Oct-1 specific and Oct-2 specific probes.
X. laevis genomic DNA was digested with restriction enzymes, 
fractionated through an agarose gel and then Southern blotted 
to a nitrocellulose filter. DNA was hybridised to labelled 
probe containing the POU domain of Xl-Oct-IB, or a fragment 
from the C terminus of Xl-Oct-lB (which would not be expected 
to hybridise to other POU domain containing genes, and hence 
termed the Oct-1 specific probe), or a fragment from the 
N terminus of human 0ct-2A (termed the Oct-2 specific probe). 
The human 0ct-2A clone was a gift of P. Matthias (see Muller 
et^ al (1988)). The origin of the probes is illustrated in 
figure 19A, and an autoradiograph of the Southern blot in 
figure 19B.
Oct-1 specific and POU domain probes give essentially the 
same hybridisation pattern to Eco RI and Hind III genomic DNA 
digests. The hybridisation pattern to a Pst I digest is 
distinct for the two probes, but this is to be expected since 
Pst I cuts between the two probes in the cDNA, and will 
therefore do so in the gene. However, it is striking that the 
Eco RI/Hind III hybridisation pattern is similar, and that 
the POU domain probe does not react to a large number of 
fragments, since in mammals there is a large family of POU 
domain-containing genes. This may indicate that in X_j_ laevis 
there is no large family of POU domain genes, or that if such 
a family exists the POU domains are sufficiently diverged
Chapter 7.
-130-
Southern blot of X. laevis genomic DNA probed with POU
domain, Oct-1 specTfic and Oct-2 specific probes.
(A) Restriction maps of Xl-Oct-IB and human 0ct-2A (Muller 
et al (1988)) showing the fragments isolated for use as 
"SoutKern blot probes.
(B) 10 ug of 2L. laevi8 genomic DNA digested with the 
restriction endonucleases indicated was electrophoresed 
on a 0.8% agarose gel, Southern blotted to a 
nitrocellulose filter, and then DNA hybridised to the 
probes indicated, labelled by nick translation. 
Hybridisation was in 6x SSC and 50% formamide at 42°C, 
and final washing conditions were 2x SSC at 50°C. Lambda 
DNA digested with Eco RI and Hind III was run as a 
marker, and the position of marker bands is indicated.
Figure 19.
Sac I EcoRI
_LL
OCT-2 S PEC IFIC  
E (460bp)
(1925)
EcoRI
_J
B
OCT-1
SPECIFIC
PROBE
POU
DOMAIN
PROBE
OCT-2
SPECIFIC
PROBE
l!i l!i  l!i
KB
Results and Discussion
from the Oct-1 POU domain to be not detected even at low 
stringency (final washing conditions were 2x SSC at 50°C).
The hybridisation of the human Oct-2 specific probe to 
X. laevis genomic DNA digests gives a 'smudged' appearance. 
However, at least two high molecular weight fragments are 
detected in the Eco RI track. This may indicate that the 
X. laevis genome contains homologues of Oct-2. However, as 
described above the X^ laevis Oct-1 POU domain does not 
appear to hybridise to other POU domains, which could mean 
that (unlike mammals) X^ laevis Oct-1 and Oct-2 POU domains 
are significantly diverged. Alternatively, there may not be 
an Oct-2 homologue. The probe contains a glutamine rich 
region of Oct-2, and glutamine rich probes hybridise to 
multiple X^_ laevis cDNAs at low stringency (J. C. Richardson 
pers. comm.). This could account for the 'smudged' 
hybridisation pattern.
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Detection of Xl-Oct-IA and Xl-Oct-IB transcripts In X. laevis 
oocyte RNA by RNase protection assays.
Introduction.
It was decided to assay the levels of Oct-1 transcripts in 
oocytes using RNase protection assays, in order to 
demonstrate that the Oct-1 clones were from X^ laevis oocytes 
and not contaminants from some other source, and to make a 
rough estimate of the amount present.This method was chosen 
rather than Northern blot hybridisation because it is more 
sensitive, and Northern blots required polyA+ selected RNA 
and long exposures to detect Oct-1 transcripts in oocytes, 
and could not detect Oct-1 transcripts in liver (see chapter 
5). Also, the Northern analysis detected a single transcript, 
whereas RNase protection assays should be able to detect and 
distinguish Xl-Oct-IA and Xl-Oct-IB transcripts. RNase 
protection assays do, however, have the disadvantage that if 
transcripts were to vary, for example by alternate splicing, 
they would probably not be detected. Whilst this work was in 
progress it was reported that the levels of X». laevis Oct-1 
transcripts, assayed by RNase protection, were roughly 
constant through early development (M. Perry, pers. comm.).
Chapter 8.
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8.1 Subcloning of a fragment of Xl-Oct-IA into a 
transcription vector, for use in the preparation of 
synthetic RNA probes.
The 265 bp 5' Bam HI to 3' Pst I fragment from Xl-Oct-IA 
(see restriction map, figure 12) was isolated and subcloned 
into pBluescript sk- (Stratagene). Labelled antisense 
transcripts were made using T7 RNA polymerase from template 
DNA which had been linearised at the polylinker Sac I site. 
Including polylinker sequences the probe produced in this way 
is approximately 360 bases in length. The fragment protected 
by Xl-Oct-IA should be 265 bases, and the difference in 
length between probe and protected fragment allows protected 
probe to be distinguished from undigested probe.
8.2 The probe detects both Xl-Oct-IA and Xl-Oct-IB synthetic 
RNA.
As a test to check the assay system, assays were set-up with 
full length unlabelled sense Xl-Oct-IA and Xl-Oct-IB 
synthetic transcripts (produced from the original excised 
clones in pBluescript sk- with T7 or T3 RNA polymerase).
These assays are shown in figure 20A. Sense Xl-Oct-IA 
synthetic RNA protects a major band of about the predicted 
size (265 bases), which is smaller than the probe. There is 
no signal with the 'no RNA' control assays. Sense Xl-Oct-lB 
synthetic RNA protects a smaller fragment (about 50 bases). 
The source of this protected fragment is not obvious from a 
comparison of the Xl-Oct-IA and Xl-Oct-lB sequences, since
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Detection of Xl-Oct-IA and Xl-Oct-IB transcripts in oocytes
by RNase protection assays.
(A) RNase protection assays with Xl-Oct-IB and Xl-Oct-IA 
synthetic sense transcripts. 50pg of synthetic RNA was 
hybridised with 250 000 cpm of internally labelled 
antisense synthetic RNA probe (265 bases of Xl-Oct-IA + 
about 95 bases of vector polylinker sequence) and then 
digested with RNases (A and Tl). The reaction products 
were electrophoresed on an 8% denaturing polyacrylamide 
gel. An autoradiograph of the gel is shown. Duplicate 
assays were carried out. Undigested probe and mock 
hybridisation with no RNA controls are included. The 
positions of fragments protected by Xl-Oct-IA and 
Xl-Oct-IB transcripts is indicated. Markers are pBR322 
digested with Hpa II and labelled by end-filling.
(B) RNase protection assays with a mixture of Xl-Oct-IA and 
Xl-Oct-IB synthetic sense transcripts (50pg each RNA) 
and total oocyte RNA (20ug, equivalent to A oocytes). 
Assays were carried out as described above. The 
positions of protected fragments from Xl-Oct-IA and XI- 
Oct-IB transcripts is indicated. Undigested probe and 
mock hybridisation with no RNA controls are included.
Figure 20.
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they are not perfectly matched over a region as long as 50 
bases. Presumably the RNases do not cut, or cut less 
efficiently at particular short mismatches between probe 
(Xl-Oct-IA) and transcript (Xl-Oct-IB). The test shows, 
therefore, that this probe should be able to be used to 
detect and distinguish Xl-Oct-IA and Xl-Oct-IB transcripts.
8.3 Xl-Oct-IA and Xl-Oct-IB transcripts can be detected in 
X. laevis oocytes.
Assays were set-up with a mixture of Xl-Oct-IA and Xl-Oct-IB 
synthetic sense transcripts (as control) and with total 
oocyte RNA. The result is shown in figure 20B. The mixture of 
synthetic transcripts and oocyte RNA give similar protection 
patterns, indicating that transcripts of both clones are 
present in, and derived from X^ laevis oocytes. The synthetic 
transcript assay contains approximately 50pg of each RNA 
species. Consequently, by a comparison of signal intensity, 
the 20ug of total oocyte RNA contains roughly lOpg of each 
Oct-1 transcript, which is equivalent to 2.5pg per oocyte. 
Since an oocyte contains about 50ng (1% of 5ug total RNA) of 
A+ RNA the abundance of each Oct-1 transcript is roughly 1 in 
20 000. It is possible that the transcripts are present 
solely in the layer of follicle cells which surround the 
oocyte (these were not removed before preparing the RNA used 
for cDNA synthesis). However, this is unlikely since follicle 
cell RNA constitutes less than 1% of oocyte RNA, and if 
transcripts were present solely in follicle cells their
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abundance would be 1 In 200 transcripts. It also seems 
Improbable that Oct-1 transcripts are present solely in the 
follicle cells since, as will be shown later, there are 
roughly equivalent amounts of Oct-1 protein in the oocyte and 
unfertilised egg (which has lost the layer of follicle 
cells).
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Expression of Xl-Oct-IA synthetic RNA In mlcro-ln.jected 
oocytes.
To confirm that Xl-Oct-IA contained an open reading frame of 
the predicted length it was decided to attempt to express 
synthetic sense transcripts in micro-injected oocytes.
The Xl-Oct-IA cDNA in the vector pBluescript sk- 
(Stratagene) was linearised with Sac I, and transcribed with 
T7 RNA polymerase to produce sense transcripts. Approximately 
lOnl of capped transcript (concentration approximately 
25ng/ul) was micro-injected into the cytoplasm of X^ _ laevis 
oocytes, and translation products labelled by overnight 
incubation in medium containing ^S-met h i o n i n e . Labelled 
proteins were resolved by SDS-PAGE and detected by 
fluorography. The result is shown in figure 21B. There was no 
detectable translation of synthetic transcripts, since an 
extra band cannot be seen with protein extract from injected 
oocytes, relative to protein extract from un-injected 
oocytes.
Previous experience in our laboratory (R. W. Old and 
G. Sweeney, pers. comm.) has shown that shortening of the 5' 
untranslated leader of clones to just before the initiation 
codon can enhance expression of synthetic transcripts in 
micro-injected oocytes. Consequently it was decided to 
shorten the leader of Xl-Oct-IA in an attempt to enhance 
expression.
The Xl-Oct-IA cDNA (flanked by Eco RI sites) was subcloned
Chapter 9.
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Expression of Xl-Oct-IA synthetic transcripts in micro-
injected oocytes.
(A) Xl-Oct-IA was subcloned into the Eco RI site of M13mpl8 
and site directed mutagenesis used to create the Sal I 
site indicated. This site was used to shorten the leader 
sequence of the clone, removing an upstream out of frame 
AT G  codon.
(B) Xl-Oct-IA in pBluescript SK- (stratagene) was linearised 
with Sac I and transcribed with T7 RNA polymerase to 
generate full-length transcripts.
A  fragment from the Sal I site made in the leader of 
Xl-Oct-IA to the Sal I site in the M13mpl8 polylinker 
w as subcloned into pBluescript KS+ (Stratagene). This 
subclone was linearised with Kpn I and transcribed with 
T 7  RNA polymerase to generate shortened leader 
transcripts.
Approximately lOnl of synthetic capped transcript (RNA 
concentration approximately 25ng/ul) was micro-injected 
into the cytoplasm of laevis oocytes. Oocytes 
(injected and not injected controls) were incubated 
overnight in medium containing 35S-methionine, protein 
extract was prepared from pooled oocytes and the 
proteins resolved by SDS-PAGE (10X separating gel). 
Labelled proteins were,detected by fluorography. The 
size and position of methylated protein markers is
indicated. * indicates the position of an extra labelled 
protein band present in extract from oocytes which had 
been injected with shortened leader transcripts.
Figure 21.
0
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into M13mpl8t and site directed mutagenesis used to convert 
the sequence GTCGTC (16 bases upstream of the first in frame 
ATG) to a Sal I site (GTCGAC). This is illustrated in figure 
21A. A fragment from this Sal I site to the Sal I site in the 
M13mpl8 polylinker was subcloned into pBluescript ks+ 
(Stratagene). Sense transcripts were produced with T7 RNA 
polymerase from DNA template which had been linearised with 
Kpn I. Capped transcript, with the shortened leader, was 
micro-injected into the cytoplasm of laevis oocytes at an 
equivalent concentration to the full-length transcript. 
Translation products were detected as described above. An 
extra protein band (relative to un-injected oocyte extract, 
and extract from oocytes injected with the full-length 
transcript) in extract from oocytes injected with the 
shortened leader transcript indicates that this transcript is 
expressed in oocytes. The size of the product exactly 
corresponds to that predicted from the open reading frame 
determined b y  sequencing (79kD).
The reason why the full-length transcript is expressed at 
lower levels than the shortened leader transcript is unclear. 
There is an upstream out of frame AUG codon (see figure 21A), 
but this would not be expected to inhibit translation (Kozack
(1989)). Kozack suggests that the AOs ribosomal subunit binds 
to the 5' end of mRNA and scans along until it finds the 
first AUG codon in a favourable context for the initiation of 
translation. A favourable context for initiation is 
determined b y  the sequence surrounding the AUG. The most
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important residues are a purine three bases upstream of the 
AUG and a G immediately after the AUG (PuXXAUGG). The purine 
(usually A) upstream of the AUG is most important, with other 
residues having little effect on the efficiency of 
translation if this residue is present. However, in the 
absence of the purine the downstream G is essential. 
Consequently, the upstream AUG is in an unfavourable context 
for the initiation of translation, and 'leaky' scanning 
should allow the ribosome to reach the correct AUG. 'Leaky 
scanning' is also more efficient when, as is the case here, 
the AUG is followed by a stop codon. The first in frame AUG 
is in a favourable context for the initiation of translation, 
having an A in the correct position upstream of the AUG. 
Consequently there is no obvious reason why the full-length 
transcript is expressed at a lower level than the transcript 
with the shortened leader. Inefficiency of translation is not 
restricted to the micro-injected oocytes. Neither synthetic 
transcript (full-length or shortened leader) can be expressed 
in vitro in rabbit reticulocyte lysate (not shown).
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Preparation of Xl-Oct-IA fusion protein constructs. 
Introduction.
It was decided to express Xl-Oct-lA fusion proteins In 
E. coll for two reasons. Firstly, in order to produce large 
amounts of Xl-Oct-lA for use as an antigen. The antigen 
fusion protein would be injected Into rabbits to raise a 
polyclonal antiserum. At the time of preparing these fusion 
proteins human Oct-1 and Oct-2 had been cloned and the highly 
conserved POU domain recognised. Consequently, a fusion 
protein lacking the POU domain would be required if the 
antiserum was to be specific to Oct-1. Secondly, I wanted to 
show that Xl-Oct-lA encoded a functional octamer-binding 
protein. Fusion proteins (containing the POU domain) would be 
used to demonstrate this.
This chapter describes the fusion protein constructs made. 
The use of fusion proteins to raise a polyclonal antiserum, 
and in band shift assays will be described in later chapters.
Most fusion proteins made were T7 gene 10 fusions, made in 
the high level expression pET-3 series vectors (Rosenberg 
et al (1987)). The pET-3 series vectors (a, b,c) have a 
Bam HI cloning site in each of the reading frames. Fusion 
proteins are produced from clones in these vectors in the 
E. coll strain BL21 (DE3) (Studier and Moffatt (1986)). BL21 
(DE3) has an integrated copy of T7 RNA polymerase under the 
control of the lac promoter. IPTG induces expression of T7 
RNA polymerase from the lac promoter, which transcribes the
Chapter 10.
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message for the fusion protein from the T7 gene 10 promoter 
in pET-3 series vectors. A beta-galactosldase fusion protein 
was also made in the vector pBluescript sk- (Stratagene). It 
was intended to show that the polyclonal antiserum raised 
reacted with Oct-1 by inhibiting the formation of octamer 
element:fusion protein complexes (in band shift assays). To 
demonstrate that the antiserum was not reacting to the T7 
gene 10 part of the fusion protein, this beta-galactosidase 
fusion protein was also made.
10.1 Making a Bgl II site at the 5' end of Xl-Oct-IA.
The pET-3 series vectors have a Bam HI cloning site. 
Consequently, to produce Xl-Oct-IA fusion proteins extending 
from the 5' end of the coding sequence, it was necessary to 
introduce a Bam HI compatible site by oligonucleotide 
directed mutagenesis. A Bgl II site was selected, rather than 
a Bam HI site, for reasons which will become apparent later. 
The Bgl II site made allowed fusion proteins to be made by 
cloning into the Bam HI site of pET-3B, and by cloning into 
the Bam HI site of pBluescript sk- (Stratagene). The 
Xl-Oct-IA cDNA was subcloned into the Eco RI site of M13mpl8 
and oligonucleotide directed mutagenesis used to convert the 
sequence AGATGC at nucleotide 196 (15 amino acids downstream 
of the first in frame methionine) to a Bgl II site (AGATCT). 
This is illustrated in figure 22.
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Xl-Oct-IA sequence contained in fusion protein constructs.
The amino acid sequence of the Xl-Oct-IA open reading frame 
is shown.
The generation of a Bgl II site by oligonucleotide directed 
mutagenesis is illustrated.
The 5* and 3' ends of Xl-Oct-IA coding sequence contained in 
fusion protein constructs (pET-1 to 4 and pBS-1) is 
indicated by arrows. The numbers adjacent to the arrows 
indicate the number of amino acids from the start of the 
open reading frame. pET-1, 2 and 3 were made in the vector 
pET-3B (Rosenberg e_t jil (1987)). pET-4 was made in the 
vector pET-3A (Rosenberg et_ al_ (1987)). pBS-1 was made in 
the vector pBluescript SK- (Jjtratagene).
The location of the POU domain is shown.
Figure 22.
pET-1,2,3 and pBS-1 5' endTCAGATCTA Bgl II
S mutagenesis ______A
ooi mklhsssliqnhawlSdä^mnnpsetskspesgdgntgtqtngldfqkqavpigaitsaqaqallghlhq
071 VQLAGTSLQAAAHSLNVQTKFKEEPGEPMQWQPSQQPSLQAAIPQTQLMVAGGQIAGLTLTPAQQQMLL 
141 QQAQAQLLAAAVQHSANQQHNAAGATISASAATPMTQIPLSQPIQIAQDLQQLQQLQQQNLNLQQYVLVH 
pET-3 3' endIStu 1(231)
211 PTTNLQSAQFIISQTPQGQQGLLQAQNLLTQLPQQSQANLLQSQPSITLTSQPATPTRTIAATPVQQLFQ
281 SQTTPKRIDTPSLfcfeP5DLftELE(Í»ÁKTFlC0RftlKL¿FT0¿D^áLAMGKLVátteF50Wl5Rl>EÁLWLgF 
351 KNMCKLKPLLfil(WLNDÀVLENlf5b5tLTSQ5VLS5PflH(SrtE(5LrfftfeRgl(RT5ÎETrffRVÀLEK5PLËM0
d ET-2 3 ’ end and d ET-4 5'endJBam HI(463)
421 KPTSEEITMTA&QLNHErEVIfiWECWRRQEEKRIMPESSGGSSSSPIKSLFSSPNPLVASTPSLVTSSP
491 ATTLTVNPVLPLTSAAAITSFHIPGTTGTSSANTATVISTAPPVSSVLTSPSLSSSPSATAASSEASTAG
561 ETSTTQTTSTPMTSSLNTGQVMVTASGIHTAAATALQGAAQLPTNASLAAMAAAAGLNPGLMAPSQFAAG
631 GALFSLNPGALGSALSPALMSNSTLATIQALASSGSLPITSLDAAGNLVFANAGGTPNIVTAPLFLNPQN
pET-1,4 and pBS-1 3' endj(760)
701 LSLFTSNPVSLISAASAGATGPITSLHATTSSIDSIQNALFTMASASGAASTTTSASKAQ
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10.2 Making fusion protein constructs.
The fusion protein constructs made are illustrated In figure 
22. A fragment from the Bgl II site made by mutagenesis to 
the Bam HI site in the Xl-Oct-IA coding sequence (just 3' to 
the POU domain) was subcloned into the Bam HI site of pET-3B 
to create pET-2. The pET-2 fusion protein contains amino 
acids 16 to 463 of Xl-Oct-IA fused to the first eleven amino 
acids of T7 gene 10. pET-2 can be cut with Bam HI to 
linearise at the 3' end of the cDNA insert (there is no Bam 
HI site at the 5' end as a result of the ligation of Bam HI 
and Bgl II sticky ends). This allows deletion from the 3 ’ end 
and addition of the remaining 5' end of the Xl-Oct-IA coding 
sequence as described below.
pET-2 was cut with Bam HI (at the 3' end of the cDNA insert) 
and Stu I (within the Xl-Oct-IA coding sequence contained in 
the clone), the Bam HI end blunted with the Klenow fragment 
of DNA polymerase I, and the ends ligated to create pET-3. 
pET-3 contains amino acids 16 to 231 of Xl-Oct-IA.
A fragment was isolated from the Xl-Oct-IA cDNA clone in the 
vector pBluescript SK-. The fragment extended from the Bam HI 
site in the Xl-Oct-IA coding sequence to the Bam HI site at 
the 3' end of the cDNA insert in the pBluescript SK- 
polylinker. pET-2 was cut with Bam HI (at the 3' end of the 
cDNA insert) and this fragment inserted to create pET-1. 
pET-1 contains amino acids 16 to 760 (3' end) of Xl-Oct-IA 
and the 3' untranslated region.
The fragment isolated to insert into pET-2 to create pET-1
141-
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was inserted into the Bam HI site of pET-3A to create pET-4. 
pET-4 contains amino acids A63 to 760 (3' end) of Xl-Oct-IA 
and the 3' untranslated region.
A fragment from the Bgl II site of the mutated Xl-Oct-IA 
cDNA in M13mpl8 to the Eco RI site at the 3' end of the cDNA 
insert was subcloned into pBluescript SK- to create pBS-1. 
pBS-1 contains amino acids 16 to 760 (3' end) of Xl-Oct-IA, 
and the 3' untranslated region, in frame to the beta- 
galactosidase gene of pBluescript S K-.
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Production of an anti Xl-Oct-IA polyclonal antiserum. 
Introduction.
An anti Xl-Oct-IA antiserum was primarily required to 
identify the Oct-1 band in band shift assays, and also to 
stain Western blots of protein extract. To exclude the 
possibility of the antiserum reacting with other proteins via 
a conserved POU domain, the antiserum was raised against an 
Xl-Oct-IA fusion protein lacking the POU domain.
11.1 Making an Xl-Oct-IA fusion protein for use as an 
antigen.
Two fusion protein constructs (see chapter 10) were suitable 
for use as antigens (ie. they lack the POU domain): pET-3 and 
pET-A. pET-3 contains amino acids 16 to 231 of Xl-Oct-IA in 
the vector pET-3B (Rosenberg et al (1987)), and pET-A amino 
acids A63 to 760 in the vector pET-3A (Rosenberg e_t al 
(1987)). These constructs were transformed into the E_j_ coli 
strain BL21 (DE3) (see chapter 10). Induced cultures (IPTG 
added to induce expression of T7 RNA polymerase from the lac 
promoter, which then synthesises message for the T7 gene 10 
fusion protein) and un-induced cultures were grown, and 
proteins analysed by SDS-PAGE. A photograph of the gel 
stained with Coomassie blue is shown in figure 23. The 
predicted size of the pET-3 fusion protein (215 amino acids 
of Xl-Oct-IA and 11 amino acids of T7 gene 10) is 
approximately 25kD (assuming the average molecular weight of
Results and Discussion
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Figure 23.
Expression of fusion proteins suitable for use as antigens.
Three cultures of BL21(DE3) carrying pET-3 or pET-4 were 
grown to A^q q  = 0.8. IPTG was added to two cultures carrying 
each construct to a final concentration of IraM (+). One of 
the three cultures was not induced (-). Growth was continued 
for a further two hours, after which time lOOul of culture 
was microfuged and suspended in SDS gel loading buffer, and 
electrophoresed on a 15% separating SDS-polyacrylamide gel.
A photograph of the Coomassie stained gel is shown. Size and 
position of protein molecular weight markers is shown.
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an amino acid is 110). A more intense band of this size is 
seen in the induced tracks relative to the un-induced track, 
indicating high level expression of the fusion protein. The 
predicted size of the pET-4 fusion protein (297 amino acids 
of Xl-Oct-IA and 11 amino acids of T7 gene 10) Is 
approximately 34kD. There is no visible induced band of this 
size, indicating that this fusion protein is not strongly 
expressed. This could be a consequence of instability (of 
message or protein), or due to toxicity of the fusion 
protein. Toxic proteins are known to select for the loss of 
the plasmid expressing the fusion protein, or to select for 
promoter mutations which reduce expression if, as was the 
case here, the ampicillin selection is maintained at high 
levels (Studier and Moffatt (1986)). The presence of the 
pET-4 plasmid caused a much reduced growth rate, which is 
consistent with the fusion protein being toxic. Consequently 
the pET-3 fusion protein was selected for use as an antigen.
A 50ml culture of BL21 (DE3) carrying pET-4 was grown to 
a600 “ ®*®» an(* then induced by the addition of IPTG (to a 
final concentration of ImM). Proteins were resolved on an 
SDS-polyacrylamide gel, and the gel lightly stained with 
Coomassie blue in water. A gel slice containing the fusion 
protein was cut out. A small fraction of the culture was run 
alongside a known amount of marker protein to estimate the 
amount of fusion protein contained in the gel slice. The 
fusion protein, isolated in this way, was used as an antigen.
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11.2 Production of a polyclonal antiserum.
pET-3 fusion protein (in the gel slice) was emulsified with 
Freund's adjuvant as described in Methods. A New Zealand 
White rabbit was given three injections of 50 to lOOug of 
protein at two week intervals. For the first injection 
protein was emulsified with complete adjuvant, and for 
subsequent injection with incomplete adjuvant. Prior to the 
first injection approximately lOmls of pre-immune serum was 
taken. Two weeks after the final injection immune serum was 
taken.
Antiserum was checked by using it to stain a Western blot of 
protein extract from induced and un-induced coll BL21 
(DE3) carrying the pET-3 fusion protein construct. Proteins 
were resolved by SDS-PAGE (15% separating gel) and 
electrophoretically transferred to a nitrocellulose filter. 
The filter was incubated with antiserum, and bound antibodies 
detected by incubating with a biotinylated secondary 
antibody, then streptavidin alkaline phosphatase conjugate, 
and then colour development with BCIP and NBT (which produce 
a coloured deposit on the filter in a reaction catalysed by 
alkaline phosphatase). A photograph of the stained filter is 
shown in figure 24. The antibody reacts with a band of the 
correct size (the pET-3B fusion protein is 25kD) in both 
induced and un-induced culture extracts. The reaction is 
stronger with induced culture extract, indicating that there 
is a lower basal level of fusion protein expression in the 
absence of induction with IPTG (not detected by Coomassie
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Figure 24.
The anti Oct-1 antiserum detects the coli fusion protein 
against which it was raised.
E. coli BL21 (DE3) cultures carrying pET-3 were microfuged, 
resuspended in 0.01 volumes of SDS loading buffer and the 
amount indicated resolved on a 15% separating 
SDS-polyacrylaraide gel. Induction indicates that IPTG (to a 
final concentration of ImM) was added to the culture at A^q q  
■ 0.8. Growth of induced and not induced cultures was 
continued for two hours after this point. The gel was 
electrophoretically transferred to a nitrocellulose filter, 
and the filter incubated with a 1 in 100 dilution of the 
anti 0ct-l antiserum. Bound antibodies were detected as 
follows: incubation with biotinylated anti rabbit 
immunoglobulin; incubation with streptavidin alkaline 
phosphatase conjugate; and finally colour development with 
NBT and BCIP (which give coloured products in a reaction 
catalysed by alkaline phosphatase). Size and position of 
protein molecular weight markers is shown.
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staining). Weaker reaction to proteins below the strong 25kD 
band is probably to degraded fusion protein. Consequently the 
antiserum reacts with Xl-Oct-IA produced in coli.
Antiserum was purified by affinity for the pET-3 fusion 
protein electrophoretlcally transferred to a nitrocellulose 
filter as described in Methods. Purified antibody was 
routinely used to stain Western blots o f  laevis protein 
extract in an attempt to ensure that the bands detected were 
related to Oct-1, and were not being detected by antibodies 
present in the antiserum before immunisation. However, no 
significant difference was observed between the proteins 
detected by whole and purified antiserum (see later).
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Chapter 12
The Xenopus laevis Oct-1 cDNA encodes a functional octamer- 
binding protein.
Extract from 15. coli expressing the fusion protein 
constructs pET-1, pET-2 and pBS-1 (described in chapter 10) 
were used in band shift assays to show that Xl-Oct-IA 
encodes a functional octamer-binding protein. The Oct-1 
sequence contained in these constructs is illustrated in 
figure 25A. pET-1 is the full-length cDNA in pET-3B 
(actually it lacks the first 16 amino acids from the N- 
terminal end), and pBS-1 is the full-length cDNA in 
pBluescript SK-. pET-2 and pET-3 are equivalent to pET-1 
which has been progressively deleted from the C-terminal 
end. pET-3 does not contain the DNA-binding POU-domain, and 
is therefore included as a control. Extract from E^ coli 
expressing pET-1, pET-2 and pBS-1 binds to an octamer probe 
(end-labelled 25mer duplex oligonucleotide containing the 
consensus octamer, sequence given later in figure 28F), and 
as expected pET-2 extract gives a greater mobility shifted 
band, since the Oct-1 sequence contained in this construct 
is deleted at the C-terminal end (figure 25B). This binding 
is specific as it can be competed-out by inclusion of an 
excess of unlabelled probe in the binding reaction. As 
controls, extract from the host E. coli strain (TG2) of pBS- 
1 and from 15. coli expressing pET-3 (which does not contain 
the DNA binding POU-Domain) do not bind to the octamer probe 
in band shift assays.
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Oct-1 sequence contained in fusion protein constructs and 
their binding to a probe containing an octamer motif analysed 
by band shift assays.
(A) Oct-1 fusion proteins contain Oct-1 sequence extending 
from the Bgl II site made by oligonucleotide directed 
mutagenesis to the position on the Xenopus laevis Oct-1 
amino acid sequence indicated by the name of the 
construct (pET-1, pET-2, pET-3 and pBS-1). The location 
of the POU (DNA binding) domain is shown.
(B) Band shift assays with extract from E. coli expressing 
the fusion protein constructs indicated, and a probe 
containing an octamer motif (oct probe, see figure 28F). 
Competitor (an excess of unlabelled probe) and antiserum 
(Oct ■ anti Xenopus laevis Oct-1 (raised against the 
pET-3 fusion proteinTj PI » pre-immune serum) were 
included in the binding reaction where indicated. TG2 
extract is from the host E. coli strain of pBS-1. The 
positions of undegraded pBS-1, pET-1 and pET-2 complexes 
and free probe (F) are indicated.
Figure 25
E TCAGATCTA Bgl II
44 mutagenesis 
TCAGATGCA
001 MKLHSSSLIQNHAwbsDARMNNPSETSKSPESGDGNTGTQTNGLDFQRQAVPIGAITSAQAQALLGHLHQ 
071 VQLAGTSLQAAAHSLNVQTKFKEEPGEPMQWQPSQQPSLQAAIPQTQLMVAGGQIAGLTLTPAQQQMLL 
141 QQAQAQLLAAAVQHSANQQHNAAGATISASAATPMTQIPLSQPIQIAQDLQQLQQLQQQNLNLQQYVLVH 
| pET-3(Stu I site)
211 PTTNLQSAQFIISQTPQGQQGLLQAQNLLTQLPQQSQANLLQSQPSITLTSQPATPTRTIAATPVQQLPQ
281 SQTTPKRIDTPSLEEPSDLEELEQFAKTFKQRRIKLGFTQGDVGLAMGKLYGNDFSQTTISRFEALNLSF 
POU DOMAIN
351 KNMCKLKt>LLEKWL^ AVLEMiT5b5TtTrf0"gVDI5PgH(3MegLrfftRRritfttgI BWIftVALEK5PtEH0
j pET-2(BamHI site)_
421 KPTSE'ElTMlADQLllMEKEViR'VWFTrNRROKEKRiNP'PSSGGSSSSPIKSLFSSPNPLVASTPSLVTSSP 
491 ATTLTVNPVLPLTSAAAITSFHIPGTTGTSSANTATVISTAPPVSSVLTSPSLSSSPSATAASSEASTAG 
561 ETSTTQTTSTPMTSSLNTGQVMVTASGIHTAAATALQGAAQLPTNASLAAMAAAAGLNPGLMAPSQFAAG 
631 GALFSLNPGALGSALSPALMSNSTLATIQALASSGSLPITSLDAAGNLVFANAGGTPNIVTAPLFLNPQN
1 pET-1,pBS-1
701 LSLFTSNPVSLISAASAGATGPITSLHATTSSIDSIQNALFTMASASGAASTTTSASRAQ
E
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+
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The assays shown here use extract from un-induced E_j_ coll 
cultures. Induction with IPTG (which Induces pBS-1 
expression directly, and pET construct expression indirectly 
by inducing T7 RNA polymerase) was found to have either no 
effect on the yield of these fusion proteins, or to give 
lower ylelds/degraded products. This is probably because the 
proteins produced are toxic to coli. This leads to the 
loss of the expressing plasmid, or if the ampicillin 
selection is maintained at high levels cells carrying 
plasmids with promoter mutations which reduce expression are 
selected (Studier and Moffatt (1986)). In the case of 
degraded products the toxic proteins had probably caused 
cell death.
The antiserum raised against the pET-3 fusion protein 
included in the pBS-1 band shift assay inhibits formation of 
the Oct-1 - DNA complex, whereas pre-immune serum does not. 
This demonstrates that the antibody reacts to Xl-Oct-IA, and 
not to the non-Oct-1 part of the fusion protein, since the 
antibody was raised against a T7 gene 10 fusion protein, and 
reacts with the pBS-1 fusion protein which is a beta- 
galactosidase fusion protein.
Functional expression of Oct-1 in £. coli suggests that no 
other factors are required for DNA binding activity. Mixing 
of pET-1 and pET-2 extracts in band shift assays gives two 
strong shifted bands of the mobility seen in un-mixed 
extracts (figure 25B). This shows that Oct-1 binds to the 
probe as a monomer, since if Oct-1 bound as a dimer a third
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band of intermediate size corresponding to a pET-1:pET-2 
heterodimer would be expected. The fact that pET-2 binds and 
pET-3 does not shows that the Xl-Oct-lA binding activity is 
located in a region of the protein containing the POU domain 
(which has been shown to be necessary and sufficient for the 
binding of human Oct-1, see Sturm e£ al (1988A) and Sturm 
and Herr (1988)).
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Chapter 13.
Two octamer-binding proteins can be detected in Xenopus 
laevis oocyte extract.
13.1 Oocytes contain Oct-1 and a second octamer-binding 
protein.
Band shift assays with a probe containing the consensus 
octamer (oct probe, see figure 28F) and oocyte protein 
extract detect two specific bands as a result of octamer 
binding proteins. Specific binding can be competed-out by 
inclusion of an excess of unlabelled probe in the binding 
reaction (figure 26). One strong and several weak non­
specific binding activities (of greater mobility than the 
two specific binding activities) are also detected.
The upper specific band is of a similar mobility to the 
pBS-1 fusion protein band. The pBS-1 fusion protein is of 
similar size to the protein encoded by the Xl-Oct-1 cDNA (in 
pBS-1 16 amino acids of Xl-Oct-1 coding sequence are 
replaced by 31 amino acids of the beta-galactosidase gene of 
pBluescript SK-, resulting in a protein of 775 residues 
rather than 760). Formation of the upper band (and not the 
lower band or the non-specific binding) is inhibited by 
inclusion of antiserum raised against the pET-3 Oct-1 fusion 
protein in the binding reaction. Pre-immune serum and an 
antiserum raised against Xenopus laevis thyroid hormone 
receptor (gift of R. W. Old) do not inhibit formation of 
this complex. An extra low mobility band is seen in assays
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Band shift assays showing that oocyte extract contains Oct-1 
and a second octamer-binding protein, Oct-R.
The probe contains an octamer motif (oct probe, see figure 
28F) and extract is from Xenopus laevis oocytes, except pBS-1 
extract (from E. coli expressing the pBS-1 fusion protein). 
Assays in lanes 5-10 contain antiserum (PI » anti Xenopus 
laevis Oct-1 pre-immune serum; oct * anti Xenopus laevis"Oct- 
1 (raised against the pET-3 fusion protein); THR - anti 
Xenopus laevis thyroid hormone receptor) and in lanes 5-7 
contain no protein extract to show that the sera bind non- 
specifically. Lane 2 contains an excess of unlabelled probe 
in the binding reaction as competitor. The positions of Oct- 
1, Oct-R and non-specific complexes (NS) and free probe (F) 
are indicated.
Figure 26
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containing antiserum. Assays with serum and no extract 
demonstrate that this is due to non-specific binding of a 
protein in the serum.
Consequently the upper band seen in these band shift assays 
is identified to be a result of binding of Xenopus laevis 
Oct-1. The Oct-1 band probably represents binding of the 
products of both Xl-Oct-IA and Xl-Oct-IB clones. The second 
greater mobility band is as a result of binding of a 
previously unidentified octamer-binding factor, which is 
antigenically distinct from the N-terminal domain of Oct-1 
contained in the pET-3 fusion protein. This factor has been 
termed Oct-R (for octamer-related).
13.2 An antibody against full-length human Oct-1 recognises 
Xenopus laevis Oct-1, but not Oct-R.
The effect of an antiserum raised against a a full-length 
human Oct-1 fusion protein (gift of W. Herr, see Sturm e£ al^  
(1988)) included in band shift assays with the octamer probe 
(oct probe, see figure 28F) and oocyte protein extract is 
shown in figure 27. As with anti Xenopus laevis Oct-1 
antiserum, the serum alone binds non-specifically to the 
probe giving a low mobility retarded band. The anti human 
Oct-1 antiserum inhibits the formation of the Oct-1 complex, 
but not the Oct-R complex. This confirms the identification 
of the upper specific band as being the result of Oct-1 
binding. The anti human Oct-1 antiserum was raised against a 
full-length Oct-1 fusion protein, including the POU-domain.
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Anti human Oct-1 antiserum reacts with Xenopus laevis Oct-1, 
but not Oct-R.
Band shift assays with an octamer probe (oct probe, see 
figure 28F) and with oocyte extract and/or anti human Oct-1 
antiserum included where indicated. The positions of Oct-1, 
Oct-R and non-specific complexes (NS) and free probe (F) are 
indicated.
Figure 27.
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This antibody inhibits the formation of both human Oct-1 and 
0ct-2A complexes (Sturm et al (1988A)), presumably as a 
result of the reaction of antibodies against the conserved 
POU-domain. It is possible that Oct-R binds to DNA via a 
POU-domain, however the anti human Oct-1 antiserum does not 
react with Oct-R. This result may indicate that the Xenopus 
laevis Oct-R POU domain (unlike the Xenopus laevis Oct-1 POU 
domain) is significantly diverged from the human Oct-l/Oct-2 
POU domain.
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Chapter 14.
A comparison of the binding properties and distribution of 
Oct-1 and Oct-R.
14.1 Oct-1 and Oct-R have different binding affinities.
In Xenopus laevis histone H2B gene promoters the octamer 
motif occurs as the core of an extended consensus sequence 
known as the H 2B box (see introduction section 1.1.2, and 
figure 33). The most common octamer motif in Xenopus laevis 
H2B boxes is not the perfect octamer (ATTTGCAT) but a 7 out 
of 8 match (GTTTGCAT). I have tested the binding of Oct-1 
and Oct-R to these octamer motifs in the context of the 
Xenopus laevis H2B box (oct probe - ATTTGCAT, H2B probe * 
GTTTGCAT in this context) and in the context of the mouse 
immunoglobulin heavy chain enhancer (k.oct probe * ATTTGCAT, 
k.H2B probe - GTTTGCAT in this context). The results are 
shown in figure 28. Equal amounts of the different probes, 
and an equal amount of oocyte extract was used in assays 
where comparisons are made.
As shown previously, the oct probe binds both Oct-1 and 
Oct-R. The H2B oligo is a poor competitor for Oct-1 binding, 
but an efficient competitor for Oct-R binding (figure 28A). 
Correspondingly Oct-R binds well to the H2B probe and Oct-1 
does not detectably bind. Oct-R binding to the H2B probe is 
stronger than to the oct probe (the gel exposures in figure 
28 A and B are directly comparable). The oct-1 fusion 
protein, pBS-1, does not detectably bind to the H2B probe 
(figure 28B). With the H2B probe a faint, variable and not
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Comparison of the binding affinities of Oct-1 and Oct-R for 
different octamer-containing oligos using band shift assays.
Oct and k.oct oligos contain the perfect octamer in the 
context of the histone H2B gene promoter and the 
immunoglobulin heavy chain enhancer, respectively. H2B and 
k.H2B oligos contain a 7 out of 8 match octamer motif in the 
context of the histone H2B gene promoter and the 
immunoglobulin heavy chain enhancer, respectively. The mut 
oligo is the same sequence as the H2B oligo except with two 
point mutations introduced into the octamer motif. Protein 
extract is from Xenopus laevis oocytes, except pBS-1 extract 
(from IS. coli expressing the pBS-1 fusion protein). A to E 
show band shifts using the oligos indicated as probe, and 
with the unlabelled oligos indicated as competitor. The 
positions of Oct-1, Oct-R and non-specific complexes (NS) and 
free probe (F) are indicated. F summarises the binding 
affinities of Oct-1 and Oct-R to the oligos.
Figure 28.
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efficiently competable band is seen above Oct-R and just 
below the Oct-1 position. This binding is not inhibited by 
the anti Oct-1 antiserum (not shown). The k.oct probe 
detectably binds only Oct-1. As expected the oct oligo is an 
efficient competitor for this binding and the H2B and k.H2B 
oligos are poor competitors. Oct-1 binds slightly less 
efficiently to the k.oct probe than the oct probe (figure 
28C is a long exposure to illustrate the different 
competitive abilities of the cold oligos. With an equivalent 
exposure of A and C it is apparent that Oct-1 binds slightly 
more efficiently to the oct probe than to the k.oct probe). 
The k.H2B probe does not detectably bind Oct-1 or Oct-R 
(figure 28D).
To show that Oct-R binding is octamer-dependent the H2B 
oligo with two point mutations in the octamer motif (mut 
probe, GTTTGCAT > GGTTGAAT) was used as probe and competitor 
in band shift assays. This oligo binds Oct-R less 
efficiently than the H2B oligo and is a poor competitor for 
Oct-R binding (figure 28E).
The binding affinities of Oct-1 and Oct-R for the different 
oligos are summarised in figure 28F. Oct-1 binds efficiently 
to the perfect octamer in either sequence context. Binding 
is slightly more efficient in the context of the H2B box. 
Oct-1 does not bind to the 7 out of 8 octamer most often 
seen in Xenopus laevis histone H2B gene promoters. Oct-R 
binds efficiently to both the perfect and 7/8 octamer 
motifs, but only binds in the context of the H2B gene
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Figure 29.
Distributions of Oct-1 and Oct-R determined by band shift 
assays.
Oct and H2B probes (see figure 28F) were used in band shift 
assays to maximise the binding of Oct-1 and Oct-R, 
respectively.
(A) With extract from Xenopus laevis oocytes, eggs and stages 
of early development (Nieuvkoop and Faber (1956)). The 
equivalent of one oocyte/egg/embryo was used in each 
assay.
(B) With extract from adult Xenopus laevis tissues and the 
cell line, Xtc.
The positions of Oct-1, Oct-R and non-specific complexes (NS) 
and free probe (F) are indicated.
B. OCT PROBE H2B PROBE
T is s u e s ___ ' __ Tissues
1 2 3 4 5 6  1 2 3 4 5 6
TISSUES: (1 ) OOCYTE
(2 )  OVIDUCT
(3 )  KIDNEY
(4 ) BRAIN
(5 )  BLOOD
(6 ) Xtc CELLS
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promoter. Binding Is slightly more efficient to the 7/8 
octamer.
14.2 Distribution of Oct-1 and Oct-R in tissues and early 
development.
Band shift assays have been used to analyse the 
distribution of Oct-1 and Oct-R in early Xenopus laevis 
development and in adult Xenopus laevis tissues. Oct and H2B 
probes (figure 28F) were used to maximise the binding of 
Oct-1 and Oct-R, respectively. Both Oct-1 and Oct-R are 
present at an approximately constant level throughout early 
development (see figure 29A, the assays shown ^ntained 
extract from the equivalent of one oocyte/embryo) y^Oct-1 is 
present in all adult tissues tested (oocyte, oviduct, 
kidney, brain, blood) and in the cell line, Xtc. Oct—R has a 
similar distribution, but cannot be detected in the extract 
from blood (figure 29B). Amounts of binding activity between 
different tissues are not comparable, but the relative 
intensities of Oct-1 and Oct-R bands are comparable.
Generally where both factors are present the intensity of 
Oct-1 (detected by the oct probe) and Oct-R (detected by the 
H2B probe) bands is approximately equal. However, with 
oviduct extract the Oct-1 band is much more intense than the 
Oct-R band.
♦INSERT:
T h e  a m ou nt  o f  t h e s e  f a c t o r s  v a r i e s  ( u p t o  2 - 3  t i m e s )  b e t w e e n  s t a g e s  
o f  d e v e l o p m e n t ,  b u t  t h e  v a r i a t i o n  i s  e r r a t i c  and p r o b a b l y  due t o  
e r r o r s  i n  g e l  l o a d i n g  a n d / o r  e q u a l i s i n g  e x t r a c t  c o n c e n t r a t i o n .
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Figure 30
Band shift assays to show that Oct-R cannot be detected in 
mouse L cell extract.
Oct and H2B probes (see figure 29F) were used maximise the 
binding of Oct-1 and Oct-R, respectively. Band shift assays 
with extract from mouse L cells (and with extract from 
Xenopus laevis oocytes, for comparison) are shown. XI 
indicates antiserum raised against Xenopus laevis Oct-1 and 
Hu antiserum raised against human Oct-1 included in the 
binding reaction. An excess of unlabelled probe was Included 
in the binding reaction as competitor where indicated. The 
positions of Oct-1, Oct-R and non-specific complexes (NS) and 
free probe (F) are indicated.
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14.3 Oct-R cannot be detected in mouse L cells.
A single specific band is detected in band shift assays 
using octamer-containing probes and extract from mouse L 
cells (figure 30). Band shifts with Xenopus laevis oocyte 
extract are shown for comparison, and oct and H2B probes 
were used to maximise the binding of Xenopus laevis Oct-1 
and Oct-R, respectively. The single specific band seen with 
L cell extract is due to Oct-1 binding as the shift is of a 
similar size to that produced by Xenopus laevis Oct-1 
binding and since binding is inhibited by inclusion of 
antiserum raised against human Oct-1 (Sturm et_ al  ^(1988A)) 
in the binding reaction and slightly inhibited by inclusion 
of the anti Xenopus laevis Oct-1 antiserum. Consequently a 
band equivalent to an Oct-R binding activity is not present 
in mouse L cell extract. Interestingly, mouse Oct-1 shows 
significant binding to the H2B probe, whereas Xenopus laevis 
Oct-1 does not detectably bind this probe.
14.4 Location of Oct-1 and Oct-R in the oocyte.
Band shift assays were carried out using extract prepared 
from whole and manually enucleated oocytes (see figure 31). 
These assays (which include the equivalent of one whole 
oocyte or cytoplasm) indicate that approximately 25% of 
Oct-1 and 50% of Oct-R present in the oocyte is located in 
the cytoplasm (enucleated oocyte). The non-specific binding 
activity (which is particularly clear in the assay with the 
H2B probe) serves as an internal control to show that
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Figure 31
Location of Oct-1 and Oct-R in Xenopus laevis oocvtes 
determined by band shift assays.
Oct and H2B probes (see figure 28F) were used to maximise 
Oct-1 and Oct-R binding, respectively. W indicates whole 
oocyte extract and C indicates cytoplasmic (enucleated 
oocyte) extract. Extract from the equivalent of one oocyte or 
cytoplasm was used in each assay. The positions of Oct-1, 
Oct-R and non-specific complexes (NS) and free probe (F) are 
indicated.
probe Oct 
extract W C
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enucleation without the loss of cytoplasm has been achieved. 
The lowest mobility non-specific binding activity (nuclear 
protein) is absent from the cytoplasmic extract, whereas the 
greatest mobility non-specific binding activity (cytoplasmic 
protein) is present in equal amounts in whole and 
cytoplasmic extract. A variable amount of Oct-1 and Oct-R 
binding activity was found in isolated nuclei (not shown). 
This was probably due to leakage of these proteins from the 
nucleus during Isolation of the nuclei, or because nuclei 
could not be obtained free of barth-X (the buffer in which 
oocytes are maintained, and hence nuclei isolated). This 
buffer may not maintain binding proteins in an active form.
14.5 Levels of Oct-1 and Oct-R in cells in which DNA
synthesis has been inhibited and in cells which have 
been serum starved.
Mammalian Oct-1 has been implicated in the control of the 
octamer-dependent stimulation of histone H2B transcription 
on entry into S-phase of the cell-cycle. Consequently there 
has been interest in whether the binding activity of Oct-1 
is cell-cycle regulated.
Xenopus laevis Xtc cells were treated with hydroxyurea, 
which inhibits DNA synthesis. The levels of Oct-1 and Oct-R 
(determined by band shift assays, see figure 32) show no 
significant change following this treatment. The protein 
concentration of extracts from treated and untreated cells 
was determined and equal amounts of extract used in each
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Band shift assays to determine the levels of Oct-1 and Oct-R 
in Xenopus laevis Xtc cells treated with hydroxyurea or 
serum-starved.
Oct and H2B probes (see figure 28F) were used to maximise 
Oct-1 and Oct-R binding, respectively. Duplicate flasks of 
cells were treated, and assays with extracts from these 
flasks are bracketed together. Extracts A to D were from 
cells treated as follows: (A) Untreated growing cells (B) 
Treated with 5mM hydroxyurea for 90 minutes (C) Serum-starved 
for 18 hours and then serum added back for 6 hours (D) Serum- 
starved for 18 hours. The positions of Oct-1, Oct-R and non­
specific complexes (NS) and free probe (F) are indicated.
Figure 32
EXTRACT
O ct- 1 ►  
O ct-R ►
r
NS
F  ►
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assay. Extract from duplicate flasks was assayed in each 
case. Our laboratory has previously shown that treatment of 
Xtc cells with hydroxyurea causes a rapid reduction in 
histone mRNA levels to 25% of that seen in untreated cells 
(Old et al (1985)).
Xtc cells were serum starved to block at the beginning of 
Gl phase of the cell-cycle, and then released from the 
block. The levels of Oct-1 and Oct-R (determined by band 
shift assays, see figure 32) show no significant change in 
serum starved cells relative to growing cells and adding 
complete medium back to starved cells resulted in no change 
in levels relative to starved cells. As in the case of 
hydroxyurea treatment, extract protein concentrations were 
normalised, and duplicate flasks of cells assayed.
14.6 Conclusions and speculation regarding Xenopus laevis 
Oct-1 and Oct-R based on the affinity/distribution 
data.
Oct-1 and Oct-R have different binding affinities. In 
histone H2B gene promoters the octamer motif occurs as the 
core of a longer consensus sequence known as the H2B box 
(see introduction section 1.1.2). The most common octamer 
motif in the Xenopus laevis H2B box is a 7 out of 8 match 
(GTTTGCAT) to the canonical octamer (ATTTGCAT) (see section 
1.1.2 and figure 33). I have tested the binding affinities 
of Oct-1 and Oct-R for these two octamer motifs in the 
context of the H2B box and in the context of the mouse
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Xenopus laevis histone gene promoter H2B boxes, with core 
octamer motif, aligned to each other and to the corresponding 
region of oligos used as probes in band shift assays. The 
name of the Xenopus laevis histone gene cluster (Perry et al 
(1985), Moorman et al (1982), Aldridge (1986)) in which the 
H2B box is found“T s  given in the left-hand column and the 
name of the band shift probe in which these sequences are 
found in the right-hand column. H2B, Oct and MUT probes 
contain the octamer in the context of the H2B box. k.H2B and 
k.Oct probes contain the octamer in the context of the mouse 
heavy chain enhancer.
Figure 33
OCTAMER
XIHW23 CTGCCTC GTTTGCAT GGGA
XIHW11 CTGCCTC GTTTGCAT GGGA
XIH1 CTGCCTC GTTTGCAT GGGA
XIHW8 CAGCCTC GTTTGCAT GCGA
XIH3 GCCAGTG CTTTACAT GGGC
XIHhH CTGCCTT ATTTGCAT GGGA
XIHW7 CTACCTT ATTTGCAT GGGA
XIHW24 CTÖCCT _T ATTTGCAT GGGA
CTGCCTC ATTTGCAT GGGA
CTGGGTA GTTTGCAT TTCT
CTGGGTA ATTTGCAT TTCT
CTGCCTC GGTTGAAT GGGA
H2B PROBE
OCT PROBE 
K-H2B PROBE 
K-OCT PROBE 
MUT PROBE
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Immunoglobulin heavy chain enhancer (sequences of probes are 
shown In figure 33). Oct-1 binds well to the perfect octamer 
in either context (slightly more strongly in the H2B box) 
and has low affinity for the 7/8 octamer in either context. 
Oct-R binds both octamer motifs strongly (the 7/8 octamer 
more strongly) but only in the context of the H2B box.
Little Oct-R binding to either motif in the context of the 
heavy chain enhancer is seen.
Xenopus laevis Oct-1 is similar to human 0ct-l/0ct-2 in 
that it binds well to the perfect octamer regardless of 
flanking sequences. Flanking sequences are necessary to 
stabilise the binding of human Oct-1 to degenerate octamer 
motifs, but not the perfect octamer (see section 1.3.2). 
However, Oct-R is distinct from Oct-1 in that although 
binding is octamer-dependent, it does not bind well to the 
perfect octamer (or the 7/8 octamer) regardless of the 
context. Binding of Oct-R to the perfect octamer (and 7/8 
octamer) is stabilised by the H2B box flanking sequences. 
Oct-R may be better described as a H2B box binding protein. 
As already mentioned the Oct-R POU domain (if DNA binding is 
via a POU domain) may be antigenically distinct from the 
human 0ct-l/0ct-2 POU domain (see section 13.2), and this 
may correlate with the distinct pattern of binding. In line 
with this is the observation that the X_j_ laevis Oct-1 POU 
domain used to probe a genomic Southern blot (chapter 7) 
gives a similar hybridisation pattern (at low stringency) to 
a probe from Oct-1 outside the POU domain. This indicates
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that sequences similar to the Oct-1 POU domain do not occur 
in the X laevis genome.
Mammalian Oct-1 has been implicated in the control of the 
octamer-dependent stimulation of histone H2B transcription 
on entry into S-phase of the cell-cycle. The binding 
properties of Xenopus laevis Oct-R suggest that it may have 
a role in histone H2B transcription in Xenopus laevis, 
although a functional assay for the activity of this factor 
is clearly required. Consequently I was interested to see if 
the distribution of Oct-R was consistent with a potential 
role as a ubiquitously expressed gene transcription factor.
Xenopus laevis Oct-1 is present at an approximately 
constant level throughout early development, and is also 
present in all tissues tested and in the cell line, Xtc. 
Oct-R has a similar distribution with the exception that it 
could not be detected in the protein extract from Xenopus 
laevis blood. The widespread distribution of both factors is 
consistent with their putative roles as ubiquitously 
expressed gene transcription factors.
A family of octamer-binding proteins (Oct-1 to 0ct-10) has 
been identified in the mouse (see Scholer £t al^ (1989) and 
introduction section 1.4.5). However, the distribution of 
Xenopus laevis Oct-R (which is distinct from the 
distribution of these mouse factors and any other previously 
identified octamer binding-factors) suggests that it is not 
a homologue of one of these factors, but a previously 
unidentified octamer-binding factor. In fact, a binding
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activity similar to Oct-R (which has a wide distribution in 
Xenopus laevis) could not be detected in extract from mouse 
L cells. It is also interesting to note that the probe used 
to identify the family of mouse octamer-binding proteins, 
which includes proteins present in unfertilised oocytes and 
proteins differentially expressed at stages of mouse 
embryogenesis, was from the immunoglobulin heavy chain 
enhancer. I found that a similar probe did not detect 
homologues of these mouse octaraer-binding proteins in 
Xenopus laevis oocytes and embryogenesis. However, the 
inability to detect homologues of these mouse octamer 
binding proteins should not be regarded as proof that such 
proteins do not exist. For example, various groups did not 
detect the factor 0ct-2B in mammalian B cell extract (see 
introduction, section 1.1.1). However, as mentioned earlier, 
it appears that sequences closely related to the Oct-1 POU 
domain do not occur in the X_j_ laevis genome.
Like Xenopus laevis Oct-1, mouse Oct-1 binds the H2B probe 
(7/8 octamer in H2B box) with lower affinity than the oct 
probe (perfect octamer in H2B box). However, mouse Oct-1 
binds detectably to the H2B probe, whereas Xenopus laevis 
Oct-1 binding can only be demonstrated by inclusion of a 
large excess of the cold oligo as competitor in a binding 
reaction. Consequently, mouse and Xenopus laevis Oct-1 have 
different binding affinities, presumably due to differences 
within the POU domain. The sequence of mouse Oct-1 has not 
been reported, but since mouse and human Oct-2 are identical
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within the POU domain (Hatzopoulos et al (1990)), and 
chicken and human Oct-1 are identical within the POU 
specific and POU homeo boxes (Petryniak et ¿1 (1990)) it is 
perhaps safe to assume that mouse and human oct-1 are 
identical within the POU specific and POU homeo boxes. If 
so, the two differences seen between human Oct-1 and 
Xl-Oct-IA/Xl-Oct-IB (see figure 17, the differences to the 
two clones are not the same) within the POU specific and POU 
homeo boxes (the linker between the 2 boxes is thought not 
to influence binding) probably account for the difference in 
binding affinity.
Oct-1 and Oct-R are present at a constant level throughout 
early Xenopus laevis development (from oocyte to the latest 
embryonic stage tested, stage 26). Consequently these 
proteins are stored in the oocyte, the amount in an oocyte 
being sufficient for at least the approximately 8x10^ cells 
of a stage 26 embryo (Dawid (1965)). Early amphibian 
development is extremely rapid (the approximately 30 000 
cells of the blastula stage are produced within 10 hours 
after fertilisation). Consequently, certain proteins are 
required in large amount. These include histones, which are 
required to associate with newly synthesised DNA. There are 
3 well studied strategies which are used to provide 
sufficient histone to keep up with the high rate of DNA 
synthesis (reviewed in Old and Woodland (1984), Woodland 
(1982), Woodland e£ al^  (1983)). Firstly the Xenopus oocyte 
nucleus contains sufficient stored histone protein to
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assemble about 20 000 nuclei. This protein is synthesised 
during the prolonged period of oogenesis. Secondly, histone 
mRNA is stored in the oocyte. After oocyte maturation 
translation of stored histone message begins, and provides 
sufficient histone for about one third of the histone 
present at the blastula stage. Histone mRNA in somatic cells 
is unstable, being rapidly degraded at the end of S-phase of 
the cell-cycle. In Xenopus (unlike, for example, sea 
urchins) stage specific histone genes are not present, and 
so the normally unstable message must be somehow stabilised 
in the oocyte. This could be by association with other 
factors, or alternatively by polyadenylation of histone mRNA 
(which is not polyadenylated in somatic cells). The bulk of 
histone mRNA in oocytes is polyadenylated, but becomes 
depolyadenylated by the unfertilised egg stage. Thirdly 
histone genes are reiterated to increase their overall 
amount of transcription (Xenopus has 50-100 copies of 
histone genes). Histone gene transcription first occurs at 
the mid blastula stage, and by the gastrula stage all 
histone mRNA translated is newly synthesised. In view of 
this it seems possible that histone gene transcription 
factors are stored as part of the mechanism to provide 
sufficient histone to keep up with the high rate of DNA 
synthesis observed in early development. The amount of Oct- 
1/Oct-R stored in the oocyte is equivalent to the the amount 
of RNA polymerase (I, II and III) stored, which is 
equivalent to the amount present in the approximately 80 000
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cells of the tailbud embryo (Roeder (1974)).
Part of the Oct-1 and Oct-R store of the oocyte is located 
in the cytoplasm (approximately 50% of Oct-R and 25% of 
Oct-1). This could be to avoid effects such as squelching 
(reviewed in Ptashne (1988)). Activating regions of 
transcription factors may interact (perhaps more weakly) 
with target proteins without association with DNA. 
Consequently a high concentration of an activator could 
depress transcription of genes lacking the activator target 
site by interaction with and sequestration of general 
transcription factors (for example components of the RNA 
polymerase II transcription complex). In yeast over­
production of the transcription factor Gal4 inhibits the 
transcription of genes lacking the Gal4 binding site (Gill 
and Ptashne (1988)). Squelching does not require the Gal4 
DNA binding domain. Expression of a hybrid factor containing 
the Gal4 DNA binding domain and the VP16 (HSV 
transactivator, see section 1.1.5) acidic activation domain 
depresses genes lacking the binding site in mammalian cells, 
and activates genes containing the binding site (Sadowski 
e£ jQ (1983)). VP16 has been shown to interact with TFIID 
(TATA box binding factor, and component of the RNA 
polymerase II transcription initiation complex) (Stringer 
ejt al (1990)). The acidic activation domain of VP16 and 
TFIID interact in the absence of DNA, and this interaction 
may be the cause of the squelching observed on over­
expression of VP16. Too much of the large 0ct-l/0ct-R store
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of the oocyte In the nucleus may Interact with and hence 
sequester other transcription factors, leading to the 
depression of genes not under the control of Oct-1.
There are other examples of transcription factors which are 
located in the cytoplasm of some cell types. The 
immunoglobulin kappa chain transcription factor, NF-kB, is 
present in the cytoplasm of unstimulated lymphocytes (which 
do not express immunoglobulin genes) (Baeuerle and Baltimore 
(1988)). However, in B cells (which express immunoglobulin 
genes) the transcriptional activator is located in the 
nucleus. Location in the cytoplasm seems to be determined by 
association with a cytoplasmic anchor (I-kB). The 
association is probably terminated fee allow nuclear 
localisation and transcriptional activation by protein 
kinase C dependent modification of the anchor protein. The 
dorsal gene of Drosophila. which probably encodes a 
transcription factor (Rushlow «  al (1989), Steward (1989), 
Roth e_t *^ 1 (1989), Kamens .et. j»l (1990)), is a member of a 
class of genes known as the dorsal group. Mutation of these 
genes causes dorsalisation of the embryo. The dorsal group 
genes act on each other, and dorsal being a probable 
transcription factor, is the last gene in the pathway. The 
amount of dorsal protein is equal along the dorso-ventral 
axis of the embryo, but there is a gradient of of nuclear 
localisation. More dorsal protein is present in the nucleus 
of more ventral tissues. Mutation of only one gene (cactus) 
known to effect the dorso-ventral axis causes the embryo to
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become ventrallsed. Cactus could be analogous to I-kB, that 
is a cytoplasmic anchor for dorsal, its loss causing dorsal 
to become nuclear and specify ventral tissues. It used to be 
thought that steroid hormones bound to their receptor in the 
cytoplasm, causing it to become translocated to the nucleus 
where it activated transcription. This seems to hold true 
for the glucocorticoid receptor, but most other receptors 
(eg. oestrogen, progesterone and thyroid hormone receptors) 
are present in the nucleus in the absence of hormone (Picard 
and Yamamoto (1987), Guiochon-Mantel ejt al (1989), and 
references therein). Oct-l/Oct-R could be held in the 
cytoplasm of the oocyte by association with an hypothetical 
anchor which over-rides the nuclear localisation signal. A 
nuclear localisation signal seems to consist of a short run 
of lysine/arginine residues (basic) (reviewed in Hunt
(1989) ), but this signal alone may not sufficient for 
nuclear localisation. Alternatively nuclear localisation 
could require modification of the protein. Oct-1 is known to 
be O-glycosylated and phosphorylated (Tanaka and Herr
(1990) , Murphy et al (1989)).
The octamer motif is required for the S-phase specific 
stimulation of histone H2B gene transcription (LaBella e_t al^  
(1988)) and extracts from HeLa cells synchronised in S-phase 
of the cell-cycle are able to activate transcription in 
vitro, but extracts from HeLa cells synchronised in G2 are 
not . An Oct-1 - containing fraction from HeLa cell extract 
purified by affinity for the octamer DNA sequence is able to
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activate histone H2B transcription in vitro (Fletcher e_t al^  
(1987)). Consequently there has been interest in whether the 
binding activity of Oct-1 is cell-cycle regulated and I was 
also interested to see if the binding activity of Oct-R is 
cell-cycle regulated.
There is no evidence that human Oct-1 binding activity is 
cell-cycle regulated, and the evidence from other species is 
contradictory. Synchronisation of avian cells by inhibition 
of DNA synthesis with aphidicolin indicated that the level 
of Oct-1 binding activity did not vary through the cell- 
cycle, although the level of another factor which binds to a 
promoter element responsible for the S-phase specific 
stimulation of histone HI transcription was increased at S- 
phase (Dalton and Wells (1988A)). However, synchronisation 
of hamster cells by serum starvation indicated that the 
level of Oct-1 binding activity was increased at S-phase of 
the cell-cycle (Ito e_t jil (1989)). I have found that 
inhibition of DNA synthesis in, or serum starvation of, 
Xenopus laevls cells has little effect on the levels of 
Oct-1 and Oct-R binding activity relative to that seen in 
growing cells. It appears that the stimulation of H2B 
transcription on entry into S-phase of the cell-cycle may 
not be a result of periodic octamer factor binding, 
particularly since Oct-1 is also involved in the 
transcription of ubiquitously expressed genes which are not 
cell-cycle regulated (eg. snRNA). As discussed in the 
introduction (see section 1.2.4) the explanation to this
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problem may be that there Is an as yet undiscovered cell- 
cycle regulated modification of Oct-1 (and possibly Oct-R). 
Oct-1 Is known to be phosphorylated and O-glycosylated 
(Tanaka and Herr (1990), Murphy et al (1989)). Alternatively 
there may be an interaction with another transcriptional 
regulator which is cell-cycle regulated. Oct-1 has been 
shown to interact with the herpes simplex virus 
transactivator, VP16, to activate transcription from 
octamer-TATA box promoters (see section 1.2.2) and 
transfection of VP16 stimulates the transcription of 
cellular H2B genes (Latchman e ^  al (1989)). There may be a 
cellular analogue of VP16, which recognises the flanking 
sequences of the octamer in the H2B-box, interacting with 
Oct-1 (and possibly Oct-R) to activate histone H2B gene 
transcription.
The discovery of Oct-R in Xenopua laevia complicates the 
situation. I have not shown that Oct-R is an H2B 
transcription factor, or even a transcription factor at all. 
But, it seems likely that a protein with affinity for a 
functional promoter element would be a transcriptional 
regulator, and the facts that Oct-R has preferential 
affinity for the octamer motif in the H2B box, and has a 
widespread distribution are suggestive. If, in fact, Oct-R 
is an H2B transcription factor then important questions 
arise. Firstly, why does Xenopus have Oct-R and mammals do 
not? I have only analysed L cells, but Oct-R has not been 
reported in other species. However, this could be a
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consequence of not using a probe with the correct flanking 
sequences. I have compared X^_ laevis. chicken, human and 
mouse H2B boxes (see introduction section 1.1.2). The core 
octamer motif is strongly conserved between species, however 
the sequences flanking the octamer motif are more strongly 
conserved between genes within a particular species, than 
between species. Oct-R, although binding is octamer- 
dependent, is perhaps better described as an H2B box binding 
protein. The equivalent factor in another species may 
require a probe containing the H2B box of that species to be 
detected. Such a probe has not been used to detect mammalian 
binding proteins. Secondly, why are two H2B transcription 
factors required in Xenopus? The evidence that human Oct-1 
is a H2B transcription factor is very compelling, and since 
Xenopus and human Oct-1 are so well conserved it is 
extremely likely that Oct-1 is a H2B transcription factor in 
Xenopus. An explanation for the potential existence of two 
H2B transcription factors is further clouded by the fact 
that the two factors have a similar distribution, since this 
means that there is no apparent potential for tissue/stage 
specific expression of particular histone genes by virtue of 
the different affinity of their octamer motifs for Oct-1 and 
Oct-R. If the .in vitro binding studies reflect the iri vivo 
situation then Oct-1 is unable to bind strongly to a subset 
of H2B gene promoters (containing the 7/8 octamer), whereas 
Oct-R would preferentially bind these promoters. There is no 
obvious explanation for this pattern of binding to, and
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Chapter 15.
Do the octamer motif and Oct-1/Oct-R regulate Xenopus laevls 
histone H2B genes?
Introduction.
It was decided to try and demonstrate a role for the octamer 
motif in the regulation of a Xenopus laevis histone H2B gene, 
and possibly gain evidence that Oct-l/Oct-R are H2B 
transcription factors.
A cloned Xenopus laevis histone gene cluster (gift of R. W. 
Old) was manipulated so that expression of H2A and H2B genes 
(since these genes occur as a divergently expressed pair, and 
in chicken the octamer motif regulates the expression of both 
genes. See section 1.1.2) could be distinguished from the 
expression of endogenous genes when introduced into oocytes 
by microinjection, or into cell lines by transfection. 
However, expression of the genes could not be detected in 
Xenopus laevis cells transfected using the standard methods 
used to transfect mammalian cells. I suspect that this was 
due to inefficient transfection, rather than that the histone 
gene cluster was not expressed when inside the cell. A role 
for the octamer motif in the regulation of Xenopus H2B genes 
has not been demonstrated, and was simply postulated by 
analogy to other systems. A previous study on the promoter 
sequences required for the expression of Xenopus laevis 
histone genes in microinjected oocytes made a deletion series 
through the the H2B promoter (Heindl e£ a_L (1988)), and since 
the CCAAT box was removed prior to the octamer, and this
Results and Discussion
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caused basal levels of expression to be observed, the 
presence or absence of a role for the octamer motif could not 
be demonstrated.
15.1 Preparation of a H2A-H2B expression construct.
I was provided with a Xi. laevis histone gene cluster 
(Xlhw23), which consisted of a truncated H2B gene, and 
complete H2A, H3 and HA genes, in the vector pBR325. This 
clone, pRW23, was a gift of R. W. Old. A restriction map and 
the nucleotide sequences of the coding regions, and of the 
H2A-H2B intergenic region were available (R. W. Old, pers 
comm., and Aldridge (1986)). The H2A and H2B genes occur as a 
divergently expressed gene pair, and the octamer motif is the 
7/8 octamer (GTTTGCAT) which is the most common octamer seen 
in Xenopus laevis H2B boxes (see figure 33). This octamer 
binds well to Oct-R in vitro, but does not detectably bind 
Oct-1 (see section 14.1). The H2A-H2B intergenic region is 
shown in figure 34A, and a map of Xlhw23 in figure 34B.
The first step in making an expression construct 
(illustrated in figure 34B) was to insert an internal control 
reference gene into pRW23. This is the 'albone' gene, which 
consists of the 5' end of a Xenopus laevis albumin gene (670 
bases of the 5' flanking sequence and 50 bases downstream of 
the transcription initiation site) fused to the 3' end of a 
Xenopus laevis histone H3 gene (370 bases consisting of a 
little of the 3' end of the gene and some 3' flanking 
sequence). This fusion gene was made in our lab, and is
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X1HW23 H2A-H2B intergenic region and structure of
pH2A/B.exp.
(A) X1HW23 H2A-H2B intergenic region (Aldridge (1986)). 
Position of the H2B box with core octamer is shown. 
Position of predicted CAP, TATA and CCAAT sites is also 
shown.
(B) Diagram to illustrate the modification of pRW23 to 
create pH2A/B.exp. The 'albone' reference gene was 
inserted into the Hind III site of pBR325, and the 
duplex oligonucleotide shown into the Sst I site of the 
H 2A gene. The location of primers used- Tor primer 
extension analysis of transcripts from the construct are 
indicated. The H2A primer is an 18mer, and albone and 
H 2B primers are 17mers.
0
GTA ITTCAACAAGACTCAGlATTCITrOQCIAIACACTGIAOCCAAACTGTQQOGCTGATCCTnTTAIAGTC
CTACTGCAAAGACTACGTCAAAGCAGAAGCAIACGOGATAITATCCAAlCAACOCAAAGATTAGCCTrGT
GATATITrQJTlU ITltXr IVriAATACACGTCTGGCTATGGCTGCTTGAAACrCACXXAATCAGCGAACA
CcXat
E
H2A prim ar
ACAGACCGAAGCTTAGCT 
TCGATGTCTGGCTTCGAA OLIGO INSERT
CTCGAG
Stt I
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described in Old e_t al^ (1988). The source of the gene was a 
Hind III fragment from albone A-670 (gift of A. R. Brooks) 
(Old et al (1988)). The Hind III fragment was inserted into 
the unique Hind III site of pRW23. The gene has been shown to 
express on injection into oocytes, and transcripts can be 
detected by primer extension using the albone primer, which 
extends over the junction of the 2 components of the fusion 
gene.
It was intended to assay H2A and H2B transcription by primer 
extension analysis of RNA from injected oocytes. The H2B gene 
is truncated, and consequently a primer homologous to the 
pBR325 sequence (H2B primer, see figure 34B) can be used to 
distinguish transcripts of introduced genes from those of 
endogenous genes. However, to distinguish transcripts of the 
introduced H2A gene from those of endogenous genes, it was 
necessary to insert a duplex oligonucleotide into the H2A 
gene of pRW23. The oligonucleotide (illustrated in figure 
34B) consists of Sst I sticky ends (but on insertion into a 
Sst I site, sites are not reformed, as the base adjacent to 
the sticky end is not that found in an Sst I site) and an 
off-centre Hind III site. Two Sst I sites occur in 
(pRW23+albone), one in the H2A gene and one in the H3 gene. A 
(pRW23+albone) partial Sst I digest was carried out, and a 
fragment corresponding to the linear clone (ie. only one 
Sst I site cut) was isolated. The duplex oligonucleotide was 
ligated into this fragment. Recombinants were identified by 
the loss of one Sst I site, and the position of the oligo
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insert was determined by the size of a fragment released by 
Hind III digestion (the oligo contains a Hind III site).
Hind III digestion releases the albone gene and a fragment 
from the oligo insert to the Hind III site of pBR325. If the 
oligo insert is in the H3 gene an approximately 1.7kb 
fragment is released, whereas if the insert is in the H2A 
gene a fragment of approximately 4.6kb is released. 
Orientation of the oligo insert in the H2A gene was 
determined by labelling the products of a Hind III - Sau 3A 
double digest by end filling, and visualising them by 
autoradiography after resolution on a denaturing 
polyacrylamide gel. A Sau 3A site occurs approximately 50 
bases from the Sst I site in the H2A gene. Since the position 
of the Hind III site in the oligo is off-centre, a Hind III - 
Sau 3A digest will yield a fragment of 52 or 60 bases, 
depending on the orientation of the oligo insert. One strand 
of the duplex oligonucleotide (depending on the orientation 
of the oligo insert) was used as a primer for primer 
extension analysis (H2A primer). This construct was called 
pH2A/B.exp. The predicted sizes of primer extension products 
(using the predicted CAP sites shown in figure 34A) are 
approximately 240 bases for the H2B gene, and 195 bases for 
the H2A gene. The ' albone ’ gene gives a product of around 50 
bases. Consequently it should be possible to analyse 
transcription of all 3 genes in a single reaction.
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15.2 Expression of pH2A/B.exp can be detected In 
microinjected oocytes.
pH2A/B.exp was microinjected Into the nuclei of Xenopus 
laevls oocytes, and the Injected oocytes maintained 
overnight. RNA was made from surviving oocytes and transcript 
levels from introduced 'albone', H2A and H2B genes was 
assayed by primer extension analysis. The result is shown in 
figure 35. The reference gene gives the previously reported 
product, and H2A and H2B genes products are in the predicted 
size range. It is not apparent here, but the H2B often gives 
two transcripts (around 239 and 243 bases) indicating that 
two transcription initiation sites are used. As a control, 
the primers detect no transcripts in un-injected oocytes. 
Mixture of all 3 primers shows that expression of all 3 genes 
can be monitored in a single reaction. Expression of this 
clone, as already mentioned, could not be detected in Xenopus 
laevis Xtc cells transfected using standard methods used for 
mammalian cells (data not shown).
15.3 An attempt to modulate pH2A/B.exp expression by 
competition with oct factor binding sites.
The band shift probes described in chapter 18 (see figure 
28F) provide a set of binding sites which (1) bind only Oct-1 
strongly (k.oct probe), (2) bind only Oct-R strongly (H2B 
probe), (3) bind Oct-1 and Oct-R (oct probe), (4) bind 
neither Oct-1 or Oct-R strongly ( k .H2B and mut probes). 
Consequently, these oligos were co-injected in molar excess
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pH2A/B.exp is expressed in micro-injected oocytes.
Approximately lOnl of pH2A/B.exp (0.5 mg/ml) was injected 
into the nucleus of laevis oocytes. Oocytes were 
maintained overnight, and RNA prepared from surviving 
oocytes. RNA from the equivalent of 4 oocytes was hybridised 
with 200pg of end-labelled oligonucleotide primer. 
Hybridisation to RNA from un-injected oocytes is included as 
a control. After hybridisation, primer extension with 
reverse transcriptase was carried out, and the products 
resolved on an 8% denaturing polyacrylamide gel. An 
autoradiograph of the gel is shown. H2A, H2B and albone 
primers (see figure 34) were used where indicated. The 
primer extension products from transcripts of the H2A, H2B 
and 'albone' genes are indicated. Size markers are pBR322 
digested with Hpa II and labelled by end-filling.

Figure 36.
Effect of competition with Oct factor binding sites on 
pH2A/B.exp expression in oocytes.
Approximately lOnl of pH2A/B.exp (lrag/ml) was mixed with an 
equal volume of concatemerised oligonucleotide (lmg/ml) or 
water (- track) and injected into the nuclei of oocytes. 
Primer extension analysis was performed as described in 
figure 35. A mixture of H2A, H2B and albone primers was 
used. Position of primer extension products from transcripts 
of H2A, H2B and 'albone' genes are indicated.
Oligonucleotide sequences are given in figure 28F, and the 
numbers refer to mixing of pH2A/B.exp with the following 
oligonucleotides :
1. non-specific oligonucleotide used in band shift assays.
2. Oct oligo band shift probe.
3. H2B oligo band shift probe.
4. K.oct oligo band shift probe.
5. K.H2B oligo band shift probe.
6. Mut oligo band shift probe.
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with pH2A/B.exp in an attempt to modulate H2A/H2B expression 
by competing for Oct-l/Oct-R binding. If competition were 
seen it would indicate the relative contribution of 
Oct-l/Oct-R to transcriptional activation of the H2A/B genes 
contained in this construct. The oligonucleotides were 
concatemerised to Increase their stability in oocytes. The 
non-specific duplex oligonucleotide used in band shift assays 
was included as a control competitor. After Injection 
transcript levels were monitored by primer extension. The 
result is shown in figure 36. The result of this experiment 
cannot be interpreted since all the oligonucleotides caused a 
large non-specific reduction in transcription of all 3 genes, 
including the reference gene.
15.4 Making a mutation in the octamer motif associated with 
the H2B gene of pH2A/B.exp.
Following the lack of success with oligonucleotide 
competition it was decided to try and demonstrate a role for 
the octamer motif in the control of H2A/H2B expression by 
introducing a mutation into the octamer motif. The mutation 
made (illustrated in figure 37A) converts the 7/8 octamer 
motif of Xlhw23 to the sequence of the mut band shift probe 
(see chapter 14) which shows much reduced Oct-R binding 
activity.
The Eco RI fragment, containing the histone gene cluster, 
from pH2A/B.exp was subcloned into Ml3mpl8, and 
oligonucleotide mutagenesis used to convert the octamer in
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Figure 37.
Mutagenesis of the octamer motif associated with the H2B
gene of pH2A/B.exp.
(A) The Eco RI insert from pH2A/B.exp was subcloned into 
M13mpl8, and the oligonucleotide indicated used to 
introduce a double point mutation into the H2B box of 
the H2B gene.
(B) Screening of potential H2B octamer mutants, lul and 5ul 
of M l 3 phage stock from 6 potential mutants and from the 
original non-mutant subclone was spotted onto duplicate 
nitrocellulose filters, denatured, baked and the nucleic 
acids on the filters hybridised to end-labelled 
mutagenic oligonucleotide in 6x SSC at room temperature. 
One filter was washed at 37°C (Tm-17) and one filter at 
5A°C (Tm-2) in 6x SSC.
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the H2B promoter (GTTTGCAT) to GGTTGAAT. Potential mutants 
were screened by hybridisation of single stranded phage stock 
to end labelled mutagenic oligonucleotide. The melting point 
(Tm) of the perfectly matched mutant duplex was calculated to 
be 5A°C. Six potential mutants were screened, along with the 
original non-mutant clone as control. The result is shown in 
figure 37B. All clones hybridised to probe after washing at 
37°C. All putative mutants hybridised to probe after washing 
at Tm-2 (52°C), but the non-mutant control did not hybridise 
at this temperature. Consequently the frequency of mutants 
obtained was 100%. One mutant was selected, and checked by 
sequencing. The Eco RI fragment from the mutant clone was 
inserted back into the parent vector to create 
pH2A/B.exp-mut.
15.5 Effect of the octamer mutation on H2A/B expression.
The wild-type and mutant octamer-contalning constructs were 
microinjected into the nuclei of oocytes, and levels of H2A, 
H2B and albone gene expression determined by primer extension 
analysis of RNA. The result is shown in figure 38A. Laser 
scanning densitometry of the autoradiograph indicates that 
(relative to the 'albone' reference gene, expression of which 
is a roughly twice as great in oocytes injected with 
H2A/B.exp-mut) H2A expression is reduced to AOX of that seen 
with the wild-type octamer, and H2B expression to 60X by 
mutation of the octamer motif. This effect is small, but 
reproducible. A repeat of this experiment is shown in figure
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A comparison of pH2A/B.exp and pH2A/B.exp-mut expression in
o ocytes.
(A) Approximately lOnl of pH2A/B.exp (0.5mg/ml) or 
pH2A/B.exp-mut (0.5mg/ml) was injected into the nuclei 
of oocytes. Primer extension analysis was performed as 
described in figure 35. A mixture of H2A, H2B and albone 
primers was used. Position of primer extension products 
from H2A, H2B and albone primers are indicated.
(B) A repeat of the experiment described in (A).
Figure 38.
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38B. The result Is roughly the same, except that H2B 
expression was lowered to 40% and H2A expression to 50% by 
the mutation. The effect is not in line with the 5 fold 
difference in expression reported with wild-type and mutant 
human promoter constructs transfected into somatic cells (see 
section 1.1.2). However, if significant this is the first 
reported demonstration that the octamer motif is required for 
the transcription of Xenopus H2B genes. Also, the result is 
in line with that observed for chicken H2A-H2B divergent gene 
pairs (see section 1.1.2), since the octamer motif seems to 
be required for the expression of both H2B and H2A genes.
The result is also suggestive of a role for Oct-R in the 
transcriptional regulation of H2A/H2B genes, since iri vitro 
Oct-1 from oocyte extract does not detectably bind this 
promoter, whereas Oct-R binds strongly, and the mutation made 
causes a large reduction in Oct-R binding.
The fact that only a small reduction in expression, as a 
result of the mutation, was observed could be a consequence 
of several factors. For example, the mut oligo (which has the 
same sequence as the mutant described here) shows low, but 
readily detectable, Oct-R binding activity in band shift 
assays (see chapter 14) and this may be significant. Also, a 
problem which arises with all oocyte injection experiments is 
that there may be insufficient binding factor to saturate 
injected genes, and so the majority of expression detected is 
basal level expression which would not be affected by 
promoter mutations.
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This experiment Is not definitive, and should be extended 
further. For example a mutation in the octamer which has a 
greater effect on Oct-R binding would be useful, as would a 
mutation which converts the octamer to an Oct-1 binding site.
It should be borne in mind that the oocyte is a special case 
of histone gene regulation. In Xenopus. (unlike, for example, 
sea urchin where developmental stage specific histone genes 
occur), the same histone genes are expressed in the oocyte 
independently of DNA synthesis, and in somatic cells tightly 
coupled to DNA synthesis (Old e£ al^ (1985), Woodland e£ al^  
(1984), Perry et al (1986)). Unfortunately the effect of the 
octamer motif mutation could not be tested in somatic cells 
following transfection. However, by analogy to mammalian H2B 
genes it seems likely that the octamer motif is also required 
for H2A/H2B expression in somatic cells. Oct-1 and Oct-R 
binding activities do not vary through the cell cycle, and 
consequently there must be a cell-cycle regulated 
modification/interaction with another factor in somatic cells 
(see sections 1.2.4 and 14.6). Perhaps this
modification/interaction is constitutive in oocytes to allow 
replication independent expression of H2A/H2B genes to be 
stimulated by octamer binding factors.
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Chapter 16.
The anti Oct-1 polyclonal antiserum detects proteins other 
than Oct-1 on Western blots.
16.1 The anti Oct-1 antiserum specifically detects two 
proteins In ovary protein extract.
The anti Oct-1 antiserum, the preparation of which Is 
described In chapter 11, was used to stain Western blots of 
ovary protein extract. The antiserum was raised against a 
fusion protein, produced in E_j_ coll, which spans amino acids 
16 to 231 at the N terminal end of Xl-Oct-IA. As described in 
chapters 13 and 14 the antiserum reacts with both X^ _ laevis 
and mouse Oct-1 in band shift assays. For use in staining 
Western blots, the antiserum was purified by affinity for the 
fusion protein electrophoretically transferred to a 
nitrocellulose filter. Antibodies bound to Western blots were 
detected by binding a biotinylated anti rabbit 
immunoglobulin, then binding streptavidin alkaline 
phosphatase conjugate, and then colour development with the 
substrates BCIP and NBT.
Figure 39A shows Western blots of oocyte protein extract 
stained with whole anti Oct-1 antiserum and purified anti 
Oct-1 antiserum, and as controls anti Oct-1 pre-immune serum 
and anti laevis thyroid hormone receptor (Gift of 
R. W. Old). The anti Oct-1 antisera (whole and purified) 
detect three protein bands: 130kD, 95kD and 85kD (the 95kD 
band is faint, but its presence is clearer on subsequent 
blots). The control antisera detect the highest molecular
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Figure 39.
Anti Oct-1 antiserum specifically detects two proteins in
oocyte extract.
(A) Extract equivalent to 1 oocyte was electrophoresed in A 
tracks of a 10X separating SDS polyacrylamide gel. The 
proteins were electrophoretically transferred to a 
nitrocellulose filter. The filter was cut into strips, 
and each of the A strips incubated with the antiserum 
indicated (1 in 100 dilution, in TBS). Bound antibodies 
were detected with an Amersham blotting detection kit 
(biotinylated anti rabbit immunoglobulin, followed by 
streptavidin alkaline phosphatase conjugate, followed by 
colour development with the substrates BCIP and NBT).
The position and molecular weight of protein markers is 
shown. Pre-stained molecular weight markers were used, 
and as these do not run true to their molecular weight 
they were used as positional markers (the molecular 
weight to which the bands correspond being determined by 
running adjacent to regular molecular weight markers on 
a Coomassie stained gel (not shown)). Two protein bands 
are detected as a result of specific interaction of with 
the anti Oct-1 antiserum (these bands are not detected 
by pre-immune serum and anti thyroid hormone (THR) 
antiserum), and also one protein band as a result of 
non-specific interaction (detected by all A antisera). 
The position of these bands is indicated.
(B) Extract equivalent to 1 oocyte was electrophoresed and 
electroblotted as described above. The filter was 
stained with a 1 in 100 dilution of anti human Oct-1 
antiserum, and bound antibodies detected as described 
above. The human Oct-1 antiserum detects the same non­
specific and specific bands as the X. laevis anti Oct-1 
antiserum. The location of these bancis is indicated.
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weight band (130kD), and so this band is disregarded as being 
the result of a non-specific interaction. The smaller bands 
are not detected by the control antisera, and are as a result 
of specific interaction of proteins with the anti Oct-1 
antiserum. Detection of protein bands by whole and affinity 
purified anti Oct-1 antiserum was similar, however, purified 
antiserum was routinely used for staining Western blots.
Figure 39B shows a Western blot of X^_ laevis oocyte protein 
extract, stained with anti human Oct-1 polyclonal antiserum 
(Gift of W. Herr, see Sturm ejt al (1988A)). This antiserum 
detects the two specific protein bands, and is consequently 
further evidence that a specific interaction is being 
detected.
The size of the two specific protein bands detected is 85kD 
and 95kd. This is larger than the predicted size of the 
Xl-Oct-IA product (79kd) and the size of the product of 
Xl-Oct-IA synthetic message expressed in oocytes (which is 
the predicted size, see chapter 9). Consequently, it seems 
possible that the antiserum is not detecting Oct-1, but 
antigenically related proteins, although the difference from 
the predicted size could be due to some modification.
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16.2 Oct-1 and the proteins to which the anti Oct-1 antiserum 
reacts on a Western blot can be separated on a sucrose 
gradient.
Protein extract from the equivalent of 100 oocytes was 
loaded onto an 11ml 30% (w/v) to 10% sucrose gradient, and 
the gradient centrifuged at 37000rpm and 4°C for 45 hours.
The gradient was fractionated into 20x 0.5ml fractions. Every 
other fraction was assayed for 0ct-l (and Oct-R) binding 
activity by band shift assays, and proteins in each fraction 
were resolved by SDS-PAGE, electroblotted to nitrocellulose 
and stained with anti 0ct-l antiserum. The results are shown 
in figure 40.
The Western blot was from a shorter gel run, and the two 
specific bands are not resolved. The specific protein bands 
are very faintly detected by the anti 0ct-l antiserum in 
fraction 13, and then detected in each fraction to the bottom 
of the gradient (fraction 1). The proteins peak in fractions 
5 to 7. The band shift assay Indicates that 0ct-l (and Oct-R) 
binding activity peaks in fraction 13. Consequently, the 
gradient separates 0ct-l binding activity and the proteins 
which are specifically detected by the anti 0ct-l antiserum 
on a Western blot. The antiserum does react to Oct-l in band 
shift assays, but this result tends to suggest that the 
antibody is reacting to proteins other than 0ct-l on a 
Western blot. The size of the proteins detected also 
indicated this, and as will be described later the proteins 
detected by the antiserum and 0ct-l have distinct
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Figure AO.
The proteins to which the anti Oct-1 antiserum reacts and
Oct-1 can be separated on a sucrose gradient.
(A) Protein extract from the equivalent of 100 oocytes was 
fractionated on an 11ml 10 to 30% (w/v) sucrose gradient 
by centrifugation at 4°C and 37000rpm for 45 hours. The 
gradient was split into 20x 0.5ml fractions. 20ul of 
each fraction was resolved by SDS-PAGE, electroblotted 
to nitrocellulose and stained with affinity purified 
anti Oct-1 antiserum as described in figure 39. The 
position of protein bands detected as a result of 
specific interaction of the antiserum are indicated (two 
specific bands are present, but not resolved on this 
short gel run).
(B) Band shift assays with the oct probe (see figure 29F). 
5ul of the sucrose gradient fraction indicated was used 
in each assay. The positions of 0ct-l, Oct-R and 
non-specific (NS) complexes and free probe (F) are 
indicated. 0ct-l and Oct-R binding activity peak in 
fraction 13.
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distributions in the oocyte. The apparent lack of detection 
on a Western blot is probably result of Oct-1 being of too 
low abundance. The proteins detected by the Oct-1 antiserum 
on a Western blot, are antigenically related to the N 
terminal end of Oct-1. The N terminal domain of human Oct-1 
is interchangeable with the N terminal domain of Oct-2, and 
deletion analysis of Oct-2 indicates that the N terminal Q 
rich region is a transcriptional activation domain (see 
section 1.3.4). Proteins related to the N terminal activation 
domain of Oct-1/Oct-2 may occur may occur in X^ _ laevis 
oocytes.
16.3 Distribution of Oct-1 related proteins in oogenesis and 
early development.
Protein extract from stages of oogenesis and early 
development were resolved by SDS-PAGE, electroblotted to a 
nitrocellulose filter and stained with an anti Oct-1 
antiserum. The result is shown in figure 41. The equivalent 
of one oocyte/egg/embryo was analysed in each case. Protein 
extract from the cell line, Xtc, was also included.
The Oct-1 related proteins are first detected in stage II 
oocytes (early vitellogenesis), and reach peak levels in 
stage III oocytes (pigment formation apparent, but no 
animal-vegetal division). The level of the Oct-1 related 
proteins is constant throughout early development, from 
mature oocyte to the latest stage tested, stage 32. The Oct-1 
related proteins are synthesised during oogenesis, and stored
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Figure 41.
Distribution of Oct-1 related proteins in oogenesis and
early development.
(A) Extract from the equivalent of one oocyte was resolved 
by SDS-PAGE, electroblotted to a nitrocellulose filter 
and stained with affinity purified anti Oct-1 antiserum 
as described in figure 39. The position of Oct-1 related 
protein bands (as a result of specific interaction with 
the antiserum) is indicated. Protein extract from 
oocytes of the stage (Dumont (1972)) indicated was 
analysed.
(B) Extract from the equivalent of one mature oocyte, one 
egg, one embryo of the stage indicated (Nieuwkoop and 
Faber (1956)), and from the cell line Xtc was resolved 
and stained with antiserum as described above. The 
position of Oct-1 related protein bands (as a result of 
specific interaction with the antiserum) is indicated.
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In the oocyte, the amount stored being equivalent to at least 
the roughly 100 000 cells present in a stage 32 embryo (David 
(1965)). As described in chapter 14, certain proteins, which 
are required in large amount during early development, are 
synthesised during oogenesis are stored to provide sufficient 
protein for the extremely rapid early development phase. The 
proteins are also detected in the Xtc cell line.
16.4 Location of the 0ct-l related proteins in the cell.
Protein extract from the equivalent of one whole oocyte, one 
oocyte cytoplasm (manually enucleated oocyte) and one oocyte 
nucleus was resolved by SDS-PAGE, electroblotted to a 
nitrocellulose filter and stained with anti Oct-1 antiserum. 
The result is shown in figure 42A. The 0ct-l related proteins 
are located entirely in the oocyte cytoplasm (no protein is 
detected in the oocyte nuclear extract, and the amount of 
protein present in one cytoplasm is equivalent to the amount 
of protein present in one whole oocyte). Since only 25% of 
Oct-1 is located in the oocyte cytoplasm (see chapter 14) 
this is further evidence that the antiserum is reacting to 
proteins other than 0ct-l on Western blots.
Protein extract was prepared from whole Xtc cells, and the 
nuclei of Xtc cells. To confirm that the nuclear preparation 
contained nuclei, and no cytoplasm, nucleic acid was prepared 
from the nuclear and whole cell Xtc extract. The nucleic 
acids were electrophoresed on an ethidium-stained agarose 
gel. The result is shown in figure 42B. The whole cell Xtc
-184-
Figure 42.
Location of Oct-1 related proteins in the cell.
(A) Extract from the equivalent of one whole oocyte (W), one 
oocyte cytoplasm (enucleated oocyte, C) and one oocyte 
nucleus (N) was resolved by SDS-PAGE, electroblotted to 
a nitrocellulose filter and stained with affinity 
purified anti Oct-1 antiserum as described in figure 39. 
The position of Oct-1 related protein bands (as a result 
of specific interaction with the antiserum) is 
indicated.
(B) Nucleic acid prepared from whole cell Xtc extract (W) 
and nuclear extract (N) was electrophoresed on a IX non­
denaturing agarose gel, stained with ethidium bromide. 
This was to check the nuclear preparation. Chromosomal 
DNA (nuclear) and ribosomal RNA (cytoplasmic) bands are 
indicated. This demonstrates that the nuclear 
preparation contains nuclear components, and no 
cytoplasm.
(C) Nuclear (N) and whole cell (W) Xtc cell extract was 
resolved and stained with antiserum as described in (A). 
The position of Oct-1 related protein bands (as a result 
of specific Interaction with the antiserum) is 
indicated.
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extract contains chromosomal DNA (nuclear) and ribosomal RNA 
(cytoplasmic), whereas the nuclear extract contains only 
chromosomal DNA. Nuclear and whole cell Xtc extract, from the 
equivalent of 200 000 cells, was resolved by SDS-PAGE, 
electroblotted to a nitrocellulose filter and stained with 
anti 0ct-l antiserum. The result is shown in figure A2C. The 
Oct-1 related proteins are entirely nuclear in Xtc cells.
In summary, proteins antigenically related to the N terminal 
(transcriptional activation) domain of 0ct-l are synthesised 
during oogenesis, stored in the oocyte cytoplasm (the amount 
equivalent to at least 100 000 somatic cells), and in somatic 
cells are located entirely in the nucleus.
There are other examples of proteins being stored in the 
oocyte cytoplasm, and subsequently becoming translocated to 
the nucleus of somatic cells. For example, the X^ laevis 
c-myc protein is accumulated during oogenesis (an amount 
equivalent to that found in A00 000 somatic cells), and 
stored in the oocyte cytoplasm (Gusse e£ al (1989)). After 
fertilisation the store rapidly migrates to the nucleus.
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Chapter 17.
General discussion and conclusions.
I have isolated and completely sequenced two X_;_ laevis 
homologues of the human octamer-binding transcription factor, 
Oct-1. The degree of relatedness of the two homologues (93% 
similar in nucleotide and predicted amino acid sequence) 
indicates that these are likely to be copies of the same 
gene, which arose during the theoretical genome duplication 
event in X^ laevis evolution. X^ laevis and human Oct-1 
display strong evolutionary conservation (85% similar in 
predicted amino sequence over a stretch of 750 amino acids), 
which presumably means that the X^_ laevis homologue has a 
similar, if not identical function to human Oct-1. Homology 
between human and X^_ laevis does, however, break down shortly 
before the N terminal end, at a point where alternate 
splicing is known to occur in human Oct-1 (W. Herr, pers. 
comm.). The full length X_;_ laevis cDNA clone which I have 
isolated may represent a novel alternately spliced form of 
Oct-1.
The X^_ laevis Oct-1 clone which contains a complete coding 
sequence (Xl-Oct-IA) has been shown by expression of of 
synthetic transcripts in micro-injected oocytes to contain an 
open reading frame of the size predicted from the nucleotide 
sequence. This clone has also been demonstrated to encode a 
functional octamer-binding protein (which requires no other 
factors to bind DNA) by use of Oct-1 fusion proteins 
(expressed in coli) in band shift assays. The observation
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that shortened an full length octamer-binding fusion proteins 
when mixed do not form a band corresponding to a heterodimer 
in band shift assays indicates that Oct-1 binds as a monomer.
Two octamer-binding proteins have been identified (in band 
shift assays) in X^ laevis oocyte, embryo and tissue extract. 
A polyclonal antiserum raised against laevis Oct-1, and 
comparison to the mobility of full length Oct-1 fusion 
proteins in band shift assays have been used to identify one 
of these proteins as Oct-1. The second, previously 
unidentified octamer-binding protein has been termed Oct-R, 
for octamer-related. Oct-1 and Oct-R have different binding 
affinities. Oct-R binds to the consensus octamer motif 
(ATTTGCAT) and a degenerate octamer motif (GTTTGCAT), which 
is the most common octamer motif found in X^_ laevis histone 
H2B gene promoters, only in the context of the H2B promoter, 
and not in another sequence context. Oct-1 does not bind the 
degenerate octamer motif in either context, but does bind to 
the consensus octamer motif in either sequence context. The 
binding properties of Oct-R are suggestive of a role in the 
regulation of histone H2B transcription (although no direct 
evidence has been obtained), and consistent with this 
possibility is the fact that Oct-R has a widespread tissue 
distribution.
Two lines of evidence suggest that the Oct-R POU domain (if, 
in fact, Oct-R binds to DNA via a POU domain) may be somewhat 
diverged from the Oct-1 POU domain. Firstly, an antibody 
raised against a full-length human Oct-1 fusion protein
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(which reacts to Oct-2, presumably via the conserved POU 
domain) does not react to Oct-R. Secondly, the laevis POU 
domain used to probe a genomic Southern blot gives a similar 
hybridisation pattern (at low stringency) to a probe from 
Oct-1 outside the P OU domain. Which indicates that sequences 
similar to the Oct-1 POU domain do not occur in the X^ laevis 
genome.
Since Oct-1 is believed to stimulate the S-phase specific 
induction of histone H2B gene transcription (see section 
1.1.2), the possibility that Oct-1 binding activity is cell- 
cycle regulated is o f  interest. In mammals it is not clear if 
Oct-1 binding activity is cell-cycle regulated. laevis 
Oct-1 (and Oct-R) binding activity does not appear to be 
cell-cycle regulated.
Oct-1 and Oct-R are stored in the oocyte, in an amount 
equivalent to at least 80 000 somatic cells. Histone protein 
and message are stored in the oocyte as part of the mechanism 
to provide enough histones to keep-up with the high rate of 
DNA synthesis in ea r l y  Xenopus development. It is possible 
that histone gene transcription factors are stored for the 
same purpose. Part o f  the Oct-1 and Oct-R store is located in 
the cytoplasm of the oocyte.
Oct-R cannot be detected in mouse L cells. I have compared 
X. laevis. chicken, human and mouse H2B boxes. The core 
octamer motif is strongly conserved between species, however 
the sequences flanking the octamer motif are more strongly 
conserved between genes within a particular species, than
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between species. Oct-R, although binding is octamer- 
dependent, would perhaps be better described as an H2B box 
binding protein. Mammals may have an 'Oct-R' with affinity 
for a species-specific H2B box. Such a probe has not been 
used to detect mammalian b i nding proteins.
By mutation of the octamer m o t i f  in the promoter of a 
X. laevis histone H2B gene promoter I have tentatively 
concluded that the octamer m o t i f  is required for the 
expression of H2B genes (independently of DNA synthesis) in 
the oocyte. The H2B gene occurs, as part of a divergently 
expressed gene pair, with a H 2 A  gene. The octamer motif may 
be required for the expression of both H2B and H2A genes. The 
degenerate octamer motif contained in this H2B promoter does 
not bind efficiently to Oct-1 in vitro, but binds well to 
Oct-R. Consequently, this indirectly suggests that Oct-R is 
required for the expression o f  the H2B gene.
A polyclonal antiserum raised against the N terminal domain 
of 2L. laevis Oct-1 reacts to proteins other than Oct-1 on 
Western blots of oocyte and embryo extract. These proteins, 
which are antigenically related to the N terminal domain of 
Oct-1, are entirely located i n  the cytoplasm of the oocyte, 
and entirely located in the nucleus of somatic cells. These 
proteins are synthesised d u ring oogenesis, and stored in the 
oocyte in an amount equivalent to at least 100 000 somatic 
cells.
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